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There is considerable evidence to suggest that male fertility is decreasing 
worldwide, and it is thought that lifestyle and environmental factors could 
play a role. Lifestyle and environmental information was collected from men 
attending a fertility clinic by questionnaire and correlated with sperm 
parameters and the outcomes of assisted reproductive techniques (ART). 
Global and gene-specific DNA methylation in these men was measured by 
bisulphite pyrosequencing and compared with questionnaire results. Finally, 
an in vitro glycation assay was developed to investigate the effects of 
advanced glycation end products (AGEs) on sperm: AGE formation, 
oxidative DNA damage and reactive oxygen species (ROS) production were 
then measured using flow cytometry and immunocytochemical methods. 
BMI was the main determining factor for sperm quality and ART outcomes in 
this study: high BMI was associated with lower sperm concentration and 
lower fertilisation rates in in vitro cytoplasmic sperm injection (ICSI) patients. 
Surprisingly, having an unhealthy diet was positively associated with 
progressive sperm motility. DNA methylation analysis revealed that exposure 
to glues, adhesives and resins was associated with higher global DNA 
methylation. A major marker of low sperm concentration was promoter 
hypermethylation of the spermatogenesis-associated gene, DAZL. 
Furthermore, global DNA methylation and MEG3 methylation were higher in 
men with greater numbers of immotile sperm and those with low sperm 
motility, respectively. Overall, elevated DNA methylation was found to be the 
main feature of poor sperm quality, however prepared sperm showed higher 
methylation than whole sperm from neat semen. This large study indicates 
that DNA methylation is likely to be linked to sperm function, although the 
role of lifestyle-acquired epimutations in this may be minor. 
Treatment of sperm with glyoxal in vitro caused rapid formation of the major 
AGE-adduct, CML. This occurred alongside an increase in oxidative DNA 
damage but did not affect sperm hyaluronidase activity. This study shows 
that one of the mechanisms of AGE-related DNA damage is due to oxidative 





1.1 The male gamete 
1.1.1 Sperm cell structure and function 
The sperm cell is the physiological carrier of the haploid paternal 
deoxyribonucleic acid (DNA) to the oocyte containing the haploid maternal 
DNA whereupon fertilisation occurs and the fusion of the parental genomes 
gives rise to a developing embryo. The sperm cell is a highly specialised 
motile cell, containing features that enable optimal transit from the male 
reproductive tract, through the female reproductive tract and to the oocyte 
with the paternal genome protected throughout.  
The sperm cell is 60-70 µm in length and made up of three major sections: 
the head, the midpiece and the tail (fig. 1.1) (Jones & Lopez, 2013). The 
sperm head contains the nucleus which carries the tightly compacted DNA 
and, unlike somatic cells, contains very little cytoplasm. At the anterior 
position of the head is the acrosome, a specialised secretory vesicle that 
contains digestive enzymes exocytosed upon sperm-egg binding during the 
acrosome reaction to break down the structural components of the zona 
pellucida surrounding the oocyte (Harper et al., 2008). The midpiece section 
contains large numbers of mitochondria which generate adenosine 
triphosphate (ATP) by oxidative phosphorylation to drive tail movement. The 
motile tail contains a central axoneme surrounded by two central singlet 
microtubules and nine doublet microtubules and flagellar movement is 
caused by the sliding of microtubule doublets past each other by ATP-driven 
dynein motor proteins  (Alberts, Johnson, Lewis, Raff, Roberts, & Walter, 
2002). The sperm centriole, located in the sperm neck at the anterior 





The journey of a sperm cell begins in the testis, specifically within the 
nbvseminiferous tubules where sperm stem cells, known as spermatogonia, 
give rise to mature sperm. Spermatogonia are diploid (2n) and divide 
mitotically to maintain the pool of sperm stem cells. To generate mature 
sperm, a spermatogonium first divides meiotically to produce primary and 
then secondary haploid spermatocytes (n). Secondary spermatocytes then 
undergo a second meiotic division to produce four haploid cells, called 
spermatids. Spermatids finally differentiate into mature sperm by 
spermiogenesis, through which spermatids become elongated, the acrosome 
forms and the nucleus condenses (Zhang et al., 2014; Jones and Lopez, 
2013). These events take place adjacent to supporting Sertoli cells which 
release mature sperm into the lumen of the seminiferous tubules. The time 
frame for the development of mature sperm from spermatogonia is around 
Figure 1.1 Structure of the sperm cell 
Morphology of the sperm cell as visualised with a light microscope 
following staining (A) and a schematic diagram of cellular 




74 days and as this is a continual process, at any given time, cells at all 
stages are present in the seminiferous epithelium. 
1.1.3 Sperm chromatin packaging 
During spermatogenesis, sperm DNA undergoes structural and chemical 
reorganisation in order to form a condensed nucleus in which the DNA is 
protected during transit to the oocyte, is transcriptionally inactive and which 
has a reduced volume to aid motility. Unlike in somatic cells in which DNA-
bound histones arrange into larger nucleosomes, the major DNA-binding 
protein in sperm is the protamine (Braun, 2001). During spermatogenesis, 
histone proteins are replaced firstly by intermediary transition proteins, then 
by protamines 1 and 2 which allows packaging of the DNA into a volume less 
than 5% of a somatic cell nucleus (Miller et al., 2010)+. The importance of 
this process is illustrated by the fact that improper histone replacement 
causes infertility in mice has also been linked to infertility in men (Cho et al., 
2001; Zhang et al., 2006). Other post-translational modifications of histones 
occur to achieve a compact chromatin state including controlled region-
specific acetylation, phosphorylation and methylation (Govin et al., 2007; 
Meyer-Ficca et al., 2005; Godmann et al., 2007).  
1.1.4 Capacitation, the acrosome reaction and fertilisation 
After ejaculation and following deposition in the female reproductive tract 
sperm undergo a number of physiological changes to acquire their fertilising 
capacity. Capacitation is the process in which the sperm cell becomes 
hypermotile to enable rapid directional swimming towards the oocyte and 
undergoes membrane changes that prime the cell for zona pellucida binding 
and the acrosome reaction. This occurs in the female genital tract. 
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The molecular changes to the cell include increased membrane fluidity which 
is achieved by modifying the cholesterol content of the membrane and 
increased permeability to Ca2+ ions; these changes are necessary for full 
capacitation and to prepare sperm for Ca2+signalling which leads to 
acrosomal exocytosis (Morales et al., 2012; O’Toole et al., 2000). Reactive 
oxygen species (ROS) production, protein tyrosine phosphorylation and actin 
polymerisation are other important processes in capacitation (review in 
Figure 1.2 Fertilisation 
Membrane-bound hyaluronidase degrades HA in the ECM following initial attachment 
to the cumulus layer (1 and 2). Soluble hyaluronidase is released during the acrosome 
reaction (3) to degrade HA at the ZP (4), allowing fertilisation (4). 
Adapted from (Salustri & Fulop, 1998) 
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Aitken and Nixon, 2013; Flesch et al., 2001; Lopez-Gonzalez et al., 2014; 
Itach et al., 2012). These changes are essential as only capacitated sperm 
can fertilise an oocyte (Quill et al., 2003). 
Prior to reaching the ZP, sperm must penetrate the surrounding cumulus 
layer. This layer contains a large number of loosely packed cumulus cells 
embedded in a dense extracellular matrix (ECM) of hyaluronic acid (HA) 
oligosaccharide chains. The sperm hyaluronidase Sperm Adhesion Molecule 
1 (SPAM1/PH-20) is a membrane glycosyl phosphatidylinositol-(GPI)-linked 
enzyme that is responsible for the initial degradation of HA in the cumulus 
ECM at a neutral pH (Lin et al., 1994) (fig 2.2). Sperm hypermotility, 
activated during capacitation, facilitates forceful burrowing through the 
cumulus layer where sperm then can bind to the ZP. The ZP is an ECM 
made up of three glycoproteins: ZP1, ZP2 and ZP3, to which as yet 
unclassified receptors on the sperm membrane bind (reviewed in Chiu et al., 
2014a). This binding triggers the acrosome reaction in sperm, in which the 
membrane of the acrosomal vesicle fuses with the sperm plasma membrane 
and its contents is exocytosed. The enzymes released allow degradation of 
the ZP and include a soluble form of SPAM1 with acidic pH, which allows 
further cleavage of HA in the ZP (Reese et al., 2010) (fig. 2.2).  
The paternal DNA is deposited into the ovum upon fusion of the sperm and 
ovum plasma membranes whereupon the paternal DNA is decondensed and 
the paternal and maternal pronuclei merge and the zygote is formed. 
1.1.5 Reactive oxygen species and oxidative stress 
Reactive oxygen species (ROS) such as the superoxide anion (.O2-), 
hydroxyl radicals (.OH) and hydrogen peroxide (H2O2) are produced during 
normal aerobic metabolism in all cells including sperm. ROS are essential for 
normal sperm function, including for capacitation, hyperactive motility, and 
sperm maturation (de Lamirande and Gagnon, 1993; Gil-Guzman et al., 
2001). Despite the beneficial actions of ROS, their levels must be controlled 
to prevent toxicity, particularly against free radicals which are highly reactive 
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due to their unpaired electrons which allow them to oxidise lipids, amino 
acids and carbohydrates. Sperm are protected from the effects of these free 
radicals by the action of radical scavenging enzymes present in sperm and in 
seminal plasma. These enzymes include superoxide dismutase, catalase 
and glutathione peroxidase, which provide antioxidant protection to the 
sperm (Zini et al., 2002; Giannattasio et al., 2002; Lewis et al., 1995; 
Noblanc et al., 2011). However, when ROS levels exceed the cell’s 
antioxidant capacity, oxidative stress occurs, to which sperm are particular 
susceptible due to the high levels of polyunsaturated fatty acids in the 
plasma membrane (reviewed in Aitken, Jones and Robertson, 2012). One of 
the most damaging consequences of oxidative stress is that is causes DNA 
damage, and this has been identified as a characteristic of sperm from 
infertile men (Mahfouz et al., 2010; Agarwal et al., 2006). Furthermore, DNA 
damage in the male germ line has been linked to adverse outcomes of 
assisted reproductive techniques (ART), particularly in patients undergoing in 
vitro cytoplasmic injection (ICSI) (Simon et al., 2013; Loft et al., 2003; Zini et 
al., 2011), therefore this is a critical risk factor for disrupted development. 
Animal studies have shown that exposure to compounds that induce 
oxidative stress can cause miscarriage or morbidity in the offspring.  
1.2 Male factor infertility 
The global prevalence of infertility is reported to be approximately 15% with 
males accounting for 20-30% of infertile cases (European Society of Human 
Reproduction and Embryology, 2014). Causative factors of male factor 
infertility (MFI) impair sperm function and integrity, affecting sperm motility, 
morphology and vitality (Guzick et al., 2001) and a number of studies have 
reported decreasing male fertility in recent years (Carlsen et al., 1992; Auger 
et al., 1995; Rolland et al., 2013; Romero-Otero et al., 2015; Centola et al., 
2016). Male factor infertility can be acquired, as in testicular injury, sexually 
transmitted disease and cancer (Rowe, 2000); or it can arise from congenital 
problems, including endocrinopathies such as androgen insensitivity 
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syndrome (Pitteloud and Dwyer, 2014), developmental disorders such as 
cryptorchidism (Lee et al., 1997), and chromosomal abnormalities such as 
Klinefelter syndrome or Y chromosome microdelections (Stouffs et al., 2014). 
Sperm production and quality can also be influenced by aspects of lifestyle, 
such as diet and exercise, and environmental exposures to toxicants, or 
other xenobiotics (reviewed by Sharpe, 2010). As the most common type of 
male infertility is idiopathic – exhibiting one or more abnormal semen 
parameters with no identifiable cause (Baker, 1994) – there is increasing 
interest in the impact of these latter factors, and the epigenetic mechanisms 
underlying them. The changes to semen parameters associated with MFI 
include reduced concentration (oligozoospermia) or a complete absence of 
sperm (azoospermia), poor sperm motility (asthenozoospermia), abnormal 
sperm morphology, or significantly reduced seminal volume. The World 
Health Organisation (WHO) has classified threshold values of semen 
parameters for male infertility and these are as follows: sperm concentration, 
15x106/ml; total motility, 40%; progressive motility, <32%, total sperm count, 
39x106; morphology, 4% normal forms; and semen volume, <1.5 ml (Cooper 
et al., 2010). 
1.2.1 Assisted reproductive technologies 
As the levels of infertility have risen, so has the use of ART due to the 
increased availability of treatment in most countries (Inhorn and Patrizio, 
2015). The number of children born through ART now stands at over 5 
million (European Society of Human Reproduction and Embryology, 2014), 
which highlights the importance of this as a standardised therapy for 
infertility. Upon consultation at a fertility clinic, semen parameters are 
analysed to determine if the patient has MFI according to the criteria 
described above. In cases where these parameters are normal, in vitro 
fertilisation (IVF) is usually carried out, in which sperm and egg are incubated 
together and sperm must bind and penetrate the ZP and fuse with the egg 
plasma membrane as described earlier. IVF treatment is mostly used for 
female factor infertility. For cases with MFI, the primary treatment is ICSI 
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whereupon a single sperm is selected by an observer and injected directly 
into the oocyte. In this scenario, sperm bypass the normal cellular and 
molecular barriers to fertilisation and the paternal DNA is delivered directly. 
ICSI is in fact the primary technology used, comprising approximately two 
thirds of all fertility treatments worldwide (European Society of Human 
Reproduction and Embryology, 2014). 
1.2.2 Lifestyle and environmental factors associated with MFI 
The increase in prevalence of MFI is thought to be linked to several 
environmental and lifestyle factors which are affecting sperm parameters. A 
major concern is that many of the damaging consequences of these lifestyle 
factors may manifest at the molecular and DNA level, in which case they will 
not be identified by standard semen analysis upon consultation for ART.  
1.2.2.1 Obesity 
Overweight and obesity are the most important predictors of diabetes, and 
the current obesity epidemic is due to a combination of genetic, epigenetic 
and environmental factors including diet and sedentary lifestyles (Hu et al., 
2001; Chen et al., 2012; Locke et al., 2015). The rapid rise in obesity has 
occurred alongside the reported decreases in semen quality and many 
studies have investigated the effects of this on MFI. A 2010 meta-analysis by 
McDonald et al. involving 31 studies found no evidence of an association 
between body mass index (BMI) and sperm concentration or total sperm 
count, although there were differences in testosterone and sex-hormone 
binding globulin. However, more recent studies have suggested that there is 
a role for obesity in reducing sperm quality (Sermondade et al., 2013; 
Eisenberg et al., 2014). Furthermore, obesity is associated with a longer time 
to pregnancy in the general population (Ramlau-Hansen et al., 2007a). The 
deregulation of male reproductive hormones is one of the main hypotheses 
behind reproductive dysfunction in obese men. Al-Ali et al. (2014) found that 
BMI was not related to sperm quality, based on concentration, motility and 
morphology, but they did find significant changes in male hormone levels, 
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luteinising hormone (LH) and testosterone. In males, oestrogens exert a 
negative feedback effect on the hypothalamic-pituitary-gonadal (HPG) 
system causing a decrease in the production of gonadotrophins (LH and 
follicle stimulating hormone (FSH)) and there is a strong hypothesis that 
obesity deregulates this HPG axis. Furthermore, although there may not be 
changes in standard semen parameters, numerous studies have shown 
increases in DNA damage in the sperm of obese men attending fertility 
clinics (Chavarro et al., 2010; Dupont et al., 2013), although a recent study of 
1503 men from the general population found no association between sperm 
DNA damage and BMI (Bandel et al., 2015). Nevertheless, this DNA damage 
is thought to be driven by obesity-induced ROS production leading to 
oxidative stress (Tunc et al., 2011) and as ROS levels are already a marker 
for infertility, the effects of obesity on sperm may be more pronounced in 
men with existing fertility problems.  
1.2.2.2 Smoking 
Tobacco smoke is known to be hugely detrimental to many aspects of health 
and yet smoking prevalence remains staggeringly high with no clear sign of 
reducing (Ng, et al., 2014). Many publications have reported adverse effects 
of smoking on sperm parameters (Künzle et al., 2003; Zhang et al., 2013; 
Hamad et al., 2014), which is thought to occur in a dose-dependent manner 
(Ramlau-Hansen et al., 2007b) and to improve upon smoking cessation 
(Santos et al., 2011). Similarly to the effects of obesity, smoking has been 
shown to be associated with altered reproductive hormone levels through 
altering the HPG axis (Jeng et al., 2014; Ramlau-Hansen et al., 2007b), 
which could be a source of deregulated spermatogenesis leading to poorer 
sperm quality. However, hormone levels were not found to be different in the 
sperm of fertile smokers (Pasqualotto et al., 2006). Alternatively, or in 
conjunction with this effect, the generation of oxidative stress through 
smoking could be a source of damage to sperm (Saleh et al., 2002). As 
smoking has been linked to abnormal histone to protamine transition (Hamad 
et al., 2014), this disrupted chromatin state could lead to a vulnerability of 
sperm DNA to oxidative stress. Furthermore, smoking has been found to be 
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associated with aberrant sperm parameters in fertile men, highlighting the 
wide-ranging effect of this habit (Vine, 1996). Higher levels of sperm DNA 
damage could explain the poorer pregnancy outcomes that have been 
associated with paternal smoking (Joesbury et al., 1998; Venners, 2004), 
however the evidence for this is limited as smokers are excluded from having 
ART treatment and therefore data on this is not available. 
1.2.2.3 Environmental toxicants 
The damaging health implications of environmental toxicants are well 
documented and there is increasing concern over whether chemical 
exposure in industrialised countries, which is becoming more common, is 
affecting male reproductive function. Cross-sectional studies on chemical 
exposure have been the main source of information on the impacts on 
sperm. For example, Rubes et al. (2005) found an increase in sperm DNA 
fragmentation in men with higher exposure to air pollution, and importantly 
this occurred without a change in standard semen parameters. Furthermore, 
a study of men exposed to traffic pollutants through working at motorway 
tollgates found a decrease in total motility and forward progression in their 
sperm (De Rosa et al., 2003). As air quality standards in urban environments 
remain low (World Health Organisation, 2014), there is cause for concern for 
male reproductive health. 
Endocrine disrupting chemicals (EDCs) are chemicals which disrupt normal 
endocrine function by mimicking hormones or antagonising receptors, and 
have been implicated in abnormal reproductive development (Chevalier et 
al., 2015). Studies where physiological concentrations of EDCs have been 
measured in study participants provide more conclusive results than 
correlative studies. Phthalates are one such example of EDC which are used 
in the manufacturing of numerous everyday products such as food 
packaging, shampoos and soaps, which confer flexible binding properties 
and have been highlighted as a concern for health.  Phthalate concentration 
in urine has been associated with lower sperm concentration and sperm 
motility (Duty et al., 2003; Jurewicz et al., 2013), and a more thorough study 
12 
 
which investigated urinary phthalate levels on repeated occasions found 
higher levels of DNA damage and apoptosis in sperm with increasing 
exposure (Wang et al., 2015). Bisphenol A (BPA) is another high volume 
EDC used in plastics manufacturing and has been found to be elevated in 
the urine of exposed factory workers and this correlated with decreased 
semen quality and increased DNA damage (Meeker et al., 2010). Pesticides 
are also considered to be a widespread source of EDCs. A recent study 
measured pesticide levels in the urine of men attending a fertility clinic to 
which sperm concentration and motility were negatively correlated 
(Melgarejo et al., 2015), and in accordance with this the consumption of 
pesticide residues on fruit and vegetables has also been negatively 
correlated with sperm count and the number of morphologically normal forms 
(Chiu et al., 2015). Considering that EDCs have also been linked to birth 
defects and aberrant long term health and reproductive outcomes in children 
of exposed parents (Kristensen et al., 1997; Wohlfahrt-Veje et al., 2011; 
Anderson et al., 2006), it is important to determine whether the use of ART 
increases the likelihood of the transmission of these developmental faults. 
1.2.2.4 Diet 
Three studies arising from the Rochester Young Men’s Study found that 
certain dietary factors affect sperm quality. Firstly, dairy food intake was 
negatively correlated with sperm morphology (Afeiche et al., 2013). 
Secondly, men with a “prudent” dietary pattern consisting of high intake of 
legumes, fish, chicken, fruit, wholegrains and vegetables had higher % 
progressively motile sperm (Gaskins et al., 2012). Finally, consumption of 
sugar-sweetened beverages (SSB) was negatively correlated with % 
progressively motile sperm (Chiu et al., 2014b). Critically, the reference 
population used for these studies was young healthy men (aged 18-22 
years). This is important as it shows that dietary factors have an impact on 
men from the general population, in contrast to studies which recruit their 
study participants from fertility clinics. 
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1.2.2.5 Physical activity and sedentarism 
The number of hours of physical activity that men participated in per week 
was directly correlated with sperm concentration and sperm count, while 
sedentary behaviour measured as hours of TV watched per week was 
negatively correlated with these outcomes (Gaskins et al., 2015). Using taxi-
drivers as a proxy for sedentary behaviour due to the long number of hours 
spent driving showed that these men had a lower % morphologically normal 
sperm forms, although exposure to pollutants could have been a 
confounding factor, as a result of the effects described above. Conversely, 
there is evidence that high strenuous physical activity can be damaging for 
reproductive function such as in the case of professional cyclists 
(Gebreegziabher et al., 2004), and as was shown in an intervention study in 
which men who carried out intense treadmill running had decreased male 
reproductive hormone levels and lower sperm quality compared to a 
moderate exercise group (Safarinejad et al., 2009). However, considering the 
overall widespread health benefits of exercise, it is important to highlight that 
in general being physically active is more beneficial for semen quality and 
reproductive function than being physically inactive (Vaamonde et al., 2012).  
1.3 Sperm epigenetics 
Gene expression through the integration of transcription factors and 
modulators result in the synthesis of the messenger (m) RNA transcript from 
the DNA template. mRNA is then translated to the peptide sequence forming 
a vast variety of proteins for cellular structure and function. This canonical 
regulative control of gene transcription has been challenged by the emerging 




Epigenetics refers to the heritable changes in gene function by mechanisms 
other than changes in the underlying DNA sequence (Russo et al., 1996). In 
contrast to traditional genetics in which mutation causes direct modification 
to the genetic sequence, epigenetics involves a complex set of regulatory 
machinery that function from the DNA to chromatin levels to influence gene 
expression, without affecting the fundamental nucleotide sequence itself 
(Jaenisch and Bird, 2003). Epigenetic control can therefore modify a 
phenotypic outcome without affecting the genotype. This process is the 
fundamental driving force of variation in cell type and function in cells during 
differentiation from zygote to multicellular organism. Historically, this was 
illustrated in Conrad Waddington’s discovery of cell-fate determination by 
epigenetics (Waddington, 1957), which revealed the importance of 
Figure 1.3 DNA methylation 
The principle epigenetic modification of DNA in the mammalian genome is 
methylation of cytosine nucleotides. Methylation occurs mainly on the 5th 
carbon of the cytosine base, forming 5-methylcytosine (5-mC). DNA 
methylation is catalyzed by a family of enzymes called DNA 
methyltransferases and include DNMT1, DNMT3a and DNMT3b (box). 
Methylation mainly occurs around CpG clusters (CpG islands) at gene 
promoter regions and is associated with gene silencing. 
Adapted from Nevin and Carroll, 2015 
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epigenetics in development. The molecular systems known to initiate and 
maintain the epigenome are DNA methylation and chromatin modifications, 
including histone methylation and acetylation (Murgatroyd and Spengler, 
2011). There is a critical cross-talk between this epigenetic machinery which 
ensures correct gene expression and silencing in response to environmental 
cues (Mutskov et al., 2002; Curradi et al., 2002). 
1.3.1 DNA Methylation  
DNA methylation is the most well-studied epigenetic mechanism in mammals 
(Jones and Takai, 2001). It is a major regulator of gene expression and cell 
differentiation (Li, Bestor and Jaenisch, 1992), and therefore the capacity for 
DNA methylation marks to be stably maintained (i.e. somatically inherited) 
through cell division is the fundamental principle behind differentiation and 
the processes in which cells are able to interact with the environment.  DNA 
methylation occurs on the 5’ position of cytosine bases on eukaryotic DNA. 
Cytosines targeted for methylation usually occur in CpG dinucleotides, where 
a cytosine precedes a guanine nucleotide, although cytosine methylation can 
also occur at CpA, CpT and CpC sites (Maunakea et al., 2010). CpG sites 
are mostly located close together in clusters known as CpG islands (CGIs), 
and are commonly found in the 5’ promoter region of genes or in gene 
bodies (Lander, Linton and Birren et al., 2001; Maunakea et al., 2010).   
The process of DNA methylation is driven by the action of the DNA 
methyltransferases (DNMTs) DNMT1, DNMT3a and DNMT3b which convert 
cytosine to 5-methylcytosine (5mC) using the universal methyl donor S-
adenosylmethionine (SAM) (Okano et al., 1999) (fig. 1.3 box). DNMT1 is the 
“maintenance” methyltransferase as its primary role is to copy methylation 
patterns onto newly replicated DNA, while DNMT3a and DNMT3b are 
responsible for de novo methylation of DNA (Kaneda et al., 2004a). These 
enzymes are essential for viability as gene knockouts experiments in mice 
have shown embryonic and postnatal lethality (Li, Bestor and Jaenisch, 
1992; Okano et al., 1999). 
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CpG methylation at promoters or regulatory regions is typically associated 
with gene repression while lack of methylation promotes transcriptional 
activity (Siegfried et al., 1999; Polansky et al., 2008). Transcriptional 
repression is caused either through the direct blocking of transcription factor 
binding to DNA, or through the attraction of methyl-CpG-binding protein 
which recognise methylated sites and subsequently recruit co-repressors 
(Watt and Molloy, 1988; Nan et al., 1998; Boyes and Bird, 1991) (fig. 1.3). 
DNA methylation has a number of crucial roles in embryonic development 
and differentiation (Okano et al., 1999), X-chromosome inactivation (Kaneda 
et al., 2004b), suppression of transposable element activity (Nagamori et al., 
2015) and genomic imprinting (Kaneda et al., 2004b). 
1.3.2 Epigenetic reprogramming and imprinted genes  
Epigenetic processes in the gametes of mammals are different to those in 
somatic cells. During development, DNA undergoes two rounds of epigenetic 
reprogramming (fig. 1.4). The first is shortly after fertilisation, where the 
paternal DNA is stripped of the parental methylation signature. This global 
demethylation occurs in sperm and oocyte DNA (Guo et al., 2014; Oswald et 
al., 2000; Santos and Dean, 2004) and permits the totipotent zygote to 




Figure 1.4 Epigenetic reprogramming 
The paternal DNA (green) is rapidly demethylated following fertilisation while maternal DNA methylation (red) is 
maintained until the 2-cell stage when it is passively removed. Primordial germ cells undergo rapid global demethylation 
after their migration into the gonadal ridge to remove parental imprints and allow establishment of gender-specific imprints.  





These processes allow the developing zygote to initiate de novo methylation 
in cells of the inner cell mass (Santos et al., 2002) to regulate the expression 
of genes important in the differentiation pathways leading to the 
specialisation of cell types.  
Despite this global demethylation, some genes are excluded and retain the 
methylation marks of the parental genome. These genes are known as 
imprinted genes, and are critical for embryonic development during the early 
rounds of transcription in the embryo. Imprinted genes show mono-allelic 
parent-of-origin expression: they are only expressed from one parental allele 
(Court et al., 2014). The importance of this imprinting was illustrated in early 
pro-nuclei transfer experiments carried out by McGrath and Solter (1984). 
They found that when two haploid male pronuclei or two haploid female 
pronuclei were combined, although each genome was contributing half of the 
genetic information, there were sex-specific epigenetic marks corresponding 
to paternal or maternal DNA that were critical for embryonic development. 
Imprinted genes escape demethylation so that correct gene expression can 
be initiated in the developing embryo, hence why their mutation results in 
severe developmental imprinting disorders (Reik and Walter, 2001; Soejima 
and Higashimoto, 2013).  
These imprints continue to persist in somatic cells after fertilisation, however 
developing germ cells must undergo a second round of reprogramming to 
allow the establishment of new imprinting regions (Reik and Walter, 2001; 
Kaneda et al., 2004b). PGCs have already acquired regional DNA 
methylation on their migration to the gonadal ridge (precursor to the gonads), 
similar to somatic cells (Maatouk et al., 2006), and demethylation therefore 
allows establishment of mature germ cell gender-specific genetic imprints 
(Hajkova et al., 2002). The establishment of male imprints are complete in 
prospermatogonia by the newborn stage and global methylation of repeat 
sequences are highly methylated by the fetal prospermatogonia stage 





Imprinted genes are controlled by differentially methylated regions (DMRs) at 
CpG sites or CpG islands within or close to the gene itself (Neumann et al., 
1995). If a gene is paternally imprinted, its DMR is heavily methylated in 
sperm while unmethylated in oocytes, whilst a maternally imprinted gene is 
unmethylated in sperm but methylated in oocytes. Maternally and paternally 
imprinted genes usually exist in clusters where their expression is controlled 
by DNA methylation at cis-regulatory sites known as imprinting control 
regions (ICR). The methylation state of the ICR determines the methylation 
status of the genes in the cluster either over short- or long-range (Lin et al., 
2003).  
Figure 1.5 Methylation at the IGF2-H19 imprinting control region (ICR) 
Imprinted genes exhibit parent of origin gene expression. This is achieved 
through methylation-dependent gene silencing at imprinting control regions 
(ICR). On the maternal allele at the IGF2-H19 locus the ICR is not 
methylated, allowing CTCF binding which silences IGF2 gene transcription 
through downstream enhancer activity. Maternally unmethylated H19 
promoter (white lollipops) allows H19 transcription. On the paternal allele, 
CpG sites are methylated (black lollipops) on the ICR and in the H19 
promoter region. This prevents CTCF binding, which allows enhancers to 
activate IGF2 while silencing H19. 





One of the best characterised ICRs is at chromosome 11q15 which contains 
the insulin-like growth factor 2 (IGF2) and the downstream non-coding RNA 
gene, H19, which are expressed from the paternal and maternal 
chromosomes, respectively. Their expression is controlled by an enhancer 
downstream of H19, which is in turn controlled by methylation at an ICR 
located between the two genes (Hark et al., 2000) (fig. 1.5). The ICR 
contains a number of binding sites for the transcriptional repressor, zinc 
finger CCCTC-binding factor (CTCF), which in the absence of methylation 
can bind to the ICR and activate the downstream enhancer. This in turn 
activates H19 transcription while IGF2 is silenced. When the ICR is 
methylated, as it is in sperm, CTCF cannot bind and the downstream 
enhancers are free to activate IGF2 expression while H19 becomes silenced 
(Kerjean et al., 2000). Beckwith-Weidemann syndrome is an imprinting 
disorder which arises from the loss of imprinting at the IGF2-H19 locus. 
When uniparental disomy occurs, both alleles are inherited from one parent. 
In the case of Beckwith-Weidemann syndrome, both alleles come from the 
father and none from the mother (Henry et al., 1991). This results in 
hyperactivation of IGF2 as the ICR is methylated on both alleles. As IGF2 is 
a growth promoter, the disease is characterised by serious foetal and 
neonatal overgrowth as well as a predisposition to tumour growth (Morison 
and Reeve, 1998).  
Another example of an important ICR is located at chromosome 14q32 at the 
intergenic (IG) region between the paternally expressed (i.e. maternally 
imprinted) delta-like 1 homolog (DLK1) gene and the maternally expressed 
gene 3 (MEG3) (i.e. paternally imprinted) (Kagami et al., 2010). This region 
bares similarities with the IGF2-H19 locus as it contains a CTCF binding 
region (Wylie et al., 2000). The IG-DMR is methylated on the paternal 
chromosome and unmethylated on the maternal chromosome, and 
inheritance of the paternal allele as a result of maternal deletion results in 
complete silencing of MEG3 and overexpression of DLK1 resulting in a lethal 
phenotype (Lin et al., 2003). Numerous other genes are controlled through 
this ICR and loss of imprinting therefore causes severe developmental 





this region is considered to be a possible marker for predisposition to type 1 
diabetes (Wallace et al., 2010). 
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are examples of 
imprinting disorders that occur due to opposing errors on the same locus on 
chromosome 15q11-q13 (Buiting et al., 2003). PWS occurs as a result of a 
deletion of part of the paternal chromosome or as a result of maternal 
uniparental disomy, while AS occurs as a result of maternal chromosome 
deletion. This region contains a number of genes that are maternally 
imprinted and exclusively paternally expressed, including the small nuclear 
ribonucloprotein polypeptide N (SNRPN) gene (Reed and Leff, 1994). 
Therefore, deletions of the paternal allele results in no expression of this 
gene leading to the PWS phenotype. In a small number of cases, PWS and 
AS can arise due to methylation errors, or epimutations, at the imprinted 
genes within this region, instead of causing a change to the DNA sequence. 
These epimutations are likely to arise due to improper reprogramming during 
development (Buiting et al., 2003). 
There are over 100 known imprinted genes in humans (Kelsey and 
Bartolomei, 2012), most of which are involved in foetal, placental and brain 
development, post-natal growth, behaviour and metabolism (Tycko and 
Morison, 2002). Imprinting ensures that a critical balance of gene dosage is 
maintained when parental chromosomes act together and its disruption can 
lead to abnormalities in male fertility as well as the severe developmental 
defects discussed. 
1.3.3 DNA methylation in sperm function and male infertility  
The identification of aberrant methylation in the sperm of infertile men has 
led to speculation that deregulated epigenetic control may be one of the 
causes of infertility. The differentiation of spermatids into mature sperm 
occurs simultaneously with remethylation of the genome following the 
second wave of reprogramming where new imprints are laid down (Kishigami 





point may therefore be a source of abnormal germ cell development, leading 
to MFI. 
Most studies investigating the association between aberrant DNA 
methylation and infertility have focused on candidate imprinted genes 
(Poplinski et al., 2010; Kobayashi et al., 2007; Minor et al., 2011; Ankolkar et 
al., 2013; Boissonnas et al., 2010). This is because imprinted genes in germ 
cells have unique reprogramming events which means they show specific 
methylation signatures, and due to the importance of paternally imprinted 
genes in post-zygotic gene expression (Carrell and Hammoud, 2010).  
Initial epigenetic studies comparing imprinted gene methylation in sperm 
DNA of oligozoospermic men, in comparison with normozoospermic men, 
have tended to show a decrease in methylation of paternally imprinted genes 
such as H19 and an increase in maternally imprinted genes such as 
mesodern-specific transcript (MEST) (Marques et al., 2007). Specifically, 
loss of methylation at the 6th CTCF binding site upstream of H19 has been 
associated with severe sperm defects in morphology, motility and 
concentration (Marques et al., 2007; Boissonnas et al., 2010). Others have 
corroborated this methylation pattern seen in the H19 gene in further studies 
with oligozoospermic men (Poplinski et al., 2010; Kobayashi et al., 2007; 
Montjean et al., 2013). Interestingly, Minor et al. (2011) found that sperm 
retrieved from the testes of men with obstructive azoospermia also 
demonstrated hypomethylation of H19, suggesting that aberrant methylation 
may be a product of the testicular environment and not singularly due to 
spermatogenesis failure. MEG3, also known as GTL2, is highly methylated in 
sperm (Geuns et al., 2007) and has also been shown to be hypomethylated 
in oligozoospermic men compared to normal men, similar to that of H19 
(Kobayashi et al., 2007; El Hajj et al., 2011). 
Maternally imprinted genes which normally show low levels of methylation in 
sperm have exhibited increases in methylation in men with poor sperm 
quality. MEST hypermethylation has repeatedly been linked to low sperm 
count, low progressive sperm motility and poor sperm morphology (Poplinski 





candidate gene for the developmental disorder Silver-Russel Syndrome 
(SRS) and interestingly, in leukocyte DNA from a patient with SRS, Kagami 
(2007) found hypermethylation at CpG sites in the MEST gene occurred at a 
number of the same sites in the paternal DNA, suggesting improper 
reprogramming in the offspring and a heritability of some paternal 
methylation marks. Similarly, the SNRPN gene was found to be 
hypermethylated in oligozoospermic patients as well as patients with 
abnormal protamine ratios (Hammoud et al., 2010), However SNPRN 
hypomethylation has been associated with infertility elsewhere (El Hajj et al., 
2011). Increased methylation of pleiomorphic adenoma gene like 1 
(PLAGL1), also maternally imprinted, has been associated with poor sperm 
quality (Houshdaran et al., 2007), and proper methylation of this gene is 
critical for prenatal and post-natal growth in healthy infants (Azzi et al., 
2014). 
Studies mostly focus on a particular set of genes and gene-regulatory 
regions to determine how lifestyle and environment affect methylation, as 
these are the sites which are most likely to affect their associated gene’s 
expression. However, investigating global DNA methylation has been 
important for determining genome-wide changes to DNA including at 
intergenic regions and at repetitive elements (Maunakea et al., 2010). The 
short-interspersed element, ALU, and the long interspersed element 1 (LINE-
1) are examples of repeat elements which are used as markers for global 
methylation (Chalitagorn et al., 2004; Yang et al., 2004). They comprise 10% 
and 17% of the human genome, respectively and therefore largely represent 
epigenetic changes at multiple loci (International Human Genome 
Sequencing Consortium, 2004). These elements have retrotransposon 
activity which means they can replicate and move about the genome if 
uncontrolled, leading to disrupted function of other genes. Therefore they are 
heavily methylated to prevent this activity (Yoder et al., 1997). LINE-1 and 
ALU methylation has been used as a marker for global methylation in sperm, 
and ALU hypomethylation has been linked to poorer sperm quality and 
negative ART outcomes (El Hajj et al., 2011); this may be therefore be more 





determination of global methylation is the use of enzyme-linked 
immunosorbent assays (ELISA) to measure 5-methyl-cytosine (5MedCyd) 
concentration. As with the repeat elements, 5MedCyd concentration has also 
been found to be positively correlated with sperm parameters (Montjean et 
al., 2014). However, not all studies have reported significant differences in 
global methylation between fertile and infertile men (Kobayashi et al., 2007; 
Ankolkar et al., 2013; Boissonnas et al., 2010).  
Aberrant DNA methylation at imprinted genes has been widely associated 
with sperm abnormalities and infertility, as discussed. However, methylation 
at non-imprinted sites may also be important for expression of the paternal 
genome in the developing embryo. High throughput array technology has 
allowed the exploration of methylation across the whole genome, and has 
resulted in the finding that many non-imprinted genes are also linked to poor 
semen parameters (Houshdaran et al., 2007; Schütte et al., 2013).   
Methylenetetrahydrofolate reductase (MTHFR) is a major regulatory gene in 
folate metabolism, remethylation and DNA synthesis. It is vital for providing 
sufficient methyl groups for DNA synthesis and methylation and is thought to 
have an important role in spermatogenesis due to its association with low 
sperm count and non-obstructive azoospermia (Khazamipour et al., 2009; 
Singh et al., 2005). MTHFR promoter hypermethylation has been strongly 
associated with idiopathic male infertility (Wu et al., 2010), and interestingly, 
this hypermethylation has been shown to occur alongside hypomethylation of 
H19 (Rotondo et al., 2013). Given the role of MTHFR in normal methylation, 
its deregulation could have knock-on effects for other genes. Not only has 
MTHFR hypermethylation been associated with male infertility, but also with 
spontaneous abortion rates (Rotondo et al., 2012), highlighting the potential 
consequences of aberrant methylation.   
Spermatogenesis genes are also susceptible to DNA modifications and can 
be directly linked to male infertility. Deleted in azoospermia-like (DAZL) is a 
key spermatogenesis gene important for primordial germ cell formation, while 
it is also expressed in mature sperm (Kee et al., 2009; Lin et al., 2002). 





the promoter of DAZL are associated with abnormal semen parameters 
(Teng et al., 2012; Navarro-Costa et al., 2010), indicating that this is an 
important gene for male fertility. DAZL has been found to be abundantly 
expressed in the pre-implantation embryo from the 2-cell stage, however this 
is thought to come through maternal genome control, and so the contribution 
of paternal DAZL methylation is yet to be determined (Cauffman et al., 2005).  
As 50% of male infertility cases have an unknown cause, this suggests that it 
is in fact a multifactorial disease. As DNA methylation is an important 
regulator of biological processes, including spermatogenesis, and given the 
examples of aberrant methylation in infertile men, it is likely that this 
epigenetic mechanism plays a part.  
1.3.4 Lifestyle and environmental effects on sperm DNA methylation  
The crucial feature of the epigenome is that it is receptive to the 
environment; this is the fundamental principle behind the cellular response to 
external stimuli. However, it also means that damaging environmental and 
lifestyle factors can negatively influence DNA methylation and consequently 
cause aberrant gene expression, leading to cellular dysfunction and disease 
(Murgatroyd et al., 2010; Jones and Baylin, 2002). Evidence that lifestyle and 
environmental factors can alter sperm DNA methylation suggests that these 
factors may contribute to MFI.  
1.3.4.1 Age  
The effects of paternal age on semen quality and reproductive outcomes 
have been explored for years with variable findings. A 2010 review confirmed 
that there are significant reductions in semen parameters with increasing 
age, and that paternal age is also associated with reduced fertility, 
pregnancy complications, and adverse childhood health outcomes (Sartorius 
and Neischlag, 2010). Global DNA methylation, as well as gene-specific 
methylation, changes across different cell types and tissues with advancing 





study which looked at sperm DNA methylation in the same individuals 10 
years apart: the authors found subsets of genes exhibiting age-related hypo- 
and hypermethylation (Jenkins et al., 2014). As such, it is possible that 
deregulated gene expression through changes in the epigenome could 
contribute to the age-related declines in fertility. Interestingly, Adkins et al. 
(2011) found correlations between methylation at a number of CpG sites in 
newborns and paternal age, indicating that age-induced paternal epigenetic 
modifications may be maintained in the embryo.  
1.3.4.2 Obesity  
There is considerable evidence to show that obese individuals exhibit altered 
DNA methylation at numerous gene promoters and CpG islands in blood 
samples (Ding et al., 2015). Obesity has been found to be associated with 
aberrant sperm methylation in some, but not all, studies (Donkin et al., 2015; 
Hesson et al., 2015). Although the evidence for the effects on sperm DNA 
methylation is inconclusive, imprinted genes have been shown to be 
hypomethylated in the children of obese fathers compared with normal 
weight fathers (Soubry et al., 2013). This suggests that obesity does induce 
some epigenetic changes. Critically, this disruption of DNA methylation 
profiles in newborns can have implications for future health, as illustrated by 
Godfrey et al. (2011) who found that altered methylation in adiposity-related 
genes at birth was related to adolescent obesity. This research suggests that 
there may be a preconceptual influence of paternal health on long-term gene 
regulation in offspring. Interestingly, the changes in DNA methylation as a 
result of obesity could be reversible as one study found positive changes in 
sperm DNA methylation in men on an exercise intervention programme 
(Denham et al., 2015).  
There is considerable interest in whether paternal germline epimutations are 
heritable as this suggests a much more important role for paternal lifestyle 
and environmental exposures than previously thought. One study, which 
investigated DNA methylation in the offspring of obese fathers, found that a 





umbilical cord blood leukocyte DNA of offspring from obese fathers (Soubry 
et al., 2013). Longitudinal health studies have also suggested a role for 
paternal epigenetic inheritance. The pre-pubescent slow growth period 
(SGP) in males coincides with the emergence of the first viable pools of 
spermatocytes where the cells may be particularly vulnerable to epigenetic 
change. A study of a large cohort of Swedish males found increased 
mortality rates of individuals whose grandfathers experienced over-
nourishment during the SGP (Pembrey et al., 2006). Concurrently, 
cardiovascular mortality rates were found to be lower in men whose 
grandfathers experienced a restricted food supply during the SGP, yet when 
food supply was in excess, diabetes mortality in grandchildren was high 
(Kaati, Bygren and Edvinson, 2002). These studies highlight a possibility for 
epigenetic inheritance through multiple generations, and DNA methylation 
could be a mechanism for this.  
Mouse models have been an insightful platform for the study of the 
transgenerational epigenetic effects of nutrition on offspring health and 
disease. Overfeeding and starvation of male mice prior to mating can result 
in metabolic deregulation in their offspring (Jimenez-Chillaron et al., 2009; 
Binder et al., 2012). A recent seminal study that sought to determine whether 
these characteristics are transmitted through the epigenome found that 
induced paternal prediabetes led to altered methylation in the sperm DNA. 
This caused altered gene expression in glucose uptake and metabolism 
genes and insulin signalling genes in the offspring, leading to glucose 
intolerance and insulin resistance (Wei et al., 2014). Furthermore, Fullston et 
al. (2013) found that the effects of paternal obesity could be detected as far 
as the F2 mouse generation and affected sperm mRNA profiles as well as 
DNA methylation. Therefore, paternal environmentally-acquired epigenetic 
changes, such as through obesity, could have serious implications for 





1.3.4.3 Smoking  
Cigarette smoking is considered to be one of the major environmental 
modifiers of CpG methylation (Breitling et al., 2013). Smoking has been 
shown to reduce DNA methylation at multiple loci, and critically, these 
modifications can be partially reversed on smoking cessation (Tsaprouni et 
al., 2014). It is well known that prenatal maternal smoking has serious 
implications for developmental gene expression, and consequently offspring 
health (Markunas et al., 2014; Richmond et al., 2015), however, the role of 
paternal smoking in DNA methylation in offspring is less understood. Xu et 
al. (2013) found significant differences in gene-specific methylation in sperm 
DNA of mice exposed to cigarette smoke, however, in humans paternal 
smoking was not found to be linked to altered H19 or IGF2 DMR methylation 
in umbilical cord DNA of newborn children (Bouwland-Both et al., 2015).   
1.3.4.4 Environmental toxicants  
One of the causes of MFI through environmental exposures is likely to be 
through the hormonal deregulation caused as a result of exposure to EDCs. 
Aberrant DNA methylation of sperm DNA may occur as a result of this 
disruption or through a separate mechanism. LINE-1 hypomethylation has 
been detected in the sperm of men exposed to BPA compared with non-
exposed men (Miao et al., 2014). Mouse studies, again, have shed light on 
the transmission of these epigenetic modifications through the male 
germline: Igf2 DMR methylation was perturbed in the F2 males of pregnant 
mice exposed to BPA resulting in metabolic dysfunction (Susiarjo et al., 
2015). Animals exposed to vinclozolin and dichlorodiphenyltrichloroethane 
(DDT) have also demonstrated generational epigenetic modifications and 
associated diseases (Guerrero-Bosagna et al., 2012; Skinner et al., 2013). 
However, the extent of this epigenetic memory in humans in response to 





1.3.5 Imprinting defects and ART  
With the use of ART treatment increasing (European Society of Human 
Reproduction and Embryology, 2014), there is concern over the use of 
subquality sperm during these procedures, which may harbour DNA damage 
or aberrant DNA methylation marks. There is also concern over the effects of 
ART methods themselves on gamete DNA integrity, as cells are exposed to 
various culture conditions in vitro, alongside female hormonal stimulation and 
cryopreservation of sperm and oocytes.  This concern has arisen due to the 
reported increase in the frequency of imprinting disorders, such as BWS, in 
children born through ART, which are normally extremely rare in the general 
population (Lazaraviciute et al., 2014; Olivennes et al., 2001). Therefore, 
ART may present some risks to gamete DNA integrity. 
Cryopreservation of sperm and oocytes is a routine process in ART 
procedures and has become more popular as couples delay parenting until 
later in life. Studies in mice have linked oocyte vitrification to reduced 
methylation at imprinted genes in blastocysts, and this was attributed to 
reduced DNMT expression (Cheng et al., 2014). This was partially supported 
in a human oocyte cryopreservation study (Petrussa et al., 2014). Human 
sperm cryopreservation, however, has been reported to be completely safe, 
conferring no changes to methylation at imprinted genes, spermatogenesis-
related genes or MTHFR in the sperm DNA (Kläver et al., 2012).  Ovarian 
stimulation has also been linked to altered imprinted gene methylation of 
embryos in some cases, but not in others (Sato et al., 2006; Market-Velker et 
al., 2010; Denomme et al., 2011).  
There are a number of debates ongoing with regards to the impact of 
aberrant sperm methylation on ART outcomes. The first concerns whether 
sperm imprinting defects are associated with poorer ART outcomes 
(Ankolkar et al., 2013; Camprubi et al., 2012). The second is whether 
aberrant methylation marks are inherited and may affect embryonic 
development and offspring health. Kobayashi et al. (2009) found that some 
imprinted gene methylation errors in conceptuses conceived through ART 





Lazaravicuite et al. (2014) found higher rates of imprinting disorders in ART 
compared with non-ART children, they could not identify any significant 
methylation differences at specific imprinted genes between these groups. 
The extent of the contribution of DNA methylation to male infertility and 
germline inheritance is still unclear. However, as the epigenome evidently 
acts as the connection between the environment and gene regulation, 
lifestyle and environmental interventions may play some part in improving 
fertility and preventing offspring disease. 
1.4 Advanced glycation end products and male reproductive 
function 
Advanced glycation end products (AGEs) are a heterogeneous group of 
compounds that form as a result of the reaction between sugars and 
biomolecules, and are the cause of a number of diabetes- and age-related 
diseases where AGE levels are elevated. These diseases include 
cardiovascular disease, diabetic nephropathy, nerve damage, retinopathy 
and atherosclerosis (Hanssen et al., 2015; Forbes and Cooper, 2012; Duran-
Jiminez et al., 2009; Ahmed et al., 1997; Stitt et al., 1997). Ultimately, AGEs 
are thought to be an important contribution to the multisystem functional 
decline in health that occurs with ageing. Obesity, diabetes and ageing have 
been linked to declines in semen quality and fertility (Eisenberg et al., 2014; 
Sartorius and Neischlag, 2010). Despite the prevalence of AGEs in these 
conditions, there is very little research on their effects on reproductive 
function. So far, AGEs have been located in the male reproductive tract, on 
sperm cells and in soluble form in the seminal plasma (Mallidis et al., 2009; 
Karimi et al., 2011). This suggests that they may form modifications on 
functionally important sperm proteins or DNA adducts, or additionally as AGE 
formation is implicated in ROS production, this could be a source of oxidative 





1.4.1 Structure and function of AGE 
AGEs are formed in vivo from the spontaneous non-enzymatic reaction of 
reducing sugars with proteins, lipids and nucleic acids, through the Maillard 
reaction, lipid peroxidation and the polyol pathway (Ott et al., 2014). AGE 
adducts accumulate in the body over time as a normal part of the ageing 
process; however their formation is accelerated under hyperglycaemic 
conditions, insulin resistance, dyslipidemia and due to oxidative stress in 
diabetes (Ulrich and Cerami, 2001; Thomas et al., 2005; Unoki and 
Yamagishi, 2008). AGE compounds are also formed exogenously from the 
cooking of foods at high temperatures and in tobacco smoke (Uribarri et al., 
2010; Cerami et al., 1997), meaning that lifestyle and environment can 
introduce high levels of AGE to the body. Endogenous and exogenous AGE 
interact with the cell membrane receptor for AGE (RAGE), initiating 






1.4.2 Formation and action of AGEs 
Glycation incorporates a chain of reactions known as the Maillard reaction 
which begins with the non-enzymatic reaction of a carbonyl group from a 
reducing sugar, with free amino groups in protein, lipid or nucleic acids 
(Goldin et al., 2006). AGEs form as a normal part of metabolism as glucose 
reacts with biomolecules, and their accumulation in the body is a normal part 
of aging. However, under conditions of hyperglycaemia, hyperlipidaemia and 
Figure 1.6 Glycation of lysine by glucose 
The carbonyl group of glucose reacts with the amine group of a lysine 
residue, forming a reversible Schiff’s base adduct. A number of 
rearrangements occur to form an Amadori product. This then undergoes 
further glycation and oxidation reactions to form Nε-(carboxymethyl)lysine 
(CML). 





under oxidative conditions, AGE formation is accelerated and becomes 
pathogenic (Singh et al., 2001). AGE formation occurs on extracellular and, 
more rapidly, on intracellular proteins (Giardino, Edelstein and Brownlee, 
1994; Thornalley et al., 2003). 
The first stage of the Maillard reaction is the condensation reaction between 
the carbonyl group of a reducing sugar, such as glucose, with the free amino 
group of a protein, initially forming a Schiff’s base which is completely 
reversible. The main residues in proteins targeted for this are arginine and 
lysine. Schiff base levels are maintained at equilibrium with the surrounding 
glucose concentration (Brownlee et al., 1984). Covalent modifications then 
more slowly turn the Schiff’s base into a stable Amadori product (fig. 1.6). 
The most familiar Amadori products are fructosamine and glycated 
haemoglobin (HbA1c) which are used widely as markers for serum glucose 
levels. These products are known as early-glycation adducts and are 
reversible although the rate of formation is faster than the rate of the reverse 
reaction (Brownlee et al., 1984). To form end-stage glycation adducts, or 
AGEs, Amadori products undergo a number of further reactions including 
condensation, fragmentation and rearrangements that reorder their functional 
groups and these may occur under oxidative and non-oxidative conditions 
(Booth et al., 1997). This results in the formation of stable irreversible adduct 
formation on the target molecule. AGEs cause damage by generating ROS, 
fluorescing, forming cross-links and binding to cell surface receptors 
(Thornalley, 1998). One of the major AGE-protein epitopes is N-ε-
carboxymethyl lysine (CML), formed on lysine residues as a result of 
sequential glycation and oxidative reactions of Amadori products (Booth et 
al., 1997) (fig. 1.6). The presence of CML in numerous tissues, including the 
male reproductive tract, suggests it could be involved in several AGE-
associated pathologies. In addition, CML is formed earlier on in the Maillard 
reaction than other non-CML AGEs, making it a useful AGE compound to 
target for short in vitro studies. As the most prevalent biological sugar, 
glucose levels are the major contributor to the Maillard reaction, however 
other reducing sugars such as fructose, ribose  and glucose-6-phosphate 





AGEs can be broadly grouped into three categories: firstly, fluorescent cross-
linking AGE such as pentosidine; secondly, non-fluorescent cross-linking 
AGEs such as imidazolium dilysine cross-links; and finally, non-crosslinking 
AGEs such as pyrraline and CML. 
AGEs can also be generated from through the polyol pathway, also known 
as the sorbitol pathway, which shows prevalent activity in diabetes (Oates et 
al., 2002). This is a two-step enzymatic pathway in which glucose is firstly 
converted to sorbitol by aldose reductase and then oxidised to fructose by 
sorbitol dehydrogenase (fig. 1.7). This reaction is also elevated as a result of 
hyperglycaemia and the enzymes required for the reaction are elevated in 
diabetic tissues (Lorenzi, 2007). The pathway eventually generates AGEs as 
Figure 1.7 Formation of advanced glycation end products 
AGEs form from the non-enzymatic glycation of proteins by glucose 
through the Maillard reaction, or through the enzymatic polyol pathway, or 
through autoxidation of glycose. Reactive AGE intermediates are formed 





fructose is phosphorylated and broken down into 3-deoxyglucosone (3-DG), 
an AGE precursor (Szwergold et al., 1990). 3-DG is a potent AGE-
intermediate that rapidly forms AGE-adducts (Hamanda et al., 1996). 
Furthermore, AGEs can also be generated from the autoxidation of 
monosaccharides including glucose.  
As well as forming Amadori products, a Schiff’s base can also fragment to 
generate reactive AGE intermediates, namely α-oxoaldehydes or α-
dicarbonyls, which are about 20,000 times more reactive than glucose in 
glycation reactions, and these compounds themselves react with proteins, 
lipids and nucleic acids to form AGEs (Thornalley, 1996). These 
Figure 1.8 Formation of AGEs by methylglyoxal and glyoxal 
The dicarbonyl compounds methylglyoxal (MG) and glyoxal (GO) are reactive 
intermediates produced by cell metabolism, glucose autoxidation, and lipid 
peroxidation. 
These highly reactive compounds may react with amino and sulfhydryl groups 
in proteins to form irreversible advanced glycation end products (AGEs). Nε-
(carboxymethyl)lysine (CML) and Nε-(carboxyethyl)lysine (CEL) are the major 






intermediates include methylglyoxal (MG), glyoxal (GO) and 3-DG. MG and 
GO are also formed from the degradation of proteins glycated by glycose 
and from the autoxidation of monosaccharides (Thornalley et al., 1999) (fig. 
1.8). This widespread formation of AGE intermediates means they are 
present in almost all cases where AGEs are present. The rapid glycating 
activity of these intermediates makes them a useful tool for in vitro glycation 
experiments. When these intermediate react with proteins, they can form a 
range of products. MG predominantly reacts with lysine residues to form the 
minor AGE Nε-(1-carboxyethyl)lysine (CEL) (fig. 1.8) and the imidazolium 
crosslink, methylglyoxal-lysine dimer (MOLD) (Al-Abed and Bucala, 1995; 
Ahmed et al., 1997), while its major product is the arginine-derived 
hydroimidazolone Nδ-(5-hydro-5-methyl4-imidazolon-2-yl)-ornithine (MG-H1) 
which accounts for 90% of adducts (Biemel et al., 2002; Ahmed and 
Thornalley, 2005; Dobler et al., 2006). The major AGE products of glyoxal 
are CML (fig. 1.8) and glyoxal-lysine dimer (GOLD) (Odani et al., 1998; 
Glomb and Monnier, 1995). These AGEs are the major biomarkers of the 
Maillard reaction in tissue proteins that accumulate in the body with age and 
in chronic diseases, generating oxidative stress (Ahmed, 1997; Shangari et 
al., 2004).  
Sugars vary in their reactivity in the Maillard reaction, with the rate of AGE 
formation on intracellular proteins being slowest in the presence of glucose 
and more rapid with intracellular natural sugars such as fructose, glucose-3-
phosphate and glucose-6-phosphate (McPherson et al., 1988). The principal 
carbohydrate used as an energy source for glycolysis by spermatozoa is 
fructose, though glucose is thought to also have a role, and both drive 
hyperactivated sperm motility (Mann, 1946; Williams and Ford, 2001). During 
metabolism, these sugars could also potentially be the substrates of 






1.4.3 AGEs in male reproduction 
Studies have reported the effect of diabetes on standard semen parameters 
and pregnancy outcome with conflicting results (Mulholland et al., 2011; La 
Vignera et al., 2012; Agbaje et al., 2007). However, there have been 
consistent reports showing that male diabetics have higher sperm DNA 
damage, higher ROS levels, and lower antioxidant capacity than non-diabetic 
subjects (Agbaje et al., 2007). Karimi et al. (2011) found that expression 
levels of RAGE were higher in sperm samples from diabetic patients and this 
correlated with an increase in sperm DNA fragmentation. It is likely that the 
AGE-mediated damage arises due to oxidative stress. 8-oxoguanine is a 
biomarker for oxidative DNA damage and has also been detected at elevated 
levels in diabetic patients in correlation with DNA fragmentation (Agbaje et 
al., 2008). Sperm DNA damage has previously been associated with lower 
probability of pregnancy and lower implantation rates (Meseguer et al., 
2011). However, the real effects of sperm DNA fragmentation on embryo 
quality and development are inconclusive and require further investigation 
(Zini et al., 2011). 
The principal mode of action of AGE occurs through interaction with the cell 
surface receptor, RAGE. RAGE belongs to the immunoglobulin (Ig) 
superfamily and is a pattern recognition receptor which can bind to numerous 
ligands. The AGE-RAGE pathway has been implicated in a number of 
diabetic complications (reviewed in Yan et al., 2008). It has also been 
implicated in adverse birth weight outcomes   (Chiavaroli et al. 2012). AGE-
RAGE signalling activates pro-inflammatory pathways through the 
transcription factor nuclear factor ĸB (NF-ĸB) (Yan et al., 2008; Bierhaus et 
al., 2001).  Once activated, NF-ĸB binds and activates a number of pro-
inflammatory genes including cytokines and adhesion molecules. NF-ĸB also 
feeds back to trigger expression of more RAGE and the production of ROS 
(Yao and Brownlee, 2010). Therefore, activated cells remain viable while 
also becoming more responsive to AGEs (Bierhaus et al., 2001). RAGE has 
been detected in cells of the testis, epididymis, and on the sperm acrosome 





sperm is in the generation of ROS through activation of NADPH oxidase 
(Wautier et al., 2001), which can be damaging to sperm due to their 
vulnerability to oxidative stress.  
In vitro glycation of proteins with sugars or AGE intermediates has provided 
insight into the exact mechanisms of protein modification in terms of which 
amino acids are targeted and of the functional consequences of glycation. 
For example, MG and GO inhibit the binding capacity of epidermal growth 
factor receptor (EGFR) with EGF in a time and dose-dependent manner in 
cultured cells due to modification of the receptor (Portero-Otin et al., 2002). 
The impact of glycation on the structure and function of platelet-derived 
growth factor receptor and insulin have also been illustrated using MG 
(Cantero et al., 2007; Jia et al., 2006). As AGEs are present on sperm 
(Mallidis et al., 2007), it is likely that glycation of sperm proteins occurs 
during spermatogenesis. If this occurs on functionally important proteins, 
fertilisation capacity could be diminished and could explain the poorer sperm 
quality in diabetics. As described in section 1.1.4, Spam1 is a sperm plasma 
membrane protein with hyaluronidase activity that breaks down HA in the 
ECM of the cumulus layer surrounding the oocyte and the ZP. Izumo1 is 
another sperm membrane protein essential for sperm-egg binding: IZUMO-
null sperm can penetrate the zona pellucida but cannot bind to the egg 
(Inoue et al., 2005; Inoue et al., 2013). Finally, Fertilin beta (ADAM2) is one 
subunit of the Fertilin complex present on the sperm plasma membrane that 
interacts with integrins on the egg surface through its disintegrin domain 
during fertilisation (Chen et al., 1999). These proteins are indispensable for 
successful fertilisation and their exposure to glycating agents during 
spermatogenesis in the testes and in the seminal plasma could contribute to 
their malfunction. 
1.5 Summary 
An extensive amount of research on the causes of idiopathic male infertility 





environmental factors can modify sperm quality at the physiological, 
molecular or genetic level.  
As some studies have found evidence that certain exposures may be 
heritable through the male germline, epigenetic changes have been 
implicated as the primary mechanism. Given the breadth of roles of the 
epigenome, and specifically of DNA methylation, numerous different 
pathways could be leading to sperm dysfunction and to adverse ART 
outcomes. Many studies have focussed on the imprinted genes and on 
global methylation as the source of this dysfunction, while others have found 
that candidate non-imprinted genes associated with infertility are affected by 
lifestyle and environment.  Although controlled mouse studies have 
conclusively shown that lifestyle and environment can affect sperm quality, 
methylation and pregnancy outcomes, further human studies are needed to 
determine which, if any, of these factors are true risks.  
Obesity, diabetes and ageing have been implicated as drivers of male 
infertility, yet very little research has been carried out on the role of AGE 
compounds in disrupting reproductive function. Given that AGEs have a 
primary role in age- and diabetes-related comorbidities, they could present 
an important risk to sperm function. In vitro cellular glycation experiments 
have shed light on the effects of glycation in other cell types, however, none 
so far have done this with sperm. The use of a relatively straight forward in 
vitro glycation assay to highlight the effects of AGEs on sperm could 
stimulate further research into this new field and help to expose additional 
mechanisms behind infertility. 
Overall, in order to successfully tackle the increasing rates of male infertility, 
it is important to identify which lifestyle and environmental factors cause 






The aims of this study were to determine whether lifestyle and environmental 
factors affect sperm quality through the analysis of standard semen 
parameters and of sperm DNA methylation. We then sought to determine 
whether these changes to sperm function or DNA quality could have 
implications for ART outcomes. Using an in vitro assay for glycation as a 
model for ageing and diabetes, we also sought to investigate the action of 
AGEs in sperm and on functionally relevant sperm proteins. 
1.6.1 Objectives: 
1. To develop assays for and use bisulphite pyrosequencing to quantify DNA 
methylation at functionally important DMRs at maternally and paternally 
imprinted genes and at important non-imprinted genes in sperm. To 
determine whether this methylation and global methylation levels in sperm 
are affected by lifestyle and environmental factors, in men attending a fertility 
clinic, and whether these affect ART outcomes. 
2. To determine whether lifestyle and environmental factors are associated 
with aberrant semen parameters and ART outcomes in men attending a 
fertility clinic. 
3. To develop an in vitro glycation assay to investigate the effects of 
glycation on sperm and sperm DNA damage. To determine whether AGE-






Materials and methods 
2.1 Lifestyle, DNA methylation and ART outcomes  
Men undergoing assisted reproductive techniques at the department of 
Reproductive Medicine, Saint Mary’s Hospital, Central Manchester NHS 
Foundation Trust, were recruited for research approved by NRES Committee 
North West-Preston, REC Reference: 12/NW/0482, ERP/91/078 (Altakroni, 
2015) and REC Reference: 14/NS/0082 (appendix 4).  
Upon consultation for treatment, men where asked whether they would like 
to participate in the study by donating the remainder of their sperm sample 
following treatment, and by completing a questionnaire detailing their health, 
lifestyle, environmental exposures and diet (Altakroni, 2015; appendix 1). 
Sperm samples were produced and the questionnaire filled out on the day of 
egg collection. Figure 2.1 shows the number of sperm samples collected with 
corresponding questionnaires that were used for DNA methylation analysis 
and the number of questionnaires that were collected for analysis of lifestyle, 
sperm parameters and ART outcomes only.  
[*The questionnaire was designed by A. Povey and B. Altakroni from the 
Institute of Population Health, University of Manchester (Altakroni, 2015)]. 
2.1.1 Sample collection 
Samples were produced by masturbation after 2-5 days of abstinence as 
recommended by the hospital. Two sperm samples were collected for each 
participant on the day of their treatment in sterile plastic containers: one 
containing neat semen, and the other containing prepared sperm which had 





analysis was carried out by clinical staff for neat and prepared sperm 
according to the WHO references guidelines (WHO 5th edition). Prepared 
sperm was not obtained on all occasions when there was no sample 
remaining after treatment. Sperm was then transferred from the hospital to 
the laboratory for DNA analysis. Whole sperm in neat semen samples was 
separated from seminal plasma by centrifugation at 500 x g for 10 minutes 
and removal of the plasma supernatant, followed by two washes in 1xPBS at 
500 x g for 10 minutes. Prepared sperm samples were washed twice in 
1xPBS as above to remove sperm preparation media. Sperm was counted, 
pelleted and frozen at -80°C until further analysis. Initial samples [91] were 
collected, processed and stored by B. Altakroni. Subsequent samples [31] 
were collected, processed and stored by C. Nevin. 
 
 
Figure 2.1 Outcomes of recruited participants for DNA methylation analysis 





Data on for each participant was collected from the hospital database. Sperm 
parameters data obtained included semen volume, sperm concentration, % 
progressively motile and % immotile sperm. IVF and ICSI outcomes data 
included the number of oocytes used in treatment, the number of fertilised 
oocytes, the number of cleavage stage embryos, the number of embryos 
transferred into the female, and the pregnancy outcome (yes or no). 
Information was also obtained on the hormonal protocol used for oocyte 
stimulation in the female as well as male and female age. The fertilisation 
rate (%) was calculated by dividing the number of successfully fertilised 
oocytes by the number of oocytes used for treatment and the cleavage rate 
(%) was calculated by dividing the number of cleavage stage embryos by the 





2.1.2 Normalisation of semen parameter data 
Statistical analysis requires input data to follow a Gaussian, or normal, 
distribution. When this is not the case, transformations must be applied to the 
data to reach normality. An initial analysis of histograms and Quantile-
Quantile (Q-Q) plots for semen parameters was carried out to check for 
normality (appendix 6). A histogram illustrates the frequency distribution of 
the data while Q-Q plots show the observed versus predicted values in the 
data set: if the data points follow a linear trend in the Q-Q plot (a straight line) 
then the assumption of normality has been met. A Gaussian distribution in a 
frequency histogram should show a bell-shaped curve. Shapiro-Wilk values 
for skewness were also considered for each sample as an approximation of 
normality but observation of the shape of the data was the ultimate 
consideration to prevent too many exclusions of samples in the data set.   
Figure 2.2 Schematic diagram picturing the structure of the IGF2-H19 locus.  
H19 exists 130 kb downstream of IGF2 on the reverse strand of Chr11. CTCF 
binding sites are shown as orange circles. A more detailed version of the H19 gene 
is shown with exons 1-5 as blue boxes. The green area beneath the 1st and 2nd 
exons represents a CpG island. Two red lines show the approximate regions that 





Data for sperm concentration and sperm count were not normally distributed 
and had a positive skew. To convert the data to a normal Gaussian 
distribution the log base 10 function was used in the equation 𝑥′ = 𝑙𝑜𝑔10(𝑥) 
where 𝑥′ is the transformed value, and 𝑥 is the raw value. The geometric 
means and 95% confidence intervals (CIs) were calculated by back-
transforming the log10 values, which consists of taking the anti-log (𝑙𝑜𝑔𝑥
′
=
𝑥). Data for % progressive motility (PM) and % immotile sperm did not 
require transformation as these showed a normal distribution. Both data sets 
followed the linear expected values on the Q-Q plots. Semen volume was 
normally distributed when extreme outliers were removed.  
2.2 DNA methylation analysis by pyrosequencing 
Quantification of DNA methylation at CpG sites was achieved using 
bisulphite pyrosequencing. Briefly, genomic DNA was extracted and treated 
with sodium bisulphite to convert non-methylated cytosine nucleotides to 
uracil, followed by PCR amplification of the region of interest using primers 
designed to target the bisulphite DNA. A sequencing primer was designed to 
target the region of interest and pyrosequencing was carried out using the 
PyroMark Q24 system (Qiagen, UK).  
2.2.1 Pyrosequencing assay design 
Regions of interest for each gene were chosen based on current literature 
which were deemed to be important regulatory regions for DNA methylation. 
Gene structure was observed on human genome assembly GRCh37/hg19 
using the UCSC genome browser (Genome Biolinformatics Groups of UC 
Santa Cruz, 2015). Regions of interest were determined by looking at the 
presence of CpG islands, and for promoters, the histone acetylated lysine 
mark (H3K27Ac) which is found near regulatory regions and thought to 
enhance transcription (Shyueva et al., 2014). If no CpG islands were 





DMR, sequences were input to EMBOSS CpG predictor software (Genome 
Bioinformatics Groups of UC Santa Cruz) and the minimum CpG length was 
set to 100 bp; primers were then designed for within or near these regions. 
Primer sequences for each region were either purchased as pre-designed 
CpG assays from Qiagen UK (table 2.1), or custom oligonucleotides were 
designed using the PyroMark Assay Design software (Qiagen, UK) and 
purchased through Life Technologies (UK) (table 2.2). Sites analysed 
included the H19 exon 1-spanning CpG island and the 6th CTCF binding site 
of the upstream ICR which controls H19 and IGF2 expression (fig. 2.2). 
Targets for analysis included the ICR between MEG3 and DLK1, the 
PLAGL1 CpG island spanning the first exon, the upstream region of the 
SNRPN CpG island, and the promoter regions of MTHFR, DAZL and NR3C1 
promoters (fig 2.3). Chromosomal locations and the number of CpG sites 
analysed are given in tables 2.2 along with the sequence analysed for the 






Figure 2.3 Gene schematics 
Blue boxes represent individual exons for PLAGL1, SNRPN, DAZL, MTHFR, NR3C1 
and whole genes for MEG3 IG-DMR. Green bars represent CpG islands. White 
circles show the number and distribution of CpG sites analysed. Black bars show 





2.2.2 Sperm DNA extraction for bisulphite pyrosequencing 
DNA was extracted from up to 25x106 sperm using the Qiagen Blood and 
Tissue Midi Kit (Qiagen, UK). Kit components contained the following: G2 
(lysis) buffer, QC (wash) buffer, QBT (equilibriation) buffer, QF (elution) 
buffer and filter columns. Consistent methods were used for DNA extractions 
carried out by B. Altakroni and on later samples by C. Nevin. 
Sperm pellets were resuspended in 1 ml of 1xPBS, and were added to a 
falcon tube containing 9.5 ml of G2 buffer with 19 µl RNase (10 mg/ml) 
(Sigma, UK) and 250 µl Proteinase K (1 mg/ml) (Sigma, UK). The tubes were 
incubated at 4°C overnight on a rotator. Next day, 0.5 ml dithiothreitol (DTT) 
(5 mM) (Sigma, UK) was added to the tubes and incubated at 4°C for 1 hour 
on a rotator (PODC Scientific, UK). The tubes were then transferred to a 
37°C water bath for 1 hour. A sufficient number of Qiagen filter columns were 
set up and equilibriated with 4ml of QBT buffer. The entire contents of the 
samples were then added to the columns which passed through by gravity 
flow. The columns were then washed twice with 7.5 ml QC buffer. DNA was 
eluted from the columns with 4 ml QF buffer and the flow through was 
collected. DNA was precipitated by adding 2.8 ml room temperature 
isopropanol (Fisher, UK) to each collection tube and inverting several times. 
Samples were centrifuged 12,000xg for 15 minutes at 4°C. Isopropanol was 
removed and 1 ml of 70% ethanol (Sigma, UK) was added to the pellet, 
resuspended and centrifuged 12,000xg for 5 minutes at 4°C. Ethanol was 
removed and the pellet was spun again for 2 minutes. All remaining ethanol 
was removed and pellets were allowed to air dry from approximately 2 
minutes before dissolving in 50-100 µl of TE buffer (pH 7.5). DNA was 
quantified using a Synergene HT nucleic acid plate (Biotek, UK).  
2.2.2 Bisulphite conversion 
DNA methylation involves the chemical modification of cytosine nucleotides 
by the addition of a methyl group. When treated with sodium bisulphite, 





methylated cytosine (5mC) remains as cytosine (fig. 2.4). Uracils are 
subsequently converted to thymine during PCR amplification while the 
methylated cytosines are amplified as cytosines. Subsequent sequencing of 
the PCR product allows the discerning of the methylation status of each CpG 
site. 
Sperm DNA was diluted to 100 ng/µl in nuclease-free water and 500 ng was 
used for bisulphite conversion with the EpiTect Fast DNA Bisulphite Kit 
(Qiagen, UK). According to the manufacturer’s instructions, 500 ng DNA was 
added to reaction tubes containing 80 µl bisulphite solution and 15 µl DNA 
protect buffer, to a final volume of 140 µl. The PCR tubes were placed in a 
thermal cycler (Thermo Scientific) and bisulphite conversion was completed 
using the programme detailed in table 2.3.  
Upon completion, bisulphite converted DNA was transferred to sterile 1.5 ml 
Eppendorf tubes and 310 µl of buffer BL was added and vortexed to mix. 250 
µl of ethanol (100%) was then added and again pulse vortexed to mix. The 
contents of each tube was transferred to a corresponding EpiTect Fast DNA 
Bisulphite Kit spin column for clean-up. Columns were centrifuged at 
maximum speed and washed once with 500 µl buffer BW followed by 
incubation of the tubes with 500 µl buffer BD for 15 minutes at room 
temperature. Spin columns were centrifuged, flow-through discarded, and 
two washes with 500 µl buffer BW were performed, followed by one wash 
with 250 µl ethanol (100%). One further spin was carried out to remove 
residual liquid and columns were incubated in a heat block for 5 minutes at 
60°C to evaporate remaining liquid. Following a 1 minute incubation, DNA 
was eluted from the columns in 15 µl buffer EB. Bisulphite DNA 
concentration was estimated using the Nanodrop plate reader (Thermo-
Fisher Scientific, UK) under single-stranded DNA settings and diluted to 5 






Figure 2.4 Bisulphite conversion of genomic DNA and PCR 
amplification 
Methylated cytosine nucleotides present in CpG sites (red) remain as 
cytosines while non-methylated cytosines (blue) within and outside CpG 













Table 2.2 Pyrosequencing custom oligonucleotides  
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2.2.4 Amplification of bisulphite DNA 
Pyrosequencing target regions were amplified using the PyroMark PCR Kit 
(Qiagen, UK). 25 µl PCR reaction tubes were set up according to table 2.4. 
Gradient PCR was initially carried out to determine the optimal annealing 
temperature for amplification ranging from 52-60°C and cycling conditions 
were carried out according to table 2.5. 95°C for 15 minutes; followed by 45 
cycles of denaturation, 94°C for 30 seconds; annealing, 56°C for 30 seconds; 
extension, 72°C for 30 seconds. Finally, an extension of 72°C for 10 minutes 
was included. Gradient PCR products were run on a 3% agarose gel 
containing Midori Green (0.005%) in TBE buffer at 80 V for 30 minutes and 
observed under a UV transilluminator (GBOX) for visualisation of bands. 
PCR products were frozen at -20°C until pyrosequencing. 
 2.2.5 Pyrosequencing 
Bisulphite pyrosequencing was used to quantify the mean methylation of 
single CpG sites in sperm samples. This method is a sequencing-by-
synthesis process in which the nucleotides, adenine (A), cytosine (C), 
thymine (T) and guanine (G), are sequentially added to a known DNA 




sequence and nucleotides that are complementary to the DNA template are 
incorporated by DNA polymerase (fig. 2.5). Each time a nucleotide is 
incorporated to the sequence a molecule of pyrophosphate (PPi) is released 
which is converted to ATP by ATP sulfurylase. This ATP drives the 
conversion of luciferin to oxyluciferin by luciferase, resulting in the release of 
visible light which is detected by the pyrosequencer and appears as a peak 
on the resulting pyrogram. The release of light is directly proportional to the 
number of nucleotides incorporated. For example, if two guanine nucleotides 
are incorporated at once, the peak height will be twice that of when one 
guanine nucleotide is incorporated. The sequential incorporation of 
nucleotides allows the determination of the sequence. 
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Pyrosequencing was carried out using the PyroMark Q24 and Q24 Advanced 
software and kits. Firstly, DNA was bound to Streptavidin Sepharose High 
Performance beads (GE Healthcare, UK). A master mix was made up for the 
required number of samples to be run with each sample containing 1 µl of 
beads, 40 µl binding buffer and 29 µl water. 70 µl master mix was transferred 
to a 0.2 ml PCR tube and 10 µl bisulphite DNA (5 ng/µl) was added bringing 
the total volume to 80 µl. Tubes were incubated on a shaker at maximum 
speed for 10 minutes at room temperature. Meanwhile, the sequencing 
primer was prepared. Firstly, a new assay was generated on the PyroMark 
Q24 software for each specific site and the sequence to analyse was input 
and a nucleotide dispensation order was produced. The required assay was 
Figure 2.5 The pyrosequencing reaction 
The incorporation of a nucleotide into the sequence by DNA 
polymerase results in the emission of light through a series of 




selected for each run along with the number of samples in the plate which 
gave the volumes of Enzyme and Substrate mixtures and of dNTPs to load 
into the cartridge (Qiagen, UK) based on the length of the assay sequence. 
The cartridge was loaded and secured in place in the Pyrosequencer. 
Sequencing primers were either diluted to 1X if using pre-designed CpG 
assays or to 0.3 µM for custom primers in annealing buffer (Qiagen, UK) and 
25 µl was dispensed into each well of a 24-well PyroMark sequencing plate 
(Qiagen, UK). The PyroMark Q24 workstation was then run: using a vacuum 
tool, DNA-bound beads were sequentially washed in 70% ethanol (Sigma, 
UK), denaturing buffer (Qiagen, UK), annealing buffer and wash buffer 
(Qiagen, UK). Beads were then transferred to the sequencing plate 
containing the sequencing primer. The plate was immediately transferred to 
a heat block set to 80°C and incubated for 2 minutes. Following this, the 
plate was secured into the Pyrosequencer and the sequencing experiment 
was run. Pyrosequencing output was in the form of a pyrogram (fig. 2.6) and 
results were analysed using the PyroMark Q24 software.  
PyroMark Q24 software gave an accuracy reading for each of the CpG sites 
analysed based on how correct the nucleotides in the surrounding sequence 
had been sequenced: red (failed), yellow (check), blue (passed). Red reads 
were repeated or excluded from the analysis.  
Table 2.4 Reaction mix for PyroMark PCR 
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2.2.6 Intra-individual variability (inter- and intra-day variability) 
Coefficient of variation (%CV) was calculated to determine the variation 
between pyrosequencing reads between samples obtained from the same 
PCR product and those obtained from different PCR products. %CV was 
calculated as ((SD/mean)*100). The mean %CV for the same PCR products 
run on the same sequencing plate was 1.69%. The mean variation for the 
same PCR products sequenced on different sequencing plates was 3.93% 
and the mean variation for different PCR products sequenced on the same 
sequencing plate was 2.74%. The hypomethylated genes, PEG10, SNRPN, 
PLAGL1, DAZL and MTHFR were not used to calculate the %CV as their 
extremely low methylation values caused huge changes to the %CV values 
when there were very small changes, i.e. a 1% change from a gene that is 
5% methylated would generate a %CV much greater than a 1% change in a 
gene that is 90% methylated. 
  
Table 2.5 PyroMark PCR cycling conditions 
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2.3 Global DNA methylation ELISA 
Global DNA methylation was measured by the concentration of 5-methyl-
cytosine (5MedCyd) using the Global DNA Methylation ELISA Kit 
(Cambridge Biosciences, UK). Kit components included a 96-well 5MedCyd 
DNA conjugate plate, anti-5MedCyd antibody, secondary HRP-conjugated 
antibody, assay diluent, 10x wash buffer, substrate solution, stop solution 
and 5MedCyd standard. 
2.3.1 Preparation of DNA 
500 ng of genomic DNA which was extracted using the above method 
(section 2.2.2), was converted to single-stranded DNA by incubating at 95°C 
for 5 minutes and chilling on ice. DNA was then digested into nucleosides by 
incubating with 5 units of nuclease P1 (Sigma, UK) for 2 hours at 37°C, 
followed by treatment with alkaline phosphatase (Sigma, UK) for 1 hour at 
Figure 2.6 The pyrosequencing output: pyrogram 
 
Peak height in the pyrogram correspond to the number of nucleotides incorporated. 
A negative control is included (orange line) which shows no peak. Blue boxes show 




37°C in 100 mM Tris, pH 7.5. The reaction mixture was centrifuged for 5 
minutes at 6000xg and the supernatant was used for the ELISA assay. 
2.3.2 Preparation of conjugate ELISA plate 
Standards of 5MedCyd were prepared from a stock solution provided in the 
kit ranging from 0-10 µM in assay diluent. The conjugate plate was 
rehydrated in assay diluent for 1 hour at room temperature on an orbital 
shaker and washed once in 1xPBS. 50 µl of prepared DNA sample or 
5MedCyd standard was added to the wells and incubated for 10 minutes on 
an orbital shaker. All standards were assayed in duplicate while five DNA 
samples were assayed in duplicate. 50 µl of anti-5MedCyd antibody was 
then added to each well, mixed and incubated for 2 hours at room 
temperature on an orbital shaker. Following incubation, wells were washed 
four times in 1x wash buffer and 100 µl secondary HRP-conjugated antibody 
was added to each well and incubated at room temperature for 1 hour on an 
orbital shaker.  Wells were again washed four times in 1x wash buffer. For 
the colorimetric detection, 100 µl substrate solution was added to all wells 
and incubated on an orbital shaker until a distinct colour range appeared 
across the standards. The reaction was then stopped by adding 100 µl stop 
solution to each well. Absorbance was read at a wavelength of 450 nm on a 
Synergene HT plate reader (Biotek, UK). 
2.4 Health and lifestyle questionnaire  
Participants completed a questionnaire consisting of two sections (appendix 
1): in the first section they were asked to report their exposure to smoke, 
attendance at work and diet in the last 24 hours. In the second part, 
participants were asked about their occupational exposures and hazards, 
their exposure to chemical or physical agents at home or in their job, their 
health, lifestyle and finally a food frequency questionnaire. This questionnaire 
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was designed for a previous study investigating male infertility (Altakroni, 
2015) and was implemented here as a large source of information relevant to 
DNA methylation analysis. 
2.4.1 Categorisation of health and lifestyle data 
In the health section of the questionnaire, all answers were put on a binary 
scale, “0” or “1”. Having fever or flu, or job illness was recorded as binary and 
the duration was not considered. Participants were asked about job-related 
illnesses; having stress, depression or anxiety was the only variable included 
in subsequent analyses due to its previous association with effects on sperm, 
while physical injury (e.g. breathing or lung problems) were not. Of those 
participants who self-reported sleep problems, most of these also confirmed 
to suffer from stress, therefore these two variables were combined under the 
single variable of “stress”. Type of underwear worn was recorded as either 
wearing boxer shorts or not wearing boxer shorts. 
Smoking habit was investigated on a binary scale as either non- or ex-
smokers as no participants reported to be current smokers, and also on a 
continuous scale as the number of years the participant had smoked. 
Smoking duration (years) was calculated from the difference in the reported 
age of starting and stopping smoking. The type of cigarettes smoked was not 
included in the analysis.  Alcohol consumption was similarly investigated on 
a binary scale as those who drink <1 drink per week or ≥1 drink per week, 
and on a continuous scale as units consumed per week. Participants 
recorded the type and number of alcoholic beverages they consumed per 
week and units of alcohol per drink were recorded as: one pint of 4% beer, 
2.3 units; one pint of 4.5% lager or cider, 2.6 units; one 175ml glass of 13% 
wine, 2.3 units; one 25 ml measure of 40% spirits, 1 unit (Drinkaware, 2016). 
To determine physical activity levels, participants were asked how many 
times a week they participated in mild, moderate and strenuous physical 
activity. The values given for moderate and strenuous exercise were then 
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input to the Godin equation which gave a leisure score index (LSI) for each 
participant: 𝐿𝑆𝐼 = (5 ∗ 𝑚𝑜𝑑𝑒𝑟𝑎𝑡𝑒) + (3 ∗ 𝑠𝑡𝑟𝑒𝑛𝑢𝑜𝑢𝑠). Participants that scored 
≤23 were classed as insufficiently active and those that scored ≥24 were 
classed as active based on previous reports (Amireault and Godin, 2015).   
Participants were asked about their exposure to a number of hazards either 
at work or at home, and answered as “yes” or “no”. Factors which had less 
than 10% of participants either exposed or not exposed were excluded from 
further analysis due to the possibility for low numbers to give false positive 
results. 
2.4.2 Food frequency questionnaire 
Men were asked how regularly they consumed seventy-eight food items on a 
scale of 1-7 for 1) never, 2) less than once a month, 3) once or twice a 
month, 4) once per week, 5) 2-3 times per week, 6) 4-6 times per week and 
7) every day. These food items were then grouped into 28 categories and the 
mean frequency of consumption was calculated for all the foods in each 
category. This data was analysed by principal components analysis (PCA) to 
identify where the greatest variation existed in diets of the study population 
based on foods consumed. PCA revealed that there were two distinct diet 
types with the greatest amount of variation found in the first and second 
principal components; these were diets generally deemed to be “healthy” and 
“unhealthy”. The foods that correlated together in the healthy diet included 
vegetables, nuts, cereals, green tea, vitamins, soy and low fat dairy, 
compared with the unhealthy diet in which foods that correlated included red, 
fried and processed meat, fries, butter, high fat dairy, bread, sugar and 
confectionary, and caffeinated sugar sweetened beverages (Coca-Cola, 
Pepsi, Red Bull). Items excluded from the analysis were food wrapped in 
cling-film, tinned food and spicy food as their contribution to either of these 
diets was ambiguous. 
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Each food group had a proportional loading value in each diet, which can be 
explained as the relative contribution of that food to the variation in that diet, 
e.g. red meat has a high loading in the unhealthy diet (0.33) and a very low 
loading in the healthy diet (0.08), while nuts have a high loading in the 
healthy diet (0.33) and a low loading in the unhealthy diet (0.03). Food 
groups which had a loading >0.1 in one diet and <0.1 loading in the other 
diet were classed as being associated with the former diet. Food groups with 
loading values <0.1 in both diets were excluded as these contributed very 
little to the variation in both diets; these included eggs and caffeinated non-
sugar sweetened beverages (tea and coffee). In addition, food groups that 
had high (>0.1) loading values in both diets were excluded as they 
contributed equally to both diets, i.e. participants that had a high “healthy” 
score consumed foods that were also consumed by participants that had a 
high “unhealthy” score. These items included chicken/poultry, liver, fish, fried 
fish, vegetable oil, fruit, and whole grains.  
Healthy and unhealthy diet scores were calculated for each participant by 
multiplying the frequency of consumption of each food group by the food’s 
loading value and taking the sum of these scores for each item. Men were 
then classified into quartiles for each diet type: quartiles for unhealthy diet 
were <3.975, 3.9751-4.885, 4.8851-5.82, ≥5.821. Quartiles for healthy diet 
were ≤1.47, 1.471-2.465, 2.4651-3.4025, ≥3.4025. 
2.4.3 Statistical analysis 
Statistical analysis was carried out using the IBM SPSS Statistics 20 
package while graphs were generated using GraphPad Prism 6 software. 
Descriptive statistics were analysed for each independent and dependent 
variable, observing means and standard deviations (SD) for raw methylation 
and semen parameters data, and geometric means and 95% CI when means 
had been obtained from transformed data.  
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Differences in all continuous dependent variables (DV) including % 
methylation, semen parameters, fertilisation and cleavage rates between 
binary independent variables (IV) (e.g. non-/ex-smoker) were analysed using 
an independent t-test. Differences in continuous DVs between IVs with three 
or more categories (e.g. diet quartiles) were analysed by one-way ANOVA 
and followed up using Tukey’s post-hoc test to identify differences between 
specific groups. Tests were carried out under the assumption of equal 
variance; when Levene’s test for equality of variances was not met (p<0.05), 
results were taken from the t-test not assuming equal variance. Differences 
in binary DVs (e.g. pregnancy outcome) between continuous IVs were 
analysed with non-parametric Mann-Whitney U test, and for binary DVs 
between categorical IVs the Chi squared (χ2) test was used. Multiple 
regression analysis was carried out to determine effects of significant IVs 
whilst controlling for other variables. IVs that showed multi-collinearity were 
not included in the same regressions to prevent redundancy. Spearman’s 
and Pearson’s correlations were used to identify linear relationship between 
continuous IV and DVs. 
DNA methylation data was transformed according to section 2.1.2. Genes 
that underwent transformation to normality were SNRPN, MEG3, NR3C1 and 
DAZL (appendix 12, figures 1-4). 
2.5 An in vitro sperm glycation assay 
To investigate the effects of glycation on human sperm, an in vitro model 
was developed in which sperm were incubated with various glycating agents 
and formation of a major AGE, CML, was measured. The effects of this 
glycation on sperm motility, oxidative DNA damage, intracellular ROS levels 
and HA binding were also measured. 
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2.5.1 Procurement of semen  
Semen samples were obtained from consenting donors (aged 19-51 years), 
covered by faculty ethical approval at Manchester Metropolitan University 
(appendix 7). Donors were verbally informed of the study details and given a 
participant information sheet (appendix 8). They then completed a medical 
screening questionnaire (appendix 9) and finally signed the participant 
consent form (appendix 10). Semen was produced on site in a designated, 
secured room. Participants were instructed how to produce the sample and 
given a sample collection pot (Sterilin, UK). Participants subsequently signed 
a semen procurement form each time they donated a sperm sample 
(appendix 11). 
All neat semen samples underwent standard semen analysis according to 
the WHO 5th edition before processing. Firstly, semen was liquefied at 37°C 
for 30 minutes. The total volume of semen was then measured and recorded. 
To measure sperm motility and concentration, 5 µl of semen was applied to a 
cell counting slide (Vitrolife, UK) and analysed by a Computer Assisted 
Sperm Analyser (CASA – Sperminator®, Procreative).  Depending on 
downstream experiments, semen samples were then either washed or 
prepared by density gradient centrifugation as described below. 
2.5.2 Washing of sperm and preparation by density gradient 
centrifugation 
Liquefied semen was centrifuged 800 x g for 10 minutes to separate sperm 
cells from seminal plasma. Seminal plasma was removed and flash frozen in 
liquid nitrogen before storage at -80C. Some sperm pellets were frozen at 
this point at -80°C until use. Thawed sperm pellets or fresh sperm pellets 
were resuspended in 3 ml of Sperm Preparation Media™ (SPM) (Origio, 
Denmark) and centrifuged 300 x g for 10 minutes. This wash step was 




Alternatively, motile sperm were separated from immotile and immature 
sperm and from non-sperm cells by density gradient centrifugation. Briefly, 
up to 1 ml of neat semen was layered on top of a gradient of 55% and 80% 
SupraSperm™ media (Origio, Denmark) and centrifuged 300 x g for 20 
minutes. The supernatant was removed and discarded and the sperm pellet 
was washed twice in SPM (Origio, Denmark), centrifuging at 300 x g for 5 
minutes each. The cells were then resuspended in 1 ml SPM and counted. 
2.5.3 In vitro glycation of sperm 
Motile sperm that had been separated by density gradient centrifugation 
were pelleted and resuspended in solutions of SPM containing either D-
glucose (10 mM, 30 mM or 50 mM), methylglyoxal (MG) (50 µM) or glyoxal 
(GO) (50 µM) (Sigma, UK) at a concentration of 20x106 cells/ml. Sperm were 
incubated at 34°C on a rotator for 6 days before analysis for CML formation 
and oxidative DNA damage. Sperm were also glycated for up to 4 hours with 
cells removed at 0, 2 and 4 hour time points for analysis of motility, 
hyaluronan binding capacity and CML formation.  
2.5.4 MG toxicity assay 
The concentration of MG and GO to use in the experiments was determined 
using a toxicity assay in which sperm were incubated with concentrations of 
MG at 0, 50, 100, 250 and 500 µM in SPM for 48 hours at 34°C before a 
vitality stain was carried out to determine the percentage of live sperm. 
2.3.4.1 Vitality staining 
The one step eosin-nigrosin stain for sperm vitality was prepared based on 
the guidelines published in WHO 5th edition. The stain is dye-exclusion 
mechanism in which dead membrane-damaged sperm are stained pink or 
purple, while live membrane-intact sperm exclude the dye and appear white. 
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Briefly, eosin Y (0.67%) (Sigma, UK) and sodium chloride (NaCl) (0.9%) 
(Sigma, UK) were dissolved in water with gentle heating, before nigrosin 
(10%) (Sigma, UK) was added, and the solution was boiled, then allowed to 
cool and filtered. Equal volumes of eosin-nigrosin stain and resuspended 
sperm sample were mixed and smeared onto a microscope slide using the 
feathering technique. A second smear was made using a fresh aliquot of 
sperm. Using a light microscope, 200 sperm were counted and the number 
of live and dead sperm were recorded. % live sperm were calculated as 
((#𝑙𝑖𝑣𝑒 𝑠𝑝𝑒𝑟𝑚/#𝑡𝑜𝑡𝑎𝑙) ∗ 100). 
2.5.6 Measurement of CML by flow cytometry 
Sperm were removed from the 6 hour glycation experiments at 0, 2 and 4 
hours, and pelleted by centrifugation at 350 x g to remove glycation media. 
Cells were resuspended in paraformaldehyde (4%) (Sigma, UK) and 
incubated at room temperature on an eppendorf rotator for 20 minutes. Cells 
were pelleted again and permeabilised by resuspension in 0.1% PBS-tween 
for 15 minutes. Sperm were then blocked in 10% normal goat serum (Vector 
laboratories, UK) in 1xPBS for 1 hour at room temperature. Cells were 
incubated with a mouse anti-CML primary antibody (1:50) (Life technologies 
UK) for one hour at room temperature, followed by a goat anti-mouse Alexa 
Fluor 488 secondary antibody (1:2000) (Abcam, UK) for 45 minutes at room 
temperature in the dark. A control in which primary antibody was omitted 
from the procedure was also prepared under the same conditions. Cells were 
then washed once and resuspended in 1xPBS before acquisition and 
analysis using a Facs Calibur flow cytometer (BD Biosciences, UK). Cells 
were gated using the forward-scatter/side-scatter (FSC/SSC) channels 
recorded in a dot plot, to exclude debris and large cells. Fluorescence was 
measured in the FL-1 channel and CML levels were recorded as the mean 
fluorescence intensity (MFI) of cells and recorded on a histogram. The 
boundary of fluorescence-negative and fluorescence-positive cells was set 
by gating 1-1.5% of unstained cells in the positive region. 
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2.5.7 Measurement of intracellular reactive oxygen species 
Intracellular reactive oxygen species (ROS) in sperm treated with either 
glucose, fructose, mannitol, MG or GO was measured using the CM-
H2DCFDA General Oxidative Stress Indicator (Invitrogen, UK). CM-
H2DCFDA diffuses into cells where it is oxidised to yield a fluorescent adduct 
that is trapped inside the cell and its emission can be measured in the 
Fluorescein spectrum. Briefly, treated sperm were washed in pre-warmed 
PBS and resuspended in PBS containing the ROS probe at 5 µM. The cells 
were incubated at 34°C for 30 minutes. The dye was then removed by 
centrifugation and the cells resuspended in PBS and fluorescent intensity 
was detected in the FITC emission range of the BD Facs Calibur (BD 
Biosciences, UK). A negative control of sperm unexposed to the dye was 
made and a positive control of sperm exposed to H2O2 for 15 minutes prior to 
the assay. 
2.5.8 Measurement of 8-oxoguanine by flow cytometry 
The level of oxidative DNA damage in spermatozoa incubated with glycating 
agents over 6 days was determined using the fluorometric OxyDNA Assay 
Kit (Calbiochem®, EMD Millipore, US). The assay is based on a FITC-
conjugate that binds to the 8-oxoguanine moiety of 8-oxoguanosine of 
oxidized DNA. Sperm cells were centrifuged 300 x g for 7 minutes to pellet 
the cells and remove media. Cells were fixed in 4% PFA and permeabilised 
with 70% ethanol. Cells were washed with Wash Solution (1x) and 
resuspended in 100 µL FITC-conjugate (1x), before incubation in the dark for 
1 hour at room temperature. Cells were washed once in Wash Solution (1x), 
resuspended in 1xPBS and analysed by flow cytometry. Flow cytometry was 
performed as described above, also using the FL-1 channel to determine 




2.5.9 Immunocytochemical staining of sperm for AGEs and CML 
Glycated sperm were stained for AGEs using a general anti-AGE antibody 
(Abcam, UK) and specifically for CML using an anti-CML antibody (Abcam, 
UK). 10 µl of sperm was placed on one end of a glass microscope slide and 
smeared across the slide using the feathering technique and allowed to air 
dry. Slides were then fixed by submersion in ice-cold methanol (100%) for 15 
minutes. Once dry, a water-resistant pen (Life technologies, UK) was used to 
seal the area around the cells. Slides were rehydrated in PBS-tween (PBS-T) 
for 3 minutes before blocking in 10% normal goat serum in PBS-T (0.05%) 
for 1 hour at room temperature. Slides were washed in 3x fresh changes of 
PBS-T for 1 minute each. Primary antibodies (anti-AGE or anti-CML) were 
diluted in PBS-T and added to the slides (1:200) and incubated in a 
humidified chamber overnight at 4°C. Negative controls were included in 
which the primary antibody was omitted. Next day, slides were washed in 3x 
changes of PBS-T and secondary goat anti-mouse (1:2000) or goat anti-
rabbit (1:2000) antibodies (Life Technologies, UK) were added to the slides 
staining for CML and AGEs, respectively.  Slides were incubated with 
secondary antibodies for 1 hour at room temperature in a darkened 
humidified chamber. Slides were washed a final 3 times in PBS-T before 
Figure 2.7 Slide preparation of sperm for vitality staining  
Sperm vitality was determined using the eosin-nigrosin stain. Stained 
sperm were smeared onto a glass slide by feathering (A) and visualised 




excess reagent was drained off and sperm nuclei were stained for using 
Vectashield Mounting Medium with DAPI (Vectashield, UK) and finally 
coverslipped. Fluorescent images were taken using an Axio Imager Z1 
(Zeiss, HBO 100 mercury lamp) with AxioVision 4 software. Sperm head 
fluorescence was quantified using ImageJ software and the Corrected Total 
Cell Fluorescence (CCF) was obtained using the equation CCF = initial cell 
density – (cell area x background intensity). 
2.5.10 Sperm hyaluronan binding assay 
Functional activity of plasma membrane hyaluronidase in glycated and non-
glycated sperm was measured using Hyaluronan Binding Assay (HBA) slides 
(Origio, Denmark). At 0, 2 and 4 hours of incubation with MG, GO or SPM, 8 
μL of sperm suspension was removed and placed onto a hyaluronan-coated 
slide and a coverslip applied. After a 10 minute incubation period in which 
sperm were allowed to bind to hyaluronan, the number of bound motile 
sperm and the number of unbound motile sperm on a 10x10 square grid 
were counted at 40X magnification (fig. 2.1). Immotile sperm were not 
counted. The percentage of bound sperm is the hyaluronan binding capacity 
Figure 2.8 Sperm Hyaluronan Binding Assay (HBA) 
Sperm exposed to glycation conditions were place on HBA slides and 
assessed for HA binding. Bound sperm are differentiated from unbound 
sperm by their beating tails with heads that make no progressive 




of the cells. Sperm motility was also assessed at these stages using a 
computer assisted sperm analyser (CASA) recording grades A (fast 
progressive motility), B (slow progressive motility), C (non-progressive 
motility) and D (immotile). 
2.5.11 CML levels in obese subjects 
To determine whether obese individuals have higher levels of sperm AGEs, 
CML was measured in obese men and compared with that of normal weight 
individuals. 15 men were recruited via local newspaper advertisements and 
word of mouth. Nine of the participants were obese according to World 
Health Organization guidelines (WHO, 2013), having a BMI ≥ 30 kg/m2, and 
six participants had a normal BMI of 18-24 kg/m2. The obese and normal-
BMI groups were not age-matched due to the low number of volunteers. 
Semen analysis was carried out as described in section 2.5.1. Three of the 
subjects had sperm count of <10x106 cells/ml and did not have the minimum 
required for the CML assay. One individual could not produce a sample, 
resulting in five participants for each group. The immunoassay was run as 
detailed in section 2.5.6 and stained cells were analysed by flow cytometry. 
2.6 In vitro glycation of hyaluronidase protein 
To determine the effects of glycation on the SPAM1 hyaluronidase activity, 
firstly molecular cloning was carried out to generate the recombinant form of 
the protein. However, this was not successful, and so a commercially 
available hyaluronidase, Cumulase™ (Origio, Denmark), was used. This 
enzyme is used in preparation for ICSI to disperse the cumulus cells in 
retrieved oocytes. Furthermore, to determine the effects of glycation, a 




2.6.1 Generation of recombinant SPAM1 protein 
2.6.1.1 Molecular cloning 
A pENTR223 vector containing cDNA insert of sperm adhesion molecule 1 
(SPAM1/PH-20/hyaluronidase) was obtained from the Harvard Medical 
School PlasmID Repository (Clone ID: HsCD00375886). The SPAM1 insert 
was amplified by PCR using primers designed based on the full length 
SPAM1, transcript variant 1 (XM_011516523). SPAM1F: 5’- 
TGGCATGGATCCATGGGAGTGCTAAAATTCAAGCAC -3’, and SPAM1R: 
5’- TGGCAAGTCGACGAAGAAACCAATTCTGCTAATA -3’.  Briefly, 1 ng 
plasmid DNA was added to SPAM1 primers (0.3 µM) and 5x MyTaq 
Reaction Buffer (Bioline, UK). Cycling conditions included an initial 
denaturation at 95°C for 15 minutes, followed by 30 cycles of denaturation at 
95°C for 15 s, annealing at 61°C for 30 s, extension at 72°C for 30 s, and a 
final extension of 72°C for 5 minutes.  
The PCR products were separated on a 0.8% agarose gel at 50 volts for 1 
hour and visualised under ultraviolet (UV) light using a Gel Imaging System 
G-BOX (BioRad). The product was expected to be 1533 bp. Bands were 
excised and cleaned up using QIAquick Gel Extraction Kit (Qiagen, UK). 
Molecular cloning was carried out at the Laboratoire de Biologie du 
Développement de Villefranche-sur-mer, Sorbonne Universités. Briefly, 
sequences were cloned into the pGEX 4T1 vector, which contained a 
glutathione-S-transferase (GST) tag sequence. A restriction digest was 
performed on pGEX 4T1 vector using the restriction enzymes BamHI and 
SalI and the SPAM1 insert was ligated into the multiple cloning site. Clones 
were transformed into E.coli BL21 RiPL cells (Agilent, UK) using heat shock 
for 2 minutes at 42°C followed by plunging on ice. Cells were plated out onto 
liquid broth (LB) agar (10% tryptone, 5% yeast extract, 10% NaCl) with 




2.6.1.2 Bacterial cell culture and induction with IPTG 
A single successful recombinant colony was inoculated into 5 ml LB media 
(10% tryptone, 5% yeast extract, 10% NaCl) and allowed to grow overnight 
at 37°C, with shaking for aeration at 270 rpm (Thermo Scientific, UK) . The 
following day, 0.5 ml or 5 ml overnight culture was added to 50 ml LB media 
or 1 L LB media and grown for 2.5 hours until the log growth phase. When an 
OD600 value between 0.4 and 0.6 nm was reached, 1 ml of non-induced 
culture was removed and saved for later analysis while the remaining cells 
were induced with 0.5 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
(Sigma, UK). Cells were harvested at 2 and 5 hours post-induction. Later, to 
reduce the formation of inclusion bodies, cells were grown as above and 
allowed to cool to room temperature before induction with IPTG, followed by 
growth at 16°C or 20°C overnight with shaking at 270 rpm. Cells were 
centrifuged at 600 x g for 10 minutes and pellets were frozen until lysis. 
2.6.1.3 Protein purification 
Bacterial cells were lysed in 1xPBS containing lysozyme (1 mg/ml) and 
Triton X-100 (0.2%) on ice for 30 minutes. DNase and RNase were added to 
a final concentration of 5 µg/ml to reduce the viscosity of the solution. Cells 
were spun down to separate soluble protein, and the insoluble pellet was 
resuspended in a detergent-based lysis buffer containing N-lauroylsarcosine 
(1.5%), diethanolamine (25 mM) and EDTA (1 mM). The GST-SPAM1 
recombinant proteins were purified on a column using Glutathione 
Sepharose 4B (Sigma, UK) and eluted with 20 mM reduced glutathione (50 
mM Tris, pH 8.0) (Sigma, UK). Protein could not be successfully purified so 
the experiment was terminated here and a commercial hyaluronidase 
enzyme was used. 
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2.6.2 Hyaluronidase substrate gel assay 
2.6.2.1 Assay development 
A substrate gel assay was developed to quantify hyaluronidase activity of the 
commercial enzyme Cumulase™ (Origio, UK) by polyacrylamide gel 
electrophoresis (PAGE). A 10% polyacrylamide separating gel was prepared 
using 30% acrylamide/bisacrylamide. Hyaluronic acid (10 mg/ml) was 
dissolved in water at 4°C for 24 hours and added to the separating gel mix to 
a final concentration of 0.1 mg/ml. A 7.5% stacking gel was prepared without 
hyaluronic acid. Gels were loaded with 5-10 µg of Cumulase protein™ and 
run at 15 mA per gel for 1 hour 40 minutes. Following electrophoresis, gels 
were washed in 3% Triton X-100 in 50 mM HEPES (pH 7.4) for 2 hours on a 
benchtop rotator to remove SDS. A number of buffers were tested for 
enzymatic activation of the hyaluronidases: 0.1 M sodium formate (pH 3.75) 
with 0.15 M NaCl; 50 mM HEPES (pH 7.4) with 0.15 M NaCl; 12.5 mM 
sodium acetate (pH 3.0), 25 mM sodium acetate (pH 4.0), 50 mM sodium 
acetate (pH 6.0) and 100 mM sodium acetate (pH 7.0). Gels were incubated 
with the buffers for 16-39 hours, followed by staining with Alcian blue (0.5%, 
3% acetic acid) for 2 hours. Gels were destained in 7% acetic acid until clear 
bands could be seen on the gels. Following this, protein bands were stained 
using Coomassie blue (0.5%, 50% methanol, 10% acetic acid) and destained 
in 50% methanol, 10% acetic acid. Gels were visualised and photographed 
on a Chemidoc touch transilluminator (Bio-Rad, UK). Band sizes were 
analysed using Image Lab (Bioline, UK). 
2.6.2.2 Glycation of Cumulase™  
Cumulase™ protein concentration was measured using the Pierce BCA 
Protein Assay Kit (Thermo Fisher Scientific, UK) using bovine serum albumin 
(BSA) standards provided with the kit. Glycating agents MG (5 µM), GO (5 
µM), glucose (20 mM), fructose (20 mM) and mannitol (20 mM) were then 
diluted in PBS (pH 7.4) (Fisher, UK) with sodium azide (0.02 mM) and added 
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to an equal volume of Cumulase™ enzyme (0.5 mg/ml). A sample of 
Cumulase™ enzyme with PBS alone was included (0.5 mg/ml) to account for 
non-glycation induced changes in the protein. A sample of BSA protein alone 
with PBS was also included to account for support protein activity as there is 
human serum albumin (HSA) present in Cumulase™. Samples were 
incubated at 37°C and 50 µl aliquots were removed at days 0, 3, 7 and 14 
and snap frozen in liquid nitrogen until measurement. 
2.6.2.3 Measurement of glycated Cumµase™ using the hyaluronidase 
substrate gel assay 
A 10% polyacrylamide separating gel containing HA and 7.5% 
polyacrylamide stacking gel were prepared as described in section 2.6.2.1. 
Cumulase samples were mixed with sample buffer at a 4:1 ratio and 20 µl of 
this was loaded on to the gels. Gels were run at 15 mA per gel for 1 hour 30 
minutes. Gels were treated for hyaluronidase activity as described in section 
2.6.2.1, with the exception that the hyaluronidase assay buffer used was 25 
mM sodium acetate (pH 4.0) for all gels, and this was carried out at 37°C for 





Effects of lifestyle and environment on DNA 
methylation and infertility 
3.1 Introduction 
Over half of male factor infertility cases are idiopathic and the discovery of 
differences in methylation between fertile and infertile men has led to 
speculation that this could be one of the causes (Hammoud et al., 2010; 
Aston et al., 2015). DNA methylation is a major regulatory mechanism for 
gene expression and primarily silences genes by preventing transcription 
factor interaction with DNA at important regulatory sites, such as promoters. 
Several lifestyle factors have been linked to changes in the sperm DNA 
methylation as well as to aberrant semen parameters, including age, obesity, 
alcohol consumption, nutrition, physical activity and exposure to 
environmental toxicants (Jenkins et al., 2014; Donkin et al., 2015; Ouko et 
al., 2009; Aarabi et al., 2015; Denham et al., 2015; Chiu et al., 2015; De 
Rosa et al., 2003). Therefore, current research seeks to determine whether 
the decrease seen in male fertility is linked to lifestyle-induced changes in the 
methylome.  
Much of the research on sperm methylation has focussed on imprinted 
genes (Kobayashi et al., 2007; Boissonnas et al., 2010; Geuns et al., 2007; 
Ankolkar et al., 2013; Poplinski et al., 2009). Imprinting is the process of 
silencing or activating certain genes in a parent of origin-specific manner, to 
confer mono-allelic gene expression. These genes are crucial to ensure the 
correct balance of gene expression in the developing embryo, which if 
disturbed results in developmental abnormalities (Jacob et al., 2013) and 
DNA methylation is the main regulatory mechanism controlling this (Kaneda 
et al., 2004). As many studies have reported differences in imprinted gene 
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methylation between the sperm of fertile and infertile men, a major question 
resides over whether this has arisen due to abnormal reprogramming during 
germ cell development, which could be a source of deregulated gene 
expression leading to infertility, or alternatively, whether sperm epimutations 
are acquired during post-natal life from lifestyle and environmental 
exposures, leading to aberrant methylation.  
DNA methylation also varies at non-imprinted genes important for regulating 
epigenetic machinery or important in sperm function. The 5,10-
methylenetetrahydrofolate reductase (MTHFR) gene codes for a key enzyme 
involved in folate metabolism, the pathway by which methyl groups are 
obtained for DNA methylation. Hypermethylation of the MTFHR promoter has 
been found in infertile men (Wu et al., 2010; Botezatu et al., 2014), and 
critically, this hypermethylation has been linked to hypomethylation at other 
genes in infertile men (Rotondo et al., 2013) suggesting a disruption of the 
methylation process itself. Furthermore, array-based sequencing studies 
have shown that fertile and infertile men actually have very distinct 
methylation patterns across numerous genes with varying roles (Houshdaran 
et al., 2007; Urdiguino et al., 2015; Shütte et al., 2013). These differences in 
normal DNA methylation may have implications for offspring health and may 
be a mechanism behind the transgenerational effects of male health 
(Northstone et al., 2014; Axelsson et al., 2013; Soubry et al., 2015). 
Understanding the transmission of non-genetic factors through the male 
germ line is critical to elucidating the origins of disease. 
The “deleted in azoospermia-like” (DAZL) gene encodes an RNA-binding 
protein which is essential for gametogenesis. Disruption of Dazl in C. 
elegans, causes meiotic arrest in oogenesis (Karashima et al., 2000), in 
Xenopus, is required for early primordial germ cell differentiation (Houston 
and King, 2000), and in mice, leads to spermatogenic arrest (Schrans-
Stassen et al., 2001). In humans a lack of DAZL transcript causes 
azoospermia (Lin et al., 2001). Importantly DAZL expression is regulated by 
DNA methylation at a CpG island at its promoter, which is unmethylated in 
reproductive cells (Linher et al., 2009). A few recent studies have shown that 
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alterations in DAZL DNA methylation closely associate with spermatogenesis 
disorders in patients with infertility (Navvaro-Costa et al., 2010), suggesting 
this may be a strong candidate gene for spermatogenic failure. 
Assisted reproductive techniques (ART) bypass the selection processes that 
happen during normal fertilisation, particularly in ICSI when a single sperm is 
injected into the oocyte which circumvents sperm binding and penetration of 
the ZP. Therefore, there is much interest in whether aberrant DNA 
methylation signatures in the sperm of infertile men could have 
consequences and for fertilisation rates and for success of the developing 
embryo. As there is some evidence of an increase in imprinting disorders 
following ART, it is possible that aberrant sperm methylation could play a role 
(Lazaraviciute et al., 2014). Indeed, some studies have shown that 
methylation errors in sperm are associated with poor ART outcomes (Kuhtz 
et al., 2014) and even that the same epimutations have been found in the 
offspring as in the paternal sperm DNA (Kobayashi et al., 2009). However, 
other research shows that aberrant embryonic methylation is not linked to 
sperm DNA methylation (Camprubi et al., 2012) and aberrant sperm 
methylation does not affect ART outcomes (Ibala-Romdhane et al., 2011). As 
more than 5 million babies have been born through ART, this is an important 
area of public health research that requires further study. 
3.1.1 Aims 
The aims of this chapter were to:  
1. Identify the associations between sperm DNA methylation, health, 
lifestyle, and chemical or physical hazard exposure.  
2. Determine whether sperm DNA methylation is associated with 
aberrant semen parameters. 
3. Determine whether differences in sperm DNA methylation are 





3.2.1 DNA methylation and lifestyle 
3.2.1.1 Global and gene-specific sperm DNA methylation 
Percentage DNA methylation is binary, i.e. methylated or not and refers to 
the proportion of DNA copies (i.e. cells) that are methylated. Firstly, the 
descriptive statistics were analysed for each gene. Table 3.1 shows the 
mean methylation of all neat semen samples. The paternally imprinted genes 
H19 exon 1 and MEG3 were hypermethylated, showing close to 100% 
methylation. H19 CTCF6 showed a mean methylation of 40.06% with a large 
range including hypomethylated (6.2%) and hypermethylated (76.2%) 
samples. The maternally imprinted genes PLAGL1 and SNRPN were 
hypomethylated, having methylation levels close to 0%. The non-imprinted 
genes MTHFR and NR3C1 also had low levels of methylation, and the 
spermatogenesis-associated gene DAZL had a low mean methylation with a 
large amount of variation ranging from 0.42% to 20%. 
Table 3.1 DNA methylation summary table 
Raw data for global and gene specific DNA methylation (%) is shown. Patients 
with varicocele (n=3) were excluded. 
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3.2.1.2 CpG site-specific methylation 
In many genes, certain CpG sites in a regulatory region can be more 
important than others. Individual CpG site methylation was analysed within 
each gene region using box and whisker plots to identify sites with greater 
variability, and therefore more likelihood of demonstrating lifestyle-influenced 
changes. CpG site methylation was also correlated with mean methylation 
across all sites in the region and Pearson’s correlation (r) values were 
analysed to identify those sites that differed from the mean trend (table 3.2). 
In sperm, at paternally imprinted genes, patients that show low levels of 
methylation are considered aberrant, while at maternally imprinted genes, 
those that show higher levels of methylation are considered aberrant. 
H19 CTCF6 
H19 is a paternally imprinted, and therefore methylated, gene. The 6th CTCF 
binding site exhibits variable methylation due to its role in CTCF binding. 
Figure 3.1 A shows the box and whisker diagrams for the 6th CTCF binding 
site (CTCF6). There are 30 CpG sites overall in the 6th CTCF binding site 
and these sites represent CpGs 5-12 within that region. There was a large 
amount of variation across all sites with the largest SDs at CpGs 4, 6 and 8 
and the smallest SD at CpG 3, which also had the lowest mean methylation 
at 25.51% (table 3.2). The mean methylation of all the CpG sites was 40.07 
(table 3.1) and all individual CpG sites were highly correlated with this 
(p<0.0001). The extreme cases in the 95th percentile and 5th percentile all 
appeared at more than 1 CpG site and no cases present in the 95th 
percentile appeared in the 5th percentile at any sites, and vice-versa. 
Therefore, generally samples were hyper- or hypo-methylated at several 
CpG sites. All cases that were in the 5th percentile had normal semen 
parameters. 
H19 exon 1 
H19 exon 1 showed methylation levels more typical of a paternally imprinted 
gene, i.e. heavily methylated (fig. 3.1 B).  All CpG sites in this region showed 
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hypermethylation with CpG sites 1, 2, 4 and 5 having mean methylation 
above 90% and CpG 3 having the lowest methylation at 86.45% and the 
largest SD at 4.43 (table 3.2) which signifies the largest and most deviant 
amount of variation in the population, however this site along with all others 
was highly correlated with the mean CpG methylation (p<0.0001). Cases that 
appeared most frequently in the 5th percentile (low methylation) were more 
likely to be oligozoospermic than those in the 95th percentile: three out of five 
patients that appeared in the 5th percentile were oligozoospermic. Some of 
the cases in the 95th percentile of exon 1 were also in the 95th percentile of 
the 6th CTCF binding site, though not all. None of the cases in the 5th 
percentile were present in the 5th percentile of the 6th CTCF binding site. It 
seems likely, therefore that these two sites are operating differently.  
PLAGL1 
PLAGL1 and SNRPN are maternally imprinted genes, therefore in sperm 
they exhibit low levels of methylation. Figure 3.2 A supports this as PLAGL1 
showed mean methylation less than 5% at all CpG sites. All sites showed 
Figure 3.1 H19 CTCF6 and exon 1 box and whisker plots 
CpG site-specific methylation (%) is shown for the H19 gene at the 6th CTCF 




similar SDs (0.5-0.78%) and all were highly correlated with the mean CpG 
methylation (p<0.0001). 
SNRPN 
SNRPN methylation showed a large amount of variation at all CpG sites, with 
many patients showing higher than average methylation which can be seen 
by the extension of the upper whisker (fig. 3.2 B). In the 95th percentile, two 
out of four patients were oligozoospermic, and in the 5th percentile, one out 
of two patients was oligozoospermic. The cases in the 95th percentile were 
not the same cases as those for PLAGL1 suggesting not all individuals 
showed hypermethylation across all sites.  Furthermore, patients in the 5th 
percentile were not found in the 95th percentile in the paternally imprinted 
genes H19 and MEG3, which suggests that aberrant de-methylation at 
paternal imprints is not related to aberrant re-methylation at maternal 
imprints. All CpG sites were highly correlated with the mean (p<0.0001). 
Figure 3.2 PLAGL1 and SNRPN box and whisker plots 
% DNA methylation at individual CpG sites is shown for the maternally 
imprinted PLAGL1 (A) and SNPRN (B) genes. Boxes show the median, 
25th and 75th percentiles. 
 82 
 
MEG3-IG DMR  
Like H19, MEG3 is also a paternally imprinted gene, and shows close to 
100% methylation (fig. 3.3). CpGs 6, 7 and 9 had the lowest methylation 
means at 69.49% (±3.83), 69.02% (±7.46), 54.93% (±5.34). CpG 8 had the 
largest SD at 10.77%. All sites were highly significantly associated with the 
mean CpG methylation (p<0.0001) except for CpG 6 (p<0.01) and CpG 9 
which was not correlated with the mean (p>0.05). Therefore the two sites of 
interest would be CpG 8 which has the largest variation and CpG 9 which 
deviates largely from the mean. Two patients which were hypomethylated at 
CpG 7 (12%) and CpG 9 (16%) were normozoospermic. The individuals in 
the 5th percentile for MEG3 were not consistently in the 5th percentile at all 
CpG sites, unlike for H19. Two of the cases that were in the 5th percentile for 
MEG3 were also in the 5th percentile of H19 exon 1, however none matched 
the cases in the 5th percentile of H19 CTCF6.  
MTHFR promoter 
MTHFR is a non-imprinted gene whose transcript is critical to the methylation 
cycle itself, and its promoter therefore shows low levels of methylation (fig. 
3.3 B). The CpG sites showed methylation levels of 1.93% (±0.68), 1.24% 
(±0.48) and 2.5% (±0.71). The variation (SD) was similar across the sites 
and all sites correlated significantly with the mean (p>0.0001). As higher 
MTHFR methylation could lead to lower methylation at other genes, 
similarities between patients in the 95th percentile of MTHFR were compared 







The NR3C1 gene is involved in the stress pathway and is not an imprinted 
gene. The promoter usually shows about 5% methylation in sperm. CpG 
sites 1-4 showed large levels of variation which is clear from the SDs (fig 3.4 
A and table 3.2). CpG 2 had the highest mean methylation (8.9%) and the 
largest SD (2.64%). CpGs 5-7 had low levels of methylation and very small 
SDs. CpG 5 had the lowest methylation 1.36% and the smallest SD (0.81%). 
CpGs 5-7 may be important CpG sites as their variation is low, therefore 
tightly controlled, while CpGs 1-4 might be most affected by lifestyle and 
environmental stimuli. There was no consistency in patients appearing in the 
95th or 5th percentiles indicating no blanket hypo- or hyper-methylation for all 
sites. 
Figure 3.3 MEG3 and MTHFR box and whisker plots  
% DNA methylation at individual CpG sites is shown for the paternally imprinted 





The DAZL gene has important roles in spermatogenesis and therefore 
normally has low levels of methylation in sperm. DAZL showed large levels 
of variation across all CpG sites. Mean methylation was below 7% at all 
CpGs however the upper range was extremely large indicating many men 
with hypermethylation of this gene (fig. 3.4 B). Participants with the highest 
levels of methylation were consistently heavily methylated at all CpG sites. In 
the 95th percentile, three out of four men were oligozoospermia, while none 
of the participants in the 5th percentile were. There was no association 
between hypermethylated sites in DAZL and hypomethylation at paternally 
imprinted genes or hypermethylation at maternally imprinted genes. 
Figure 3.4 NR3C1 and DAZL box and whisker plots 
% DNA methylation at individual CpG sites is shown for the non-imprinted 





Table 3.2 Individual CpG site methylation (%) 
Means and SD were calculated for all participants at each CpG site. Correlations (r) were made between CpG site methylation 
and mean methylation across all CpG sites in each gene to identify those which did not follow the mean changes. Significant 
correlations are shown in bold. *p<0.05 
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3.2.1.3 Normalisation of DNA methylation data 
In order for parametric statistical analysis to be carried out, data must show a 
Gaussian, or normal, distribution, typified as a bell-shaped curve on a 
frequency distribution graph. Many of the genes showed positively or 
negatively skewed data which require transformations to a Gaussian 
distribution. 
For example, SNRPN was highly positively skewed and a reciprocal 
transformation (1/𝑥) was carried out (fig. 3.5 A and B). DAZL also underwent 
a reciprocal transformation. NR3C1 was log10 transformed and MEG3 was 
reversed and log10 transformed. 5MedCyd, H19 CTCF6. H19 exon 1, 
MTHFR and PLAGL1 did not require transformation.  
Table 3.3 shows the means and 95% confidence intervals for global and 
gene-specific methylation following transformation. Geometric means were 
calculated either from original methylation values if the data was not 
transformed, or by back-transforming the means and 95% CI of data that 
was transformed.  
 
Figure 3.5 Normalisation of SNPRN data 
Histograms illustrating the normalisation of SNRPN data from a highly 





3.2.1.4 Participant demographics, health and lifestyle 
 
 
Table 3.3 Summary of transformed global and gene-specific methylation data 
Table 3.4 Frequencies of exposures 24 hours 
prior to sample collection 
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Participants completed a questionnaire regarding their health, lifestyle and 
exposures. In the first section of the questionnaire (appendix 1), participants 
were asked about their exposure to secondary cigarette smoke, attendance 
at work and diet in the 24 hours prior to giving their sperm sample (table 3.4). 
In the second part of the questionnaire, participants were asked about their 
health and lifestyle (tables 3.5 and 3.6) and exposure the certain chemical 
and physical agents (table 3.7). An initial exploration of the questionnaire 
results was carried out to examine trends in the data set.  
 
Table 3.5 Participants health and lifestyle 3 months 
prior to the study 
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The median age was 36 years (25 to 57 years), however most ages 
clustered closer to the median as the 25th and 75th percentiles were 32 and 
39, respectively (table 5). The study population was mostly White men with 
one Black “other” male and one Pakistani male. 10.4% of men were exposed 
to smoke in the previous 24 hours, and 71.1% had attended work. Red meat 
was the most common type of meat consumed in the previous 24 hours 




Thirteen participants (13.4%) reported to have had fever or flu in the 3 
months prior to the study, and 6/13 of these reported cases also had an 
illness that was caused by or made worse by their job (table 3.5). Sixteen 
individuals reported to have a work-related illness and half of these were due 
to stress, depression or anxiety (n=8) and sleep problems (n=3). Other 
reasoning included breathing or lung problems (n=3), headaches and/or 
eyestrain (n=5), bone, joint or muscle problems affecting 
arms/hands/neck/shoulders (n=3), hips, legs or feet (n=1) or back (n=1), 
however these were not excluded from further analyses as these physical 
problems are not relevant to sperm DNA methylation. The smoking history of 
patients consisted of non-smokers (52.6%) or ex-smokers (47.4%) and the 
number of years of smoking was considered due to the consequences of 
long term smoking on health (table 3.6). The median BMI was 25.18 kg/m2 
with around 51.7% of men having a normal weight, 32.7% being overweight 
Table 3.6 Continuous participant demographics 
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and 15.7% being obese; furthermore, roughly 50% of men were physically 
active and 50% were insufficiently active (table 3.5). Alcohol consumption 
was moderate as although 69.1% of men reported to consume more than 
one alcoholic drink per week (table 3.5), the number of units consumed were 
relatively low: the 75th percentile was 15.6 units (table 3.6) which is 
considerably lower than the weekly recommended limit of 21 units. 
 
Table 3.7 Participants exposure to chemical or physical 
agents at work or at home 3 months prior to the study 
Frequencies and percentages of exposure to each chemical 
or physical agent are shown. Heavy vibrating machinery 
includes equipment or vehicles. 
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Participants were questioned about their exposure to various chemical and 
physical hazards (table 3.7). Some participants additionally reported long 
periods of driving and exposure to X-rays and these are included in the 
summary data. Exposure to pesticides, herbicides, fertilisers, dry cleaning 
fluids, PVC/plasticisers, hot environments, non-ionizing radiation, driving and 
X-rays was low, with less than 10% of men exposed. These variables were 
not included in any further analysis due to the low statistical power and false 
positives that low numbers could generate. The most frequent exposures 
were metal dust or fumes, oils or greases, detergents and soaps, glues and 
adhesives and resins, paints and varnishes and lacquers, printing inks or 
dyestuffs, solvents, and heavy vibrating machinery, equipment or vehicles. 
3.2.1.5 DNA methylation and lifestyle factors 
3.2.1.5.1 Sperm DNA methylation and age, BMI, smoking duration 
(years) and alcohol use 
Current literature suggests that with increasing age, global DNA methylation 
decreases, while gene-specific methylation may become hypo- or hyper-
methylated. In this study, spearman’s correlation revealed that neither global 
nor gene-specific methylation was correlated with age (table 3.8). When only 
men classed as fertile upon consultation at the hospital were investigated, 
global methylation still did not show a significant change with age 
(Spearman’s ρ = -0.329; p=0.146; n=21). When infertile men were 
investigated, global methylation was not significantly different with age 
(Spearman’s ρ=-0.137; p=0.387; n=42). 
The associations between BMI, duration of previous smoking, physical 
activity levels (LSI) and weekly alcohol consumption with DNA methylation 
were also investigated. Spearman’s correlation revealed no significant 




Table 3.8 Age and sperm DNA methylation 
Spearman’s correlation, ρ, was carried out for 
global methylation and for each gene or region 





3.2.1.5.2 Effects of 24 hour exposures on DNA methylation 
Although this study focussed on lifestyle and environment in the 3 months 
prior to the study, exposures in the 24 hours prior to the sample donation 
were investigated for their potential to confound the methylation results. Men 
who consumed white meat in the previous 24 hours had a 6.51% higher 
methylation at H19 CTCF6 and 0.24% lower methylation at PLAGL1 (table 
3.10). Other gene-specific and global methylation were not altered in 
response to 24 hour exposures (tables 3.10 and 3.11).   
3.2.1.5.3 Effects of lifestyle and health factors on DNA methylation 
Lifestyle factors in the 3 months prior to the study were investigated as this is 
the approximate duration of spermatogenesis, in which time sperm in a 
Table 3.9 DNA methylation and lifestyle correlations 
Spearman’s correlation, ρ, was carried out for global methylation and for 
each gene or region with BMI, leisure score index (LSI), smoking years, and 




single sample would be affected by these factors. Tables 3.12 and 3.13 list 
these health and lifestyle factors along with the differences in % DNA 
methylation at each gene. Those who reported to have a job illness had 
higher levels of global methylation (413.91 nM) than those who did not 
(370.3 nM) (p=0.06). Those who reported illness due to stress had higher 
levels of MEG3 methylation (89.57%) compared to those who were not 
stressed (88.2%) (p=0.008). Ex-smokers had higher SNRPN methylation 
(2.3%) than non-smokers (1.96%) (p=0.047). Men who had a diet consisting 
of meat and fish had higher global methylation (387.74 nM) than those who 
consumed meat only (328.75 nM) (p=0.039), however the number in the 
meat-only category was very low (n=5) which questions the validity of this 





Table 3.10 Imprinted gene methylation and 24-hour exposures 




Table 3.11 Global and gene-specific methylation and 24-hour exposures  




Table 3.12 Imprinted gene methylation and lifestyle factors. Independent t-test t-statistics and p-




Table 3.13 Global and non-imprinted gene methylation and lifestyle factors. Independent t-test t-




Table 3.14 Imprinted gene methylation and chemical and physical exposures. Independent t-test t-statistics and 
p-values are shown. Correlations with p-value <0.1 are shown in bold. *p<0.05, **p<0.01. 
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Table 3.15 Global and non-imprinted gene methylation and chemical and physical exposures 




3.2.1.5.4. Effects of chemical and physical exposures on DNA 
methylation 
Men were asked about whether they were exposed to certain chemical and 
physical hazards at home or at work. Men who were exposed to glues, 
adhesives or resins had significantly lower SNRPN methylation (p=0.001), 
significantly higher global methylation (p=0.026) (table 3.14 and 3.15). A 
multivariate analysis was then performed with each of these variables. 
Exposures which showed an association with DNA methylation with a p-
value less than 0.1 were also included in the multivariate analysis. These 
included heavy vibrating machinery and PLAGL1 methylation (p=0.06), metal 
dust or fumes and DAZL methylation (p=0.07), and, finally, detergents and 
MEG3 methylation (p=0.09).  MTHFR, NR3C1 and H19 CTCF6 did not show 
any associations with chemical or physical exposures (p>0.1).  
Each row represents a different linear regression model showing the effect of listed 
IVs on DVs while controlling for age, BMI and abstinence time (a) and 24 hour 
white meat consumption (b). Sig. (p-values) are shown for each IV. Control 
variables, not listed, did not show any significance (p-value>0.05) except white 
meat which was linked to H19 exon 1(p=0.038). ANOVA p-values show the overall 
significance of the model as a good predictor of DV outcome considering all IVs. 
 
Table 3.16  Multivariate analysis of the effects of lifestyle and environmental 
exposures on DNA methylation 
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3.2.1.5.5. Multivariate analysis of lifestyle and environmental exposures 
on DNA methylation 
To confirm whether the exposures in the univariate analysis were significant 
when controlling for other factors, multiple linear regression models were 
carried out controlling for age, BMI and abstinence time. Although these 
control variables were not found to be associated with methylation 
independently, they may influence the trends of other exposures, and were 
therefore included as independent variables (IV).  
The results showed that exposure to glues, adhesives and resins was still 
significantly associated with an increase in global DNA methylation 
(p=0.019), but it was no longer linked to a change in SNRPN methylation 
(p=0.137). The remaining chemical and physical exposures did not show 




3.2.1.6 Comparisons and trends in DNA methylation between genes 
Alterations in DNA methylation can occur at single sites or affect multiple 
genes. This can result in two or more genes showing similar patterns of 
increasing or decreasing methylation, or genes may show opposing effects, 
i.e. higher methylation at one site can be linked to lower methylation at 
Table 3.17 DNA methylation correlation matrix 
Sig. (p) values for Spearman’s correlation, ρ, between global methylation and 
gene-specific methylation. Significant correlations are shown in bold. 
*p<0.05, **p<0.01. The direction of  the correlations for SNRPN and DAZL 




another. Furthermore, a marker of aberrant methylation processes is the 
disruption of paternal and maternal imprints, so paternally imprinted genes 
may become demethylated while maternally imprinted genes become 
methylated in sperm. Correlation analyses between genes and between 
genes and global methylation were carried out to determine whether there 
were associations between those under consideration in this study (table 
3.17). 
Bivariate correlations between global methylation and each gene showed 
that global methylation was not significantly associated with gene-specific 
methylation. 
Methylation of maternally imprinted PLAGL1 was negatively correlated with 
paternally imprinted H19 CTCF6 (p=0.03) and also negatively correlated with 
DAZL methylation (p=0.028) (fig. 3.6 B and D). DAZL methylation was highly 
positively correlated with SNRPN methylation (p=0.003) (fig. 3.6 C). Finally, 
the gene with a critical role in the methylation of DNA, MTHFR, was 







Figure 3.6 Gene correlations 
 
Graphical representation of gene methylation correlations showing goodness of fit, r2, 
values. Correlations were made using transformed data so the real trends for DAZL 









3.2.2 Sperm DNA methylation and semen parameters 
3.2.2.1 Normalisation of semen parameter data 
Semen parameters were collected from 94 men and consisted of sperm 
concentration, sperm motility grades (i.e. A, B, C and D) and semen volume. 
The different motility grades were categorised as % progressive motility (PM) 
(grade A and B) and % immotile cells (grade D) and total sperm count was 
calculated from the concentration and volume.  Table 3.18 shows the means, 
standard deviation (SD), minimum and maximum values, 25th and 75th 
percentiles and 95% confidence intervals for the raw data and following 
transformation (see section 2.1.2 for further explanation of data 
transformations). 
 
Table 3.18 Original and transformed semen parameters data 
summary 
The top section of the table illustrates the original semen parameter data while the 
bottom section shows the same parameters after transformation and/or outlier 
removal. Means for transformed data are geometric means and 95% confidence 




3.2.2.2 DNA methylation and sperm parameters 
3.2.2.2.1 Univariate analysis of DNA methylation and sperm parameters 
To investigate the association between semen parameters and DNA 
methylation, correlations were made for each parameter and each gene or 
global methylation. The analysis revealed that global DNA methylation was 
negatively correlated with % PM (p=0.016) and positively correlated with % 
immotile cells (p=0.005) (fig. 3.7 A and B). DAZL methylation was highly 
Figure 3.7 DNA methylation and semen parameters correlations  
Global methylation was negatively correlated with % progressive motility (A) and 
positively correlated with % immotile cells (B). 1/DAZL was positively correlated 
with sperm concentration (p<0.001) (C). MEG3 was negatively correlated with % 







correlated with sperm concentration (p<0.001) and sperm count (p=0.005) 
(fig. 3.7 C). As the reciprocal transformation of DAZL (1/𝐷𝐴𝑍𝐿) was used for 
data analysis, the correlation shown in the graph is in fact negative: higher 
DAZL methylation is linked to lower sperm concentration and sperm count. 
Univariate analysis showed that MEG3 methylation was negatively correlated 
with % PM (p=0.023) and that SNRPN methylation was positively correlated 
with sperm count (p=0.048).  
When sperm parameters within the WHO threshold for normality were 
analysed, the positive correlation between global methylation and % immotile 
sperm was still significant (p=0.028) and the positive correlation between 
DAZL methylation and sperm concentration was also still highly significant 
(p=0.009) (appendix 13, table 2). DNA methylation of H19 CTCF6, H19 exon 
1, PLAGL1, SNRPN, MEG3, MTHFR, and NR3C1 were not correlated with 
any semen parameters in men within the WHO threshold for normality 
(appendix 13, table 1).  
3.2.2.2.2 Multivariate analysis of DNA methylation and sperm 
parameters 
To confirm the associations between DNA methylation and sperm 
parameters found in the univariate models while controlling confounding 
Table 3.19 Multivariate analysis of DNA methylation and sperm parameters 
Each row represents a different multiple linear regression model showing the effect 
of DNA methylation (IV) on sperm parameters (DV) while controlling for age, BMI 
and abstinence time. Sig. (p-values) are shown for each IV. Control variables, not 
listed, did not show any significance (p-value>0.05). ANOVA p-values show the 




factors, multiple regression analyses were carried out with age, BMI and 
abstinence time as additional IVs. All genes that showed significance <0.1 
were included in the analysis. The results showed that increasing global DNA 
methylation is still significantly positively associated with % immotile sperm 
and negatively associated with % PM (table 3.19). Standardised β-
coefficients, which represent the relative change in the DV based on each IV, 
show that changes in global methylation are more closely linked to changes 
in % immotile sperm (p=0.017) than in % PM (p=0.043) as there is a larger 
coefficient value. 1/DAZL methylation was still significantly highly correlated 
with sperm concentration (p=0.001); so increasing DAZL methylation is 
linked to lower sperm concentration. Finally, MEG3 methylation was 
negatively correlated with % PM (p=0.024). 
 
 
Figure 3.8 DNA methylation in fertile and infertile men  
Independent t-tests were carried out between fertile and infertile men. 
MTHFR showed higher methylation in the infertile group **p<0.001. Data sets 
either side of the dotted line are plotted on the left and right y-axes. Error 
bars represent 95% CI. 
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3.2.2.3. DNA methylation in fertile and infertile men 
Following consultation and semen analysis at the fertility hospital, men were 
classed as either fertile or infertile based on their semen parameters or on 
failed previous fertility. Some men classed as infertile had semen parameters 
in the normal range, suggesting that the cause of their infertility may be due 
to factors other than the standard observable semen parameters. Therefore, 
DNA methylation was compared between these two groups of men (fig. 3.8). 
MTHFR methylation was higher in the sperm of infertile men compared with 
fertile men (p=0.006). No other genes or global methylation showed a 





Figure 3.9 DNA methylation in normozoospermic and oligozoospermic 
men 
Independent t-tests were carried out between the two groups. DAZL showed 
higher methylation in the oligozoospermic group ****p<0.0001. Data sets either 
side of the dotted line are plotted on the left and right y-axes. Error bars 
represent 95% CI. 
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3.2.2.4 DNA methylation in oligozoospermic men 
Men with sperm count less than 15x106/ml are classed as oligozoospermic. 
To identify whether this subgroup of men have different methylation levels to 
men with normal sperm concentration, DNA methylation was investigated in 
men with oligozoospermia (n=72) compared to men with normal semen 
parameters (n=12). The numbers of oligozoospermic men were low overall 
therefore consideration was taken to prevent false positive results (see 
appendix 13, table 4). 
DAZL was the only gene to show a significant difference between the 
oligozoospermic and normozoospermic groups, having methylation values of 
5.16% and 2.36%, respectively. The oligozoospermic group contained the 
two highest methylation values in the data set: 18.5% and 20% methylation 
which had concentrations of 9x106 and 13x106 cells/ml, respectively. 
3.2.2.5 DNA methylation in whole and prepared sperm 
During the preparation of sperm for ART, motile and mature sperm are 
separated from immature non-motile sperm, cellular debris and non-sperm 
cells using density gradient centrifugation. A fundamental question of this 
process is whether the purified sperm population is distinct at the epigenetic 
level from the whole sperm population as the former is subsequently used for 
IVF or ICSI. To investigate this, DNA methylation was compared between 
whole sperm, obtained from neat semen washed in PBS only, and that of 
prepared sperm, which had undergone density gradient centrifugation using 
preparation media. 
DNA methylation was significantly higher in prepared sperm than in whole 
semen for all the imprinted genes including H19 exon 1 (p<0.0001), PLAGL1 
(p=0.0052) and PEG10 (p=0.0062), as well as for MTHFR (p=0.037) (fig. 
3.10 B). Global DNA methylation was also significanly higher in prepared 
sperm with a mean of 502.4 nM (±43.42) compared with whole sperm at 





3.2.2.6 DNA methylation as a marker of WBC contaminants in whole 
sperm 
White blood cell (WBC) contamination in semen often occurs due to 
infection, and high numbers of WBCs (leukocytospermia) can cause 
infertility. Clinical sperm preparation should remove these contaminating 
cells. Two genes that are specifically expressed and non-methylated in 
WBCs are CD247 and LSP1. These genes should show hypermethylation, 
and therefore low/no expression, in sperm. Methylation of these genes was 
therefore investigated as a potential marker for WBC contamination in whole 
sperm, as this should show lower methylation levels than prepared sperm. 
Figure 3.10 DNA methylation in whole and prepared sperm  
Global methylation (n=4) (A) and methylation of the imprinted genes H19, 
PLAGL1 and PEG10 and MTHFR (B) in whole sperm (light grey bars) and 
prepared sperm (dark grey bars). Independent t-tests between whole and 
prepared sperm were carried out. Data sets either side of the dotted line 
(B) are plotted on the left and right y-axes. Error bars represent upper and 




The results showed that CD247 was in fact hypomethylated in sperm (fig. 
3.11 A) and furthermore, methylation levels were significantly lower in 
prepared than whole sperm. This contrasts the trend seen with all other 
genes and global methylation which show higher methylation in prepared 
sperm (fig. 3.10). 
LSP1 showed a hypermethylated state that was expected of this WBC 
marker in sperm, however no significant difference was found between LSP1 
methylation in whole and prepared sperm (fig. 3.11 B). WBC counts were not 
available but would have confirmed whether the change in CD247 and LSP1 
were related to WBC numbers. 
3.2.3 DNA methylation and ART outcomes 
To determine whether differential methylation was associated with altered 
fertilisation, cleavage and pregnancy rates, global and imprinted gene 
Figure 3.11 CD247 and LSP1 methylation in whole and prepared sperm 
Methylation of the WBC markers CD247 (n=16) (A) and LSP1 (n=26) (B) in 
whole and prepared sperm. Independent t-tests were used to find significant 





methylation were compared between IVF and ICSI patients and correlated 
with outcomes in each group. 
3.2.3.1 Comparison of DNA methylation in IVF and ICSI patients 
3.2.3.1.1. ART demographics and outcomes 
ART data was collected for IVF and ICSI patients and results were 
interpreted separately for DNA methylation analysis. To identify differences 
between the two types of ART treatment, parameters including protocol type, 
days of stimulation, and transfer day, and outcomes including fertilisation, 
cleavage and pregnancy rates, were compared. There was no significant 
difference in age, % fertilisation, % cleavage or % pregnancy between IVF 
and ICSI groups. However, cleavage rates were considerably higher in the 
Fig. 3.12 IVF and ICSI data  
There were no significant differences in treatment conditions or outcomes 
between IVF (n=52) and ICSI (n=37) groups as determined by the Mann-Whitney 
U test for non-parametric continuous variables (a) and χ2 test for categorical 
variables (b). Data sets either side of the dotted line are plotted on the left and 
right y-axes. Error bars represent standard deviation values. Protocol represents 
%patients that received the LD 21 protocol. 
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IVF group than the ICSI group at 83.5% and 65.5%, respectively. Pregnancy 
rates were also higher in the IVF group compared with the ICSI group 
(44.2% and 35.7%, respectively), however this was not significant. 
3.2.3.1.2 DNA methylation in IVF and ICSI patients 
Sperm DNA methylation was compared between men undergoing IVF and 
those undergoing ICSI to determine whether differences in success rates 
were related to sperm methylation. The analysis showed that SNRPN and 
DAZL methylation were significantly higher in the ICSI group compared with 
the IVF group (p=0.01 and p=0.002, respectively) (fig. 3.13). None of the 
other genes nor global methylation showed significant differences between 
the groups. 
Figure 3.13 Sperm DNA methylation in IVF and ICSI patients  
Gene-specific (A) and global DNA methylation (B) means and 95% CI are 
shown. Data sets either side of the dotted line (A) are plotted on the left and 
right y-axes. Independent t-tests were carried out to identify differences 





3.2.3.2 DNA methylation and ART outcomes  
3.2.3.2.1 Univariate analysis of DNA methylation in whole sperm with 
ART outcomes 
 
To identify whether aberrant sperm methylation of whole sperm may be 
linked to negative ART outcomes, methylation data was correlated with 
fertilisation and cleavage rates for IVF and ICSI patients. The results show 
that global DNA methylation is significantly negatively correlated with 
fertilisation rate in IVF patients (p=0.034) (fig. 3.14). No gene-specific 
methylation was found to be associated with fertilisation or cleavage rates. In 
IVF patients, NR3C1 methylation was higher in those who successfully 
achieved pregnancy compared with those who did not (p=0.027) (appendix 
13, table 5). 
Fig. 3.14 Global DNA methylation and fertilisation rate 
5MedCyd concentration was negatively correlated with 
fertilisation rates in IVF patients (n=36) (p=0.034). 
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3.2.3.2.2 Multivariate analysis of DNA methylation in neat semen and 
ART outcomes 
To determine whether global methylation is truly linked to fertilisation rates, 
and whether NR3C1 methylation is linked to a greater chance of pregnancy, 
multiple linear regression and logistical regression were carried out, 
respectively. The regressions controlled for factors that primarily influence 
ART outcomes, including female age (which is known to be the major 
prognostic factor). Male age was also controlled for, despite not previously 
being associated with DNA methylation in this study (table 3.8), due to 
existing evidence that male age can be an influencing factor for ART 
outcomes. Protocol type and the duration of stimulation of the female partner 
for egg collection were included as independent control variables, as well as 
the transfer day for pregnancy outcomes. Results are shown in table 3.20. 
Table 3.20 Multiple regression analysis of global methylation and fertilisation 
rates in IVF patients 
The association between global methylation and fertilisation rates in IVF 
patients was analysed using multiple linear regression while controlling for 
female and male age, duration of stimulation (days), and protocol type (LD 21 
or antagonist). p-values indicate the significance of each independent variable 
on fertilisation rates while controlling for all other variables. Standardised β 
values represent the number of SD changes expected in the outcome variable 
for 1 SD change in the independent variable, while all other factors are held 
constant. Unstandardised B values are the coefficients in their original units. 
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The linear regression analysis showed that global methylation was no longer 
Table 3.22 Prepared sperm DNA methylation and ART outcomes 
Statistical analysis was performed using the Pearson’s correlation for continuous 
variables (a) and the independent t-test for categorical variables (b).  
Table 3.21 Logistical regression for NR3C1 
methylation and pregnancy outcome 
Significance (p) values and odds ratios are shown for the likelihood of 
each of the IVs contributing to a change in the DV. There were no 
significant associations (p>0.05). 
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statistically significantly associated with fertilisation rates in IVF patients.  
The regression showed that the main determining factor for fertilisation rates 
was female age (p=0.011), while male age, duration of stimulation and 
protocol type did not significantly contribute.  
Logistical regression for the association between NR3C1 methylation and 
pregnancy likelihood did not show significance for any of the independent 
variables (table 3.21).  
3.2.3.2.3 DNA methylation in prepared sperm and ART outcomes 
As it is the prepared sperm which is used for IVF and ICSI, the association 
between methylation of these cells and ART outcomes was investigated. 
Pearson’s correlation between prepared sperm methylation and fertilisation 
rate and cleavage rate showed no significant associations (table 3.22). In 
addition, methylation levels were not different in prepared sperm from those 




This study set out to determine the influences of health and lifestyle factors 
and environmental exposures on sperm DNA methylation, and whether 
disrupted methylation is associated with sperm parameters and IVF and ICSI 
outcomes. DNA methylation at CpG sites plays a critical role in genome 
function, including establishing parent-of-origin imprints in sperm and 
oocytes. Due to the importance of imprinted genes in embryonic 
development and to existing research that shows that aberrant methylation at 
these sites is found in infertile men, the genes H19, MEG3, PLAGL1 and 
SNRPN were investigated. The MTHFR and DAZL genes are non-imprinted 
genes which have roles in the folate pathway and in spermatogenesis, 
respectively. As DNA methylation is one of the primary regulators of gene 
expression, aberrant methylation of these genes could have consequences 
for sperm function. The NR3C1 gene is involved in the stress response 
pathway and has been widely shown to undergo methylation changes in 
response to stress and environmental pressure; it was therefore included in 
this study as a potential marker for stress. Finally, global methyl-cytosine 
levels were measured as a wider marker for methylation changes, including 
methylation at non-CpG sites and in non-regulatory regions such as 
repetitive elements. The main purpose of this study was therefore to 
determine which lifestyle and environmental factors influence global and 
gene-specific methylation and to identify whether this is consequential for 
semen parameters and ART outcomes. 
The major finding of the association between lifestyle and environment and 
sperm DNA methylation, was that global methylation levels were significantly 
higher in men who were exposed to glues, adhesives or resins. This 
contradicts existing research that suggests that exposure to damaging 
environmental toxicants cause a decrease in global sperm methylation (Miao 
et al., 2014). Global methylation was also higher in men who were meat and 
fish eaters compared with meat eaters alone, however the number of 
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reported meat-only eaters was also very low (n=5) and was not investigated 
further. 
Factors that are thought to pose the greatest risk for male infertility are age, 
BMI and smoking (Begueria et al., 2014; Eisenberg et al., 2013; Hamad et 
al., 2014). However, this study did not find any association between these 
health risks and global or gene-specific methylation. However, SNRPN 
methylation was found to be higher in ex-smokers than in those who had 
never smoked, but this significance was lost when controlling for other 
factors. SNRPN methylation was also not correlated with the number of 
years that the individual had smoked. Jenkins et al. (2014) found an overall 
increase in global methylation levels in sperm while simultaneously showing 
site-specific hypomethylation of genes. In this study, a comparison of global 
methylation levels with gene-specific methylation did not show any significant 
correlations. 
The association between DNA methylation and sperm parameters showed 
some strong correlations. DAZL, MEG3 and global methylation were 
significantly negatively associated with sperm concentration and sperm 
motility. When looking at the study population as a whole, sperm 
concentration was found to be highly negatively correlated with methylation 
of the DAZL gene promoter. This strong association was still present when 
subjects were separated into normozoospermic and oligozoospermic groups, 
in which case methylation was significantly higher in the latter. As DNA 
methylation at regulatory sites in genes generally leads to gene silencing, 
this provides evidence that hypomethylation of the DAZL promoter as an 
essential regulatory feature for expression of this gene. Moreover, DAZL 
methylation was correlated with sperm concentration in men who had 
concentration in the normal range (≥15x106/ml), indicating that inhibition of 
spermatogenesis occurs in a dose-dependent manner based on DAZL 
methylation. This is in concordance with a study by Navarro-Costa et al. 
(2010) who found that the CpG island spanning the DAZL promoter had a 
higher number of methylated sites in sperm from oligoasthenozoospermic 
men compared to normozoospermic men. The method of analysis in the 
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study referred to was bisulphite genomic sequencing of cloned fragments of 
sperm DNA. The methylation status of CpG sites is then shown as either 
unmethylated, hemi-methylated or methylated, and the % methylation 
quantified from the number of methylated clones. In contrast, the present 
study used bisulphite pyrosequencing, for which the output results in a read 
of the percentage of methylated DNA copies (i.e. cells) in a sample, and is 
considered to be more robust. The analysis showed that there was a large 
variation in DAZL methylation within the population, with some samples 
having methylation of over 20%, which would have a considerable impact on 
expression levels. CpG site-specific analysis also revealed that all sites 
within the DAZL promoter region were correlated with the mean methylation, 
therefore the aberrant methylation we have found associated with low sperm 
concentration is broadly affecting all CpG sites rather than a select few. Li et 
al. (2013) showed similar results for the effects of DAZL on semen 
parameters and also found that the 6th CTCF binding site of H19 was 
hypomethylated in oligozoospermic men, a trend which was not found here. 
The only exposure factor that had an effect on DAZL methylation was 
exposure to metal dust or fumes, however this was not significant. Metals, 
such as lead and cadmium, are considered to be damaging to male 
reproductive function (Wirth and Mijal, 2010), and could be one of the 
mechanisms in which elevated DAZL methylation leads to lower sperm 
concentration, however further research is needed to clarify this.  
The MEG3 IG-DMR was the only imprinted gene region to show a significant 
correlation with semen parameters. Interestingly, MEG3 methylation was 
negatively correlated with % progressive sperm motility which is contrast to 
two studies which showed a negative influence of MEG3 hypomethylation: 
Kobayashi et al. (2007) found that MEG3 methylation was lower in 
oligozoospermic men, and El Hajj et al. (2011) found lower MEG3 
methylation in infertile men compared to fertile men, but did not describe any 
effects on sperm parameters. Furthermore, MEG3 was not linked to any 
lifestyle or environmental exposures in this study. 
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Global DNA methylation was significantly positively correlated with % 
immotile sperm following multivariate analysis. This is in accordance with 
studies which found that methylation of LINE-1, a surrogate marker for global 
methylation, was associated with lower sperm motility (Tian et al., 2014) and 
this suggests that hypermethylation of sperm DNA is linked to an increase in 
% immotile sperm. However, this directly contrasts the findings of Montjean 
et al. (2015) who found that global methylation was positively correlated with 
sperm progressive motility and sperm concentration, and used a similar 
ELISA method to that used in this study. The study also found an inverse 
relationship between global methylation and DNA fragmentation, suggesting 
that low levels of global methylation signify a general decrease in genomic 
integrity. Critically, a recent study which analysed DNA damage in the same 
cohort of men (Altakroni, 2015) found that high levels of DNA double strand 
breaks were found in sperm samples with high numbers of % immotile 
sperm. One of the sources of such damage is oxidative stress, and ROS 
levels have also been linked to a decrease in global methylation in sperm 
(Tunc and Tremellen, 2009). Given this evidence, lower methylation might be 
expected to be characteristic of samples with a high number of immotile 
sperm, however this is not the case according to the results of this study. In 
accordance with the finding that global methylation is positively correlated 
with % immotile sperm, the present study also showed a negative correlation 
with fertilisation rate in IVF patients, although insignificant. This again 
contradicts existing evidence that points to hypomethylation as a cause of 
poor ART outcomes (Benchaib et al., 2005). Apart from global methylation, 
the major determinant of fertilisation outcomes was maternal age, which is 
already widely acknowledged. 
A comparison of DNA methylation between IVF and ICSI patients revealed 
that DAZL methylation was significantly higher in the sperm of men 
undergoing ICSI treatment, which likely reflects the fact that ICSI treatment is 
most often used for men with poor sperm quality. There was no significant 
trend in DAZL methylation between fertile and infertile men, however, which 
can be explained by male infertility caused by factors other than low 
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concentration, such as poor motility which was not correlated with DAZL 
methylation. Additionally, infertile men can show normal semen parameters. 
Therefore the primary function of DAZL appears to be in sperm production, 
but as the results show, it has no effect on ART outcomes. 
Interestingly, the MTHFR gene showed higher methylation levels in infertile 
men yet did not show any relation to semen parameters. Mthfr plays an 
essential role in the folate/homocysteine pathway that produces methyl 
donors for the methylation process. Wu et al. (2010) found that MTHFR 
promoter hypermethylation was associated with idiopathic male infertility 
and, importantly, that men with normal semen parameters had higher 
methylation than fertile men. This supports the results of this study, which 
suggest that increased MTHFR methylation is linked to infertility without 
causing differences in standard semen parameters. This study also 
examined associations between MTHFR methylation and other genes to 
determine whether aberrant MTHFR expression might affect methylation at 
other sites, as has been shown elsewhere (Rotondo et al., 2013), however 
no significant trends were found.  This may be due to the low number of CpG 
sites analysed compared to the studies above, which despite being located 
in the same CpG island spanning the MTHFR promoter, may have missed 
more informative CpG sites. Considering the indispensable roles of DNA 
methylation in embryogenesis, it may be expected to see some correlations 
between MTHFR gene methylation and ART outcomes. Indeed, MTHFR 
hypermethylation has previously been correlated with spontaneous 
miscarriage (Rotondo et al., 2012); however no significant associations were 
found for fertilisation, cleavage or pregnancy rates in this study. 
SNRPN showed a similar trend to DAZL in that it showed higher methylation 
in the sperm of men undergoing ICSI compared to men undergoing IVF, yet 
this gene was not correlated with sperm parameters nor was it significantly 
different when comparing fertile and infertile men. This maternally imprinted 
gene typically has low levels of methylation in sperm, compared with oocytes 
in which SNRPN methylation is high (Geuns et al., 2003). Again, as sperm 
used for ICSI is generally of lower quality, this significant increase in 
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methylation may be associated with substandard sperm. Indeed, SNRPN 
hypermethylation has previously been linked to low sperm motility (Botezatu 
et al., 2014), which is the major determining factor for whether IVF or ICSI 
treatment is carried out. DAZL and SNPRN were in fact highly positively 
correlated with each other, and may be acting synchronously to affect sperm.  
Differences in methylation between neat semen and prepared sperm were 
analysed as prepared sperm is used for IVF and ICSI, and therefore the 
integrity of this DNA is important for embryogenesis. This study found that 
prepared sperm had consistently significantly higher levels of methylation 
than sperm from neat semen. This included global methylation, the paternally 
imprinted H19 exon 1 and PLAGL1, the maternally imprinted gene PEG10 
and MTHFR. Whether this increase in methylation is a positive or negative 
change is an important question. As already known, an increase in 
methylation of the hypomethylated genes PEG10 and MTHFR could be 
detrimental as it reduces expression levels. However, an increase in global 
methylation is thought to be beneficial as it indicates good genomic stability 
(Rodriguez et al., 2006). In the sister study on the same male cohort 
(Altakroni, 2015), the level of DNA strand breaks was lower in prepared 
sperm, suggesting the DNA of the purified fraction is of higher quality, which 
supports evidence from published studies (Jayaraman et al., 2012). Given 
this evidence, it can be concluded that the prepared sperm fraction had 
higher levels of methylation, which is indicative of selection of good quality 
sperm with high quality DNA. Methylation of prepared sperm was not 
associated with fertilisation, cleavage and pregnancy rates. Although this is 
in conjunction with other studies which found no association between 
prepared sperm methylation and ART outcomes (Camprubi et al., 2012), a 
major limitation here was the low number of prepared samples for analysis. 
Therefore, a definite conclusion cannot be drawn on the effects of prepared 
sperm methylation on ART outcomes. 
The use of a leukocyte-expressing gene was investigated as a prognostic 
marker for WBC contamination in sperm because specific methylation 
fingerprints can be observed for different cell types. This was investigated 
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here based on the idea that WBC genes are heavily methylated and silenced 
in sperm but unmethylated and expressed in contaminating WBCs. Firstly, 
the CD247 gene was investigated as it forms part of the T-cell receptor and 
is therefore unmethylated in these cells. However, contrary to expectations, 
this gene also showed low levels of methylation in whole and prepared 
sperm, which may suggest some role for it in sperm function. Furthermore, 
we would expect a WBC gene such as this to show higher levels of 
methylation in prepared sperm, however the opposite trend was observed. 
Again, this is reasonable if CD247 has some role in sperm function, and is 
therefore unmethylated in fractionated high quality motile sperm. Secondly, 
the LSP1 gene was investigated as a possible marker of WBC 
contamination. This gene showed high levels of methylation in sperm as 
expected, indicative of gene silencing. However there was no difference in 
methylation between prepared sperm and neat semen. This lack of finding 
may be due to semen samples containing relatively low WBCs. WBC counts 
were not available for this study, but would be required to confirm the 
differences in methylation between neat and prepared sperm and between 
different semen samples. This method for detection of different cell types by 
methylation fingerprinting has been used successfully in blood and tumour 
tissue samples (Wieczorek et al., 2009; Sehouli et al., 2011), however no 
study has yet used this method to quantify non-sperm cell DNA in neat 
semen. Although determination of WBC levels in this manner would have 
little relevance in the clinical setting as staining methods for WBC 
determination are straight forward and low-cost, this would be a useful and 
important control for sperm sequencing studies. 
3.3.1 Conclusion 
This study found that the contribution of lifestyle and environmental factors to 
changes in DNA methylation of imprinted and non-imprinted genes was low, 
but may be more significant for global DNA methylation. Although little 
association was found between imprinted gene methylation and sperm 
quality, aberrant methylation of a spermatogenesis-associated gene, DAZL, 
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is directly linked to lower sperm concentration, but has no impact on ART 
outcomes. Furthermore, global DNA methylation may be an important 
marker of overall sperm quality and ART outcomes, as global methylation 
was found to be associated with sperm motility and fertilisation rates in IVF 
patients. Overall, the results suggest that aberrant sperm methylation may 





Effects of lifestyle and environment on semen 
parameters and ART outcomes 
4.1 Introduction 
Several studies have reported a decrease in semen quality, such as the 
reductions in semen volume, reductions in sperm concentration, motility and 
normal morphology (Carlsen et al., 1992; Auger et al., 1995; Rolland et al., 
2013; Romero-Otero et al., 2015; Centola et al., 2016). Infertility is now 
experienced by 1 in 6 couples, with 30% of cases explained by factors in the 
male partner (European Society of Human Reproduction and Embryology, 
2014). Therefore, determining the main effectors of semen parameter 
changes is paramount. These decreasing fertility trends have paralleled 
lifestyle changes in Western countries such as an increase in sedentary 
behaviour and a transition to diets high in sugar, saturated fat and salt 
(Department of Health, 2010; Public Health England 2014), calling into 
question the contribution of environmental and lifestyle factors to male 
infertility. 
Diet has been shown to be an important factor associated with good fertility 
outcomes and consumption of certain foods has been linked with lower 
sperm quality (Afeiche et al., 2013; Gaskins et al., 2012; Chiu et al., 2014). 
Furthermore, a lack of physical activity has also been shown to have 
detrimental effects on fertility (Gaskins et al., 2015). Another common and 
detrimental characteristic of modern society is occupational stress (Labour 
Force Survey, 2015). Stress has been shown to interfere with fertility 
treatment (reviewed in Campagne, 2006) and direct evidence of the 
damaging effects of stress on sperm has been shown previously (Janevic et 
al., 2014). Exposure to environmental toxicants is also a risk factor for 
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infertility: consumption of pesticide-contaminated foods has been linked to 
lower numbers of morphologically normal sperm (Chiu et al., 2015) and 
occupational exposures such as glyxol ethers have been linked to a 
reduction in motile sperm count (Cherry et al., 2014). It is possible that a 
combination of some of these modifiable lifestyle factors lead to substandard 
semen quality. Additionally, advancing age has been shown to be an 
important risk factor for poor semen quality (Johnson et al., 2015) which is 
relevant at this time as more couples choose to delay child-bearing by some 
years (Royal College of Obstetricians and Gynaecologists, 2009).  
As the number of couples undergoing ART worldwide continues to rise, 
improving success rates is a priority. It is widely known that maternal factors, 
particularly age, have a major influence on both natural pregnancy and ART 
outcomes (Jolly et al., 2000; Sazonova et al., 2011). However, paternal 
influences do play an essential role. Sperm quality can affect fertilisation, 
cleavage rates, and embryo quality indicating that sperm can affect pre-
implantation development (Loutradi et al., 2006), however the influence on 
pregnancy rates is not conclusive (van der Westerlaken et al., 2009). It is 
possible for lifestyle and environmental factors to affect ART outcomes 
without causing clear changes to standard semen parameters, instead 
causing alterations at the molecular or genetic level (Anifandis et al., 2013; 
Wegner et al., 2010). In this case, the contribution of paternal lifestyle effects 
to ART outcomes could be significant.  
4.1.1 Aims 
The aims of this chapter were to 
1. To identify which lifestyle and environmental factors associate with 
sperm concentration, motility, total sperm count and semen volume in 
a population of men attending a fertility clinic. 
2. To determine whether sperm quality in neat semen and in prepared 
sperm is related to fertilisation, cleavage and pregnancy rates in IVF 
and ICSI patients. 
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3. To determine whether paternal lifestyle factors are associated with 
fertilisation, cleavage and pregnancy rates in IVF and ICSI patients. 
4.2 Results 
4.2.1 Lifestyle and semen parameters 
4.2.1.1 Semen parameters of the study population 
4.2.1.1.1 Semen parameters raw data 
A total of 169 participants were included in this study. Nine patients 
presenting with a current varicocele were excluded from the study, bringing 
the total to 160 men. Two participants did not complete the questionnaire. 
Table 4.1 shows the original semen parameters data.  
 
4.2.1.1.2 Normalisation of semen parameters 
For parametric statistical analysis purposes, continuous data must show a 
Gaussian, or normal bell-shaped, distribution, therefore the frequency 
distributions of sperm concentration, progressive motility, immotile cells, 
Table 4.1 Semen parameters of the study population 
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volume and sperm count were analysed on histograms and Q-Q plots. 
Sperm concentration and sperm count showed non-normal data and were 
mathematically transformed to log10 (see section 2.1.2 and appendix 6). 
Geometric means and back-converted 95% CI are therefore presented in the 
results for these parameters. % progressively motile, % immotile sperm and 
semen volume are presented as raw data values. 
4.2.1.1.3 Semen parameters correlation matrix 
Poor quality semen often manifests as abnormalities in more than one sperm 
parameter. The association between sperm concentration, % PM, % 
immotile, volume and total sperm count were therefore analysed to 
determine whether these parameters are linked. Pearson’s correlation 
showed that sperm concentration was strongly positively correlated with % 
PM sperm and negatively correlated with % immotile sperm (table 4.2). % 
PM and % immotile cells were highly negatively correlated which is expected 
as these variables are oppositely linked. Sperm count was highly correlated 
with concentration and volume, which was expected as total count is 
determined directly by these factors. Sperm count was also highly positively 
and negatively correlated with %PM and %immotile, respectively. Finally, 
seminal volume was not correlated with parameters other than sperm count. 
Seminal volume is highly variable, and as sperm count is directly linked to 
this, it must be taken into account that changes in sperm count could be as a 
result of natural variation in volume e.g. seasonal variation (Di Georgi et al., 
2015), rather than lifestyle-induced changes. Volume can also be reduced by 
male reproductive tract infections which can affect accessory gland function, 
including the prostate and seminal vesicles, which secrete seminal fluid and 




4.2.1.1.4 Abstinence, seminal volume and sperm count 
The duration of abstinence is one of the biggest predictors of seminal 
volume; therefore to determine whether volume, and consequently sperm 
count, was affected by abstinence time, differences were assessed between 
the number of days the participants abstained for (fig. 4.1). Most participants 
reported to have abstained from intercourse or masturbation for 2-5 days 
(n=122), while some had abstained for 6 days (n=4), 7 days (n=1), 8 days 
(n=1), 9 days (n=1) and 10 days (n=1). Twenty-seven participants did not 
give an answer to this question in the questionnaire. Mean semen volume 
showed an overall decrease between those abstaining for 2 days and those 
abstaining for 6 days, however the only significant correlation was between 
days 3 and 4 which showed an increase (p=0.037). Days 3 and 4 had the 
highest numbers of participants abstaining (n=53 and n=44) which suggests 
this is the most likely representation of true population. Sperm count was not 
significantly different between any of the time points (p=0.059). 
Table 4.2 Semen parameters correlation matrix 
Pearson’s correlation, r, and sig. (p) values are shown for associations 
between semen parameters. 
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4.2.1.2 Study population health and lifestyle demographics 
4.2.1.2.1 Health and lifestyle 3 months prior to the study 
In this study, we were interested in modifiable and non-modifiable risk factors 
that may be associated with aberrant sperm parameters such as age and 
illness. Therefore we initially analysed the data set as a whole to look at the 
overall demographics and lifestyle trends of the participants.  
 
Participants’ ages (years) were collected by the hospital as part of the patient 
consultation. The mean age of the study population was 35.86 years (23 to 
57 years) (table 4.3). BMI was categorised as healthy, <25 kg/m2; 
overweight, 25-29.9 kg/m2; and obese ≥30 kg/m2 and these made up 49%, 
31.7% and 13.9% of the study population, respectively. There was also one 
Figure 4.1 Effects of abstinence time on semen volume and sperm 
count 
There was no clear trend in semen volume and sperm count with duration 
of abstinence. One-way ANOVA statistics and Tukey post-hoc tests 
identified a significant difference in volume between three and four days. 
Significant differences are flagged (*). Error bars represent 95% CI. For 
sperm count, the mean represents the geometric mean. Numbers of men 
abstaining for 2, 3, 4, 5 and 6 days were 12, 53, 44, 13 and 4, respectively.  
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underweight case (17.5 kg/m2). 50% of men were classed as physically 
active and 50% were insufficiently active according to their leisure score 
index (LSI) which was calculated from the amount of moderate and 
strenuous exercise they reported (table 4.3). Alcohol consumption was 
moderate with 69% of men consuming at least one drink per week (table 4.4) 
and within the drinking group  the 75th percentile was 19.15 units, which is 
under the recommended limit of 21 units per week (table 4.3). The mean and 
median were similar indicating that most men were light or moderate 
drinkers. 10.3% of men said they did not wear boxer shorts. The number 
non-smokers (56.7%) was roughly equal to that of ex-smokers (43.3%) with 
a wide variation in the number of years smoked (0.5-33 years). 
With regards to health, 17.2% of men reported to have suffered from fever or 
flu in the 3 months prior to the study. 14% of men reported suffering from a 
work-related illness and 9.6% of men said that a work-related illness was due 
to stress (table 4.4). 43.7% of men were ex-smokers and within this group, 
the mean duration of smoking was 12.76±6.89 years.  
 
Table 4.3 Lifestyle demographics on a continuous 
scale 
Descriptive statistics are shown. Data for alcohol consumption and smoking 
duration is taken from only those who reported to drink alcohol more than once per 




Table 4.4 Participants health and lifestyle 3 months prior to the study 
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4.2.1.2.2 Chemical and physical exposures 
Men were then asked about their exposure to certain chemical and physical 
agents in the 3 months prior to the study. The number of men exposed to 
each factor was analysed to determine which factors could be investigated 
for their effects on semen parameter quality, i.e. which factors had sufficient 
numbers of men exposed and not exposed. Table 4.5 shows the frequencies 
of reported exposures to each factor. It shows that less than 10% of 
participants were exposed to pesticides, herbicides, fertilisers, dry cleaning 
fluids, PVC or plasticisers, extremely hot environments, non-ionizing 
radiation, X-rays or reported driving for long periods. These variables were 
not included in any further analysis.  
 





Figure 4.2 Effects of age on semen parameters 
 
Analysis of semen parameters and male age in the entire data set (A) and in 
men with normal semen parameter values (B). Age was categorised into 
quartiles (key) and a one-way ANOVA analysis of differences in each 
parameter between quartiles was carried out. No significant differences were 






4.2.1.3 Semen parameters, health and lifestyle 
4.2.1.3.1 Semen parameters and age 
To investigate the association between age and semen parameters, age 
(years) was analysed on a continuous scale and also separated into 
categorical quartiles. Age was not correlated with sperm concentration, % 
progressively motile cells, % immotile cells, seminal volume or total sperm 
count on a continuous or categorical scale (fig. 4.2 A). As the severity of 
abnormalities in men with sperm parameters below the normal reference 
limits may hide the effect of age, semen parameters were also analysed 
when restricted to the WHO recommendations for normal values: 
concentration, ≥15x106 cells/ml; progressive motility, ≥32%; immotile cells 
<60%, total sperm count, ≥39x106 cells and seminal volume, ≥1.5 ml. Men 
with normal semen parameters also showed no associations with age (fig. 





Table 4.6 Semen parameters and exposures in the 24 hours prior to the study 




4.2.1.3.1 Exposures in the 24 hours prior to the study: effect on semen 
parameters 
Sperm concentration was not correlated with any of the 24 hour exposure 
variables (table 4.6). This was the case when all samples were analysed and 
when outliers were excluded (>3x106/ml), and when an analysis was carried 
out only in men with normal sperm concentration (≥15x106/ml). Men who ate 
fish in the 24 hours before the study had lower % progressively motile sperm 
(p=0.033) and higher % immotile sperm (p=0.014). This was still significant 
when the number of progressively motile sperm was restricted to >10% 
(p=0.025) and when the number of immotile cells was restricted to <80%. 
However, neither of these trends were significant in sperm which had a 
minimum % PM of 32% (p=0.05). When samples with % PM of 32% were 
analysed, white meat consumption was linked to a reduction in % PM 
(p=0.018). Seminal volume was not correlated with any 24 hour exposures 
and this remained the case when extreme outliers were excluded, or when a 
samples ≥1.5 ml were analysed.  
4.2.1.3.2 Semen parameters, health and lifestyle 3 months previous 
An analysis of health and lifestyle in the 3 months prior to the study (table 
4.7) found that semen parameters were not related to whether the participant 
had fever or flu in the previous 3 months, whether they had a job-related 
illness, or whether this illness was due to stress. Semen parameters were 
also not related to whether the participant was an ex-smoker or had never 
smoked, or whether they were a meat-eater or meat- and fish-eater. 
Participants who were physically active (LSI≥24) compared with those who 
were insufficiently active (LSI≤23) did not show differences in their semen 
parameters (table 4.7) nor was there a difference in semen parameters when 
looking at LSI on a continuous scale (table 4.8). 
A decrease in % immotile sperm was found in men who wore boxer shorts 
(p=0.025), and this correlation was still significant in men who had normal 
motility parameters of ≥32% progressively motile cells but not when % 
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immotile cells was restricted to <80%. There were no significant differences 
in seminal volume with any of the lifestyle variables.  
Alcohol consumption was measured as the number of units consumed per 
week and men were categorised as non- or light-drinkers (<1 unit per week), 
moderate drinkers (1-21 units per week) and heavy drinkers (>21 units per 
week). Sperm concentration was found to be significantly higher in the heavy 
drinking group than the moderate group (p=0.016). When only men with 
sperm concentration ≥15x106/ml were analysed, the trend was still significant 
(p=0.028). When analysed on a continuous scale (table 4.8), alcohol 
consumption was positively correlated with sperm concentration (p=0.04), 
however this was not significant when looking at samples with ≥15x106 
cells/ml (p=0.101, n=128). Alcohol consumption was not associated with any 
other semen parameters. 
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Spearman’s correlation showed that BMI was negatively correlated with 
sperm concentration (p=0.035) and total sperm count (p=0.005) (table 4.9). 
When sperm concentration was restricted to ≥15x106/ml, BMI was no longer 
Table 4.7 Semen parameters, health and lifestyle 3 months prior to the study 
Independent t-test and one-way ANOVA F-statistics are shown along with 




correlated with sperm concentration (p=0.604, n=124) and when sperm 
count was restricted to ≥39x106 cells, this was also not significant (p=0.256). 
%PM and %immotile cells were not correlated with BMI, LSI, alcohol 
consumption or smoking years when all samples were analysed nor when 
only samples ≥32% PM or samples <60% immotile were analysed. Seminal 
volume was not correlated with these lifestyle variables when looking at all 
data or at samples ≥1.5 ml only. 
4.2.1.3.3 Semen parameters and chemical and physical hazards 3 
months previous 
Sperm concentration was not correlated with any of the chemical or physical 
hazards when all data points were analysed (table 4.9). However, 
concentration was significantly lower in men who were exposed to metal dust 
or fumes (n=24) than men who were not exposed (n=104) when only men 
with a normal sperm concentration of ≥15x106/ml were considered (p=0.018). 
Table 4.8 Semen parameters and lifestyle correlations 
Spearman’s correlation, ρ, and significance (p) values are shown. Significant 
correlations are shown in bold. *p<0.05, **p<0.01.  
 144 
 
%PM sperm, %immotile sperm and seminal volume were not correlated with 
any of the chemical or physical hazards when all samples were included, nor 
when samples were restricted to the WHO reference limits (table 2.9). 
Table 4.9 Semen parameters and chemical and physical exposures 3 months prior to 
the study 
Sig. differences between exposed and non-exposed men were determined using 
independent t-tests. T-statistics and sig. (p) values are shown. Means and 95% CI are 
shown for each exposure. Sig. results are shown in bold. *p<0.05. 
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4.2.1.3.4 Semen parameters and diet 
4.2.1.2.3 Food frequency questionnaire 
Twenty-eight food categories were generated from seventy-eight food items 
on the food frequency questionnaire. Principal components analysis revealed 
that there were two primary diet types in the population which corresponded 
to typically “healthy” and “unhealthy” diets. Figure 4.3 illustrates the relative 
contribution of each food group to both diets with each bar on the graph 
representing a different group. The contribution (or loading) of each item to 
the variance is shown by the length of the bars: longer bars contribute a 
larger amount of variance to the diet. Furthermore, the direction of the bars 
(positive or negative) indicates food items that are correlating with each other 
(refer to methods section for further explanation).  The healthy diet was 
typified by consumption of soy, low-fat dairy, all types of vegetables, 
chickpeas, nuts, cereals, green tea and vitamins while the unhealthy diet was 
typified by consumption of red, fried and processed meat, fries, butter, high-
fat dairy, bread, sugar and confectionary, and caffeinated sugar-sweetened 





Each participant was assigned a “healthy” and an “unhealthy” diet score 
Figure 4.3 Principal components analysis of diet composition 
PCA was used to determine the loading of each food group in the “healthy” and 
“unhealthy” diets, which correspond to the first and second principal components, 
respectively. Each bar represents a food group or item. The loading of each item on 
the variance in the data is illustrated by the bar length. Bar direction shows positive 
or negative correlations in the data. Labelled food groups or items are: 
chicken/poultry (1), red meat (2), very fried meat (3), processed meat (4), liver (5), 
fish (6), fried fish (7), fries (8), soy (9), vegetable oil (10), butter (11), high-fat dairy 
(12), low-fat dairy (13), eggs (14), fruit (15), vegetables (16), cruciferous vegetables 
(17), green and leafy vegetables (18), chickpeas (19), nuts (20), cereals (21), bread 
(22), whole grains (23), sugar and confectionary (24), caffeinated non-sugar 
sweetened beverages (25), green tea (26), caffeinated sugar-sweetened beverages 





which were calculated by multiplying the frequency of consumption of each 
food group by the item’s loading value and taking the sum of these scores. 
Total variance explained is the amount of variance that this combination of 
food groups represents in the diet data: the healthy diet represents the 
largest amount of variance in the data, while the unhealthy diet represents 
the second largest level of variance. 
Table 4.10 Food group loading values for “healthy” and 
“unhealthy diets 
Food groups not included in the table are chicken, liver, fish, fried fish, 
vegetable oil, eggs, fruit, whole grains and caffeinated non-sugar-
sweetened beverages due to having little effect in both diets (loading 
<0.1) or having some effect in both diets (loading >0.1). Principal 
components analysis was used to determine the loading of each food 
groups on both diets.  
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The “healthy” and “unhealthy” diets were not correlated with leisure score 
index, i.e. physical activity levels (p=0.573 and p=0.382, respectively), BMI 
(p=0.772 and 0.294), or alcohol consumption (p=0.376 and 0.736). Diet 
scores were categorised into quartiles and semen parameters were analysed 
for each quartile (table 2.11). Sperm concentration, %PM and semen volume 
did not show any association with low, low-moderate, moderate-high or high 
healthy or unhealthy diets. Men in the highest quartile for “unhealthy” diet 
had significantly lower % immotile sperm (p=0.046) than the men with the 
lowest quartile. Sperm count was significantly higher in the third quartile of 
“unhealthy” diet than in the second quartile (p=0.028), however the lowest 
and higher quartiles were not different from each other. When only samples 
in the normal range of semen parameters were analysed (table 4.12) there 
was no significance between “healthy” or “unhealthy” diet scores and semen 
parameters. There was a gradual increase in sperm concentration, volume 
and count as men’s “healthy” diet score increased, however all showed a 
drop in the highest quartile. Conversely, % PM decreased and % immotile 
sperm increased as men consumed more of a healthy diet, which also 




Table 4.11 Semen parameters based on “healthy” and “unhealthy” diets 
Means and 95% CIs are shown for semen parameters in each quartile of the “healthy” and “unhealthy” diets. Significant differences between 
quartiles were calculated using one-way ANOVA; F-statistics and p-values are shown for each parameter. Significant correlations are 
highlighted in bold. *p<0.05. 
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4.2.1.4 Multivariate analysis of lifestyle and semen parameters  
Univariate analysis revealed that sperm concentration was negatively 
correlated with BMI (p=0.035) and positively correlated with alcohol 
consumption (0.04). Sperm count showed similar but insignificant 
associations with these variables also. In addition, unhealthy diet score was 
negatively correlated with % immotile sperm (p=0.046) and positively 
correlated with total sperm count (p=0.028). To control for confounding 
variables that may be influencing these associations, multiple regression 
analyses were performed. 
Due to the evidence of the interactions between diet, BMI, physical activity 
levels and smoking habits, smoking history (ex-/non-) and LSI were included 
as control independent variables (IV), alongside ethnicity. Age was not 
included in the regression analyses as it was positively correlated with BMI 
(p= 0.031) and negatively correlated with having an unhealthy diet (p=0.001), 
and would therefore give rise to multicollinearity in the model, causing 
redundancy of some variables. In addition, age had not shown any 
association with semen parameters in the univariate analysis so could be 
Table 4.12 Effects of diet in men with normal semen parameters 
Differences in semen parameters between quartiles of 
“healthy” and “unhealthy” diets were analysed using one-
way ANOVA. F-statistics (p-value) are shown. 
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justifiably excluded. Seminal volume and total sperm count were also 
controlled for with abstinence time. 
The regression models (table 4.13) showed that BMI was significantly 
negatively correlated with sperm concentration (p=0.031) while alcohol 
consumption was no longer correlated with sperm concentration (p=0.166) 
when controlling for other variables. Overall, the model was not significant 
due to the lack of predictive power of the other IVs for concentration 
(p=0.058). The association between total sperm count and BMI was less 
significant in the regression model, decreasing from p=0.005 to 0.052, while 
the effect of alcohol consumption increased in significance slightly from 
p=0.093 to 0.083. However, the overall model was still significant (p=0.048). 
% Immotile sperm was still significantly negatively correlated with having an 
unhealthy diet in the regression model (p=0.018). Ethnicity was an important 
control variable as it showed significance for both concentration and 
%immotile sperm. 
 
In a separate multiple regression, the effect of solvents on semen volume, 
which was originally found to have a positive correlation (p=0.03) was 
Table 4.13 Multivariate analysis of the effects of BMI, diet and alcohol on 
sperm parameters 
A multiple linear regression was run with each semen parameter as the 
dependent (outcome) variable. Each row corresponds to a different 
regression model. IVs with sig. <0.1 are shown. Sig. (p) values of the overall 
model are shown in the ANOVA p-value column. IVs used in each model 
were BMI, smoking history, unhealthy diet score, LSI, ethnicity (a), plus 
alcohol consumption (b) and abstinence time (c). 
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controlled for abstinence time. The regression removed the significance of 
solvents on volume (p=0.097).  
To summarise, the multivariate analyses showed that higher BMI was 
associated with lower sperm concentration and sperm count, while those 
who consumed high amounts of alcohol had higher sperm counts. Finally, 
men with an unhealthy diet had lower levels of immotile sperm.  
4.2.2 Semen parameters and ART outcomes 
4.2.2.1 Semen parameters in IVF and ICSI patients 
The effect of different semen parameters on the outcome of IVF and ICSI 
treatment was investigated. During ART mature and motile sperm are 
Figure 4.4 Sperm parameters in IVF and ICSI patients 
Sperm concentration, count and % PM were higher while % immotile cells were 
lower in neat semen in IVF patients (A). Following preparation, sperm 
concentration and % PM were still higher in IVF than in ICSI patients (B).  Error 
bars represent upper and lower 95% CIs. Significant results of independent t-




separated from the seminal plasma and washed in media prior to fertilisation; 
this fraction is known as prepared sperm. The standard of neat semen 
parameters before preparation may convey the likelihood of ART outcomes 
as it reflects the quality of the sample as a whole. Following preparation, 
although the better quality sperm have been isolated, sperm quality may still 
reflect ART outcomes.  
In this study, 50.9% of patients underwent IVF treatment while 48.4% 
underwent ICSI. Neat semen parameters were all higher in the IVF than the 
ICSI group. Sperm concentration, % PM cells and total sperm count were 
significantly higher and %immotile cells significantly lower in the IVF group 
(fig. 4.4 A). This is reflected in the fact that there were a higher percentage of 
infertile men in the ICSI group (fig 4.5 B) (76.62%). Following preparation of 
these neat samples, sperm concentration and % PM remained significantly 
higher in the IVF than the ICSI group (fig. 4.4 B). Centrifugation of sperm 
cells results in hyperactivation, which manifests in an increase in forward 
progressive motility; this can be seen as the increase in %PM from neat to 
prepared sperm (fig. 4.4 A and B). In both neat semen and in prepared 
sperm, concentration was highly positively correlated with %PM (p<0.001). 
Due to the stark differences in semen quality in IVF and ICSI patients, ART 
outcomes for these groups were analysed separately.  
4.2.2.2 ART outcomes and demographics for IVF and ICSI patients 
Overall ART outcomes in the IVF and ICSI groups were compared along with 
primary factors that can affect ART outcomes including the egg stimulation 
protocol (L D21 or antagonist), duration of stimulation (days) and the day of 
transfer of embryos into the female (fig. 4.5 A). Fertilisation and cleavage 
rates were not significantly different between the IVF and ICSI groups. Of 
those patients who had successful fertilisation and cleavage, and following 
transfer of the embryos, pregnancy rates were slightly higher in the ICSI 
group (50%) compared to the IVF group (42.9%) however this was not 
statistically significant (p=0.401). 
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Figure 4.5 Outcomes and demographics of IVF and ICSI treatment 
Figure A shows means for fertilisation rates, cleavage rates, days of stimulation 
and transfer day, while showing the %successful pregnancies and %patients who 
underwent the L D21 protocol as a pose to the antagonist protocol. Figure B 
shows means for female and male age, ethnicity as %White British men and also 
%infertile men. Significant differences between IVF and ICSI groups were 
calculated using the Mann-Whitney U test for continuous variables (a) and χ2 for 
categorical variables (b). Total numbers of patients are shown for each bar (A). 
Total number of IVF and ICSI patients was 81 and 75, respectfully (B). Purple 







Female age was significantly higher in the IVF group than the ICSI group 
(p=0.005) while male age was not different between the groups (fig. 4.5 B). 
All men in the IVF group were White British, while in the ICSI group 12.99% 
were of another ethnic background. There was no statistically significant 
difference in the number of infertile men between the two groups. 
4.2.2.3 Univariate analysis of sperm parameters with IVF and ICSI 
outcomes 
Associations between sperm quality and ART outcomes in IVF and ICSI 
patients were investigated using Spearman’s correlation and the Mann-
Whitney U test (table  4.14). Sperm concentraiton, %PM and total sperm 
count were positively correlated with fertilisation rate (p<0.05). 
Concomitantly, % immotile cells were negatively correlated with fertilisation 
rate (p<0.05). As there was multi-collinearity between the semen parameters 
(p<0.001), it was necessary to try to identify the main impacting factor. Total 
Table 4.14 Correlations between semen parameters, fertilisation, cleavage and 
pregnancy rates in IVF and ICSI patients 
Associations between semen parameters and ART outcomes were analysed 
using Spearman’s correlation (a) for continuous variables and Mann-Whitney U 
test for categorical variables (b). Significant results are shown in bold. All semen 
parameters were correlated with fertilisation rates in ICSI samples. *p<0.05. 
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sperm count is a function of sperm concentration and is also dependent on 
seminal volume which is highly variable, so this can be excluded. % PM is 
considered to be a more informative marker of semen quality than % 
immotile cells, as % immotile sperm is a direct opposite measurement to % 
total motility. Therefore, sperm concentration and sperm % PM in neat 
semen are associated with fertilisation rates and were considered for 
multivariate analysis.  
4.2.2.4 Multivariate analysis of sperm parameters with IVF and ICSI 
outcomes 
As sperm concentration and % PM in neat semen was positively correlated 
with fertilisation rates in ICSI patients, the next step was to control for other 
factors that could influence the ART outcomes. Therefore, a multiple linear 
regression analysis was carried out to control for protocol type, days of 
stimulation, female and male age, attempt number and ethnicity.  
The multivariate analysis showed that in ICSI patients sperm concentration 
was borderline significantly associated (p=0.051) and % PM was significantly 
Table 4.15 Multiple regression analysis of sperm parameters and 
fertilisation rates in ICSI patients 
Regression analysis was performed for concentration and % PM on 
fertilisation rates in two separate models while controlling for female age, 
ethnicity, attempt, protocol and days of stimulation.  Unstandardised B and 
standardised β values are shown. p-values indicate the significance of each 
independent variable on fertilisation rates while controlling for all other 
variables. Standardised β values represent the number of SD changes 
expected in the outcome variable for 1 SD change in the independent variable, 
while all other factors are held constant. Unstandardised B values are the 
coefficients in their original units. *p<0.05. 
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associated (p=0.042) with fertilisation rates (table 4.15). The two parameters 
were run in separate regression models as they were highly correlated with 
each other, and this can lead to redundancy in the results. The strength of a 
variable’s effect can be interpreted from the standardised β-values: both 
variables had the highest β-coefficients in the models, with ethnicity also 
having some influence (β=-0.223 and -0.235 for model 1 and 2, respectively). 
Male age was initially included in the regression, however it had an 
extremely low β-value and was highly correlated with female age; this 
justified its removal. Female age did not show a significant effect in model 1 
(p=0.119) or 2 (p=0.171). None of the other variables were significant or 
borderline significant.  
Multiple regression analysis was also performed to confirm the association of 
% PM with cleavage rates in IVF patients. Table 4.16 shows that the 
significance of % PM, whilst controlling for all other factors, actually 
increased from 0.049 to 0.023. No other independent variables showed a 
significant effect on cleavage rates. Ethnicity was not included in the analysis 
as all IVF participants were White British. Standardised β-coefficients 
showed that % PM has the greatest weighting, while attempt and protocol 
type also had strong negative effects on cleavage rate. The overall 
significance of the model was 0.09. 
Table 4.16 Multiple regression analysis of % progressive motility in neat 
semen and cleavage rates in IVF patients. 
Unstandardised B and standardised β values are shown. p-values indicate the 
significance of each independent variable on fertilisation rates while controlling 
for all other variables. Progressive motility (%) was positively correlated with 
fertilisation rates. *p<0.05. 
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To summarise the effects of semen parameters on ART outcomes, sperm 
concentration and % PM were positively correlated with fertilisation rates in 
ICSI patients, however these were not significant. Furthermore, % PM was 
highly correlated with cleavage rates in IVF patients. Prepared sperm 
parameters were not associated with ART outcomes in ICSI or IVF patients. 
4.2.3 Lifestyle and ART outcomes 
4.2.3.1 Univariate analysis of lifestyle factors and ART outcomes 
To investigate the effects of lifestyle on ART outcomes, univariate analyses 
were firstly carried out between lifestyle factors and fertilisation, cleavage 
and pregnancy rates. One-way ANOVA and Tukey post-hoc tests were used 
to identify differences between categorical variables (table 4.17). Univariate 
analysis revealed that having an unhealthy diet was significantly negatively 
Table 4.17 Univariate analysis of lifestyle factors and ART outcomes in IVF 
and ICSI patients 
Continuous lifestyle variables were categorised into quartiles and analysed 
by one-way ANOVA for fertilisation and cleavage rates. IVF and ICSI 
patients were analysed separately. Significance values below 0.1 are 
reported. Tukey post-hoc tests revealed which categories were different, 
shown as flagged (*). **p<0.01. 
 159 
 
correlated with cleavage rates in ICSI patients (p=0.008). Variables which 
showed p-values of <0.1 for association with fertilisation, cleavage and 
pregnancy rates were BMI, alcohol consumption and physical activity levels 
(LSI)  (table 4.18). Results which showed a significance of at least 1.0 were 
included in a multivariate analysis. Other lifestyle factors were not associated 
with ART outcomes.  
4.2.3.2 Multivariate analysis of lifestyle and ART outcomes 
When controlling for female age, duration of stimulation, protocol and 
attempt, BMI and alcohol consumption were no longer correlated with 
fertilisation and cleavage rates in IVF patients, respectively (p=0.365, 
p=0.105). The significant univariate association between unhealthy diets and 
lower cleavage rates in ICSI patients was also no longer significant when 
controlling for other factors (p=0.109). However, the main finding was that 
BMI was significantly negatively correlated with fertilisation rates in ICSI 
patients (p=0.044) (table 4.19). In this regression analysis, % PM was also 
added to the control variables as previous analyses showed that % PM was 
slightly positively correlated with fertilisation rates (section 4.2.4). Sperm 
concentration was not included in the regression as multicollinearity between 
these variables (p=0.06) can cause redundancy. % PM and BMI were not 
correlated (p=0.943). Overall, increased BMI was linked to lower fertilisation 
rates, when controlling for other factors; ethnicity was also negatively 
correlated and % PM was positively correlated with fertilisation rates. 
Logistical regression was performed to investigate the likelihood of 
pregnancy outcome with an increase or decrease in physical activity (LSI). 
These factors were not significantly associated when controlling for female 





Table 4.18 Univariate analysis of LSI with 
pregnancy rate in IVF patients 
χ
2 
 analysis for categorical variables was 
carried out to identify differences in 
pregnancy rates between LSI quartiles.  
Table 4.19 Multiple regression analysis of BMI and fertilisation rates in ICSI 
patients 
Unstandardised B and standardised β values are shown. p-values indicate 
the significance of each independent variable on fertilisation rates while 
controlling for all other variables. BMI, ethnicity and progressive motility 
(%) were correlated with fertilisation rates. *p<0.05. 
 161 
 
4.3 Discussion  
This study investigated the associations between lifestyle factors and semen 
parameters in male partners of couples presenting to a fertility clinic. The 
study also looked at IVF and ICSI outcomes in the study population to 
determine whether semen parameters were an important factor in successful 
fertilisation, cleavage and pregnancy rates, and whether male lifestyle 
influenced this. After controlling for confounding variables, the results 
showed first and foremost that BMI was strongly negatively associated with 
sperm concentration and sperm count. Furthermore, sperm concentration 
was slightly positively correlated with alcohol consumption, while having an 
unhealthy diet was negatively correlated with the percentage of immotile 
sperm. % progressive motility of sperm from neat semen was associated 
with higher cleavage rates in IVF patients, while neat semen concentration 
and progressive motility were associated (insignificantly) with higher 
fertilisation rates in IVF patients. Finally, BMI was also associated with lower 
fertilisation rates in IVF patients. 
BMI was the only lifestyle variable found to be consistently negatively 
associated with sperm concentration throughout the various statistical 
analyses, which corroborates other findings (Sermondade et al., 2013; 
Chavarro et al., 2010; Luque et al., 2015).  However, due to the number of 
studies that have found no association between BMI and sperm quality, the 
causal link remains inconclusive (MacDonald et al., 2013). Additionally, BMI 
was not associated with sperm concentration above 15x106/ml suggesting 
that this may primarily affect men with substandard sperm quality. Inclusion 
of other estimates of body adiposity, such as waist circumference, have 
found an association with lower sperm volume and sperm count and BMI 
(Eisenberg et al., 2014), and there is evidence that weight loss intervention 
can improve sperm DNA integrity (Faure et al., 2014). Notably, this latter 
weight loss study found changes in abdominal fat without changes in BMI, 
which again highlights the inadequacy of BMI as a marker of health. Male 
obesity can lead to a lower likelihood of achieving successful pregnancy 
within 12 months of attempting (Ramlau-Hansen et al., 2007), however the 
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consequences for ART outcomes are inconclusive. Two meta-analyses 
published in 2015 found conflicting results: Le et al. (10 studies) found no 
association between BMI and pregnancy rates while Campbell et al. (30 
studies) found that higher BMI was linked to lower live birth rate; importantly, 
both studies found no differences in semen parameters. Anifandis et al. 
(2013) found a reduction in embryo quality with male BMI which was also 
independent of semen parameters. These studies collectively suggest that 
the sperm quality and ART outcomes may be independently affected by BMI. 
The result presented here found that higher male BMI was associated with 
lower fertilisation rates in ICSI patients.  This cannot be attributed to poor 
standard semen parameters as sperm are injected into the oocyte for ICSI. 
As sperm concentration was lower in men with higher BMI this may indicate 
some error in spermatogenesis. BMI can affect hormonal regulation without 
affecting standard sperm parameters (Al-Ali et al., 2014),  suggesting that 
sperm may be affected at a molecular or genetic level instead which is 
preventing successful fertilisation. The major drawback of our finding is that 
female BMI was not available and therefore could not be controlled for, which 
is known to affect egg quality and fertilisation rates (Shah et al., 2011). 
Further investigations controlling for these factors are necessary to fully 
conclude that male BMI is indeed associated with reduced fertilisation rates 
in IVF. 
How sperm quality changes with advancing age has been a topic of ongoing 
investigation. Research has shown that advancing male age is associated 
with compromised genomic integrity (review in Sharma et al., 2015), yet this 
is not always accompanied by changes to semen parameters (Nijs et al., 
2011). In this study, male age was not correlated with any of the semen 
parameters analysed. Although this corroborates some studies, a recent 
thorough meta-analysis of 90 studies concluded that male age was 
associated with decreases in semen volume, total sperm count, % total 
motility, % progressive motility, % morphologically normal sperm and also 
with an increase in DNA fragmentation (Johnson et al., 2015). The lack of 
association found in this study may be due to the relatively small range of 
ages (23-57 years) under investigation (mean=36 years) which may not 
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reveal the true extent of the trends. With regard to IVF and ICSI outcomes in 
this study, male age had no effect on fertilisation, cleavage or pregnancy 
rates, which supports the findings of existing studies (Nijs et al., 2011; 
Begueria et al., 2014; Wu et al., 2015), although some evidence remains that 
there is a paternal age effect, particularly over 40 years (Kidd et al., 2001; de 
La Rochebrochard et al., 2006). Maternal age remains the most important 
prognostic factor for ART outcomes (ESHRE Capri Workship, 2005; Hourvitz 
et al., 2009). 
The effect of modifiable lifestyle factors on sperm quality and ART is 
important to elucidate as simple lifestyle changes could improve reproductive 
outcomes. This study investigated unhealthy and healthy diets in relation to 
semen parameters and IVF and ICSI outcomes. The two diets were similar to 
those identified elsewhere of men in the United Kingdom which verifies the 
PCA analysis (Slimani et al., 2002). Men who had a more unhealthy diet 
consisting of red, fried and processed meat, fries, butter, high-fat dairy, 
bread, sugar and confectionary, and CSSBs, had lower levels of % immotile 
sperm. This is the opposite trend to what would generally be expected from 
an unhealthy lifestyle and contrasts directly to the results of one study in 
which a “prudent” diet typified by consumption of fish, chicken, fruit 
vegetables and whole grains was linked to higher levels of % progressive 
motility (Gaskins et al., 2012). In this study, Gaskins et al. recruited 
participants from a young healthy men’s study, rather than from an infertility 
clinic, suggesting that diet types may show different trends in the general 
population. This issue was confronted by analysing diet trends in men with at 
least one normal semen parameter, in which case having an unhealthy diet 
was no longer linked to lower % immotile sperm. The healthy diet was 
associated with increases in sperm concentration, volume and count up to 
the moderate-high group, but then dropped in the highest group. One 
explanation for this could be that some products associated with the healthy 
diet such as soy, can be damaging to sperm due to the phyto-estrogens 
present. Phyto-estrogens are plant-derived endocrine disruptors which mimic 
oestrogen hormone activity by binding to the oestrogen receptor and have 
been linked to lower sperm concentration, but not motility, in a study also 
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looking at men attending a fertility clinic (Chavarro et al., 2008). However, 
elsewhere phyto-oestrogens have been shown to have no effect on sperm 
parameters or hormone levels (Mitchell et al., 2001). 
It is difficult to firmly conclude the causal effects of specific food items on 
sperm parameters as individual diets vary so widely, which is why this study 
focussed on general diet trends. However some studies have attributed 
specific foods to changes in semen parameters, including sugar sweetened 
beverages, trans-fatty acids, fish and the breadth of research on anti-oxidant 
containing foods (Chiu et al., 2014; Chavvaro et al., 2014; Afeiche et al., 
2014; Zareba et al., 2013). There are few studies investigating the effects of 
male diet on ART outcomes but Xia et al. (2015) found that increased 
consumption of processed meat is associated with lower fertilisation rates. 
Although processed meat was one of the foods with the largest loading in the 
unhealthy diet, this study did not find an association between unhealthy 
lifestyles and IVF or ICSI outcomes. 
A point of consideration with regard to grouping the diets as “healthy” and 
“unhealthy” is that the other lifestyle factors in the analysis did not fit with 
typical healthy or unhealthy lifestyles, i.e. there was no association between 
healthy and unhealthy diets and BMI, physical activity or alcohol 
consumption. Therefore those individuals with unhealthier diets were not 
sharing the traditional attributes of being unhealthy, i.e. being overweight or 
obese, having low activity levels and drinking more alcohol. BMI itself was 
also not related to physical activity levels, calling into question the reliability 
of the self-reported data in the questionnaire. 
The benefits of being physically active for human health are extensive. LSI 
was calculated from the number of times per week participants carried out 
moderate and strenuous exercise for more than 15 minutes, which was 
designed and is still commonly used as a method for estimating physical 
activity levels (Godin and Shephard, 1985). LSI scores were analysed in 
terms of being active or insufficiently active, as well as on a continuous 
scale, and no correlation was identified between physical activity levels and 
semen parameters. This result is not surprising as in the current literature, 
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like BMI, there is a disparity as to whether and to what extent physical 
activity affects semen parameters. Two similar studies on young healthy men 
found contrasting results, with one reporting no effect and another reporting 
a significant improvement in sperm quality with physical activity on a 
continuous scale (Gaskins et al., 2014; Minguez-Alarcon, et al., 2014). In 
comparison, men who participated in a large amount of sedentary behaviour 
(measured as TV watching) had lower sperm concentration (Gaskin et al., 
2015). There is evidence that the type of physical activity men engage in can 
have different bearings on sperm quality, which was not accounted for in this 
study, and may be one of the reasons for no differences being detected 
(Gaskin et al., 2014). A more likely reason for no association being found in 
this study may be due to the subfertility of the study population, in which 
case any small changes in sperm quality due to physical activity may be 
negligible. However, when LSI was analysed only in men with semen 
parameters above the WHO recommendations for a normal semen sample, 
there was still no association. Gaskins et al. (2014) also found that paternal 
physical activity was not associated with clinical outcomes of ART, which is 
also the case in this study.   
Curiously, alcohol consumption was associated with higher sperm 
concentration and sperm count in the univariate analyses, with the greatest 
increase in sperm concentration being in men who consumed more than the 
recommended guidelines of 21 units per week. When controlling for 
confounding variables, these were no longer significant. Despite alcohol 
being linked to low semen quality in healthy men (Jensen et al., 2014), 
Povey et al. (2012) also found that men who consumed alcohol in the 3 
months prior to their study had lower likelihood of low-motile sperm 
concentration. This was not significant following multivariate analysis, 
however when considered in conjunction with the results from this study, 
which provided more detail in terms of the quantity of alcoholic units 
consumed per week, it suggests that there may be more to the thus far 
superficial information on alcohol and semen parameters. It is possible that 
certain personality traits that define a man’s drinking habits may also 
influence other lifestyle choices, through which moderate alcohol 
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consumption could lead to improved semen parameters. Paternal alcohol 
consumption was associated with decreased live birth rates and increased 
miscarriage rates in couples undergoing IVF treatment (Klonoff-Cohen et al., 
2003), yet no trend was seen between alcohol consumption and IVF or ART 
outcomes in this study. 
The effects of current smoking could not be investigated on this cohort of 
men as smoking is prohibited during ART treatment. Therefore, men 
reported to be either ex-smokers or non-smokers and no difference was 
found in any of the semen parameters between the non- and ex-smoking 
groups. This is in accordance with other findings related to men attending 
fertility clinics (Pacey et al., 2014; Povey et al.,2012). The duration of 
smoking (years) was also investigated to determine if long-term smoking 
could have an effect on fertility, however this also did not show any 
association with semen parameters. If men had stopped smoking more than 
3 months before giving their sperm sample, any smoking-induced damage 
may not have manifest in the present sperm, as a full round of 
spermatogenesis would have completed in that time. A more insightful 
variable to consider would be whether men had been exposed to maternal 
smoking in utero as this is known to drastically affect sperm and fertility of 
male offspring (Axelsson et al., 2013) and the extent of this damage has 
been shown in controlled animal studies (Sobinoff et al., 2014). Correct germ 
cell development is crucial for a man’s adult fertility as spermatogonia are the 
source of mature sperm post-puberty. At this vulnerable stage sperm would 
therefore be affected by exposure to toxins such as tobacco smoke. Thus, it 
would be insightful to ask men about their mother’s smoking habits  while 
pregnant as this could describe a large proportion of the variation in semen 
quality seen here. Smoking was also not associated with IVF or ICSI 
outcomes in this study.  
Men attending the fertility clinic were advised to wear loose fitting underwear 
and were asked in the questionnaire whether they wore boxer shorts. The 
results showed that wearing boxer shorts was associated with a lower 
number of immotile sperm, which supports a previous study which found that 
wearing boxer shorts was associated with better low-motile sperm 
 167 
 
concentration (Povey et al., 2012). This supports evidence that suggests that 
tight underwear can impair testicular function due to elevated scrotal 
temperatures, however the imbalance of numbers of men reporting to wear 
boxer shorts (n=139) versus not wearing (n=16) could suggest a false 
positive result here. Furthermore, some participants in the “no boxer shorts” 
group reported to wear no underwear at all which would not present the 
same risk as tight boxers.  These results should therefore be interpreted with 
caution.  
Chemical and physical exposures were not found to be associated with 
semen parameters in this study, which is in accordance with Jurewicz et al. 
(2014) who found that only exposure to high levels of noise was linked to 
poorer semen parameters, while sitting, exposure to PVC and high 
temperatures were not significantly associated. Notably, exposures which did 
not result in a change in semen parameters did show an increase in DNA 
fragmentation, indicating that many of these modifiable lifestyle factors are 
having damaging effects at the DNA rather than the morphological level. 
Other studies have shown significant effects of chemical and physical 
exposures, including lower sperm quality with heavy metals and solvents 
exposure, and specifically lower sperm motility associated with vibrating 
machinery and hot environments (De Fleurian et al., 2009).  
Exposure to pesticides, herbicides, fertilisers, dry cleaning fluids, PVC or 
plasticisers, extremely hot environments, non-ionizing radiation, X-rays or 
driving for long periods were not analysed due to low participant numbers. 
However, some of these have previously been shown to affect semen 
parameters: De Fleurian et al. found that hot environments were linked to 
lower sperm motility while Chiu et al. (2015) found an association between 
poor sperm morphology and pesticide-contaminated foods and Kumar et al. 
(2013) found poor sperm morphology in men exposed to ionisation radiation, 
i.e. X-rays. Sperm morphology was not analysed in this study, but seems to 
be an important parameter to measure for sperm quality.   
In this study, IVF and ICSI patients both represented roughly half of the study 
population. Semen parameters were all significantly poorer in the ICSI group 
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as expected; ICSI treatment involves the selection of a single sperm for 
injection into the oocyte usually due to very poor semen parameters that 
prevent fertilisation in conventional IVF. There was no difference in 
fertilisation, cleavage or pregnancy rates between IVF and ICSI groups, 
which is agreeable with existing research that shows that once embryos 
have reached the transfer stage, there is no difference in pregnancy outcome 
based on treatment type although embryo quality can differ (van der 
Westerlaken et al., 2006). Sperm quality was associated with some ART 
outcome measures. Increased sperm concentration and % PM in neat 
semen were both associated with higher fertilisation rates in ICSI patients 
which has been shown elsewhere (Lu et al., 2012; Loutradi et al., 2006). 
These two variables are also highly correlated with each other so it is difficult 
to distinguish which is the dominant factor. As ICSI involves sperm injection, 
the low fertilisation rates cannot be due to failure of sperm to successfully 
travel to or penetrate the egg plasma membrane. It is therefore probable that 
other mechanisms, possibly molecular or genetic, can interrupt fertilisation, 
such as improper expression or activity of phospholipase C zeta (PLCζ). 
PLCζ is a sperm factor released into the egg upon fertilisation which 
activates the egg by initiating intracellular calcium oscillations (Kashir et al., 
2010). Increased BMI was also found to be associated with lower fertilisation 
rates in these ICSI patients. As BMI and sperm concentration are correlated 
with each other, it is difficult to know which is causing the change in 
fertilisation rates. Again, as female BMI or other female lifestyle factors were 
not controlled for, these findings require further validation. Finally, in IVF 
patients, higher % PM in neat semen was associated with higher cleavage 
rates. 
4.3.2 Conclusion 
In conclusion, some modifiable environmental and lifestyle factors may 
influence sperm parameters, which could have consequences for IVF and 
ICSI, but male lifestyle alone has little bearing on ART outcomes. As others 
have suggested (Povey et al. 2012), although some lifestyle changes may 
 169 
 
lead to small improvements in semen quality, it is unlikely that this will occur 
to an extent that the chances of successful ART are increased.  
Chapter 5 
An in vitro model to investigate the effects of 
glycation on human sperm 
5.1  Introduction 
Lifestyle habits known to be detrimental to health include poor diet, obesity, 
sedentary behaviour and smoking. The non-enzymatic glycation of proteins, 
lipids and nucleic acids by reducing sugars to form stable covalent advanced 
glycation end products (AGEs) is thought to be one mechanism behind the 
progression of disease states as a result of these damaging lifestyle factors. 
AGE formation on biomolecules occurs as a result of the reaction of the 
carbonyl (C=O) group of reducing sugars with the amine (NH2) group of 
proteins, lipids or nucleic acids through the Maillard reaction. Glycation is 
accelerated in hyperglycaemic conditions and AGEs accumulate in the body 
over time, implicating AGEs in many diabetes- and age-related diseases. 
AGEs are also formed exogenously: cigarette smoking is a source of toxic 
AGEs that leads to an accumulation of AGEs in the tissues of smokers 
(Cerami et al., 1997; Nicholl et al., 1998); while high-temperature cooking of 
foods, particularly meats, is a dietary source of AGEs (Goldberg et al., 2004).  
Several lifestyle traits and environmental exposures can therefore contribute 
toward increasing levels of AGEs in the body. 
A decline in male fertility over recent decades has been reported in several 
studies looking at changes in semen parameters (Auger et al., 1995; Carlsen 
et al., 1992; Rolland et al., 2013; Romero-Otero et al., 2015). AGEs have 
been investigated as a potential contributor to this decline in sperm function 
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as one of the major AGEs, carboxymethyl-lysine (CML) has been found 
elevated on the sperm of diabetic men (Karimi et al., 2011; Mallidis et al., 
2009). CML is a glycoxidation product: it is formed on proteins by a 
combination of glycation and oxidation reactions (Fu et al., 1996). The major 
mechanisms of damage by AGEs are in altering protein structure and 
function, crosslinking extracellular matrix (ECM) proteins, and activating the 
inflammatory response in cells on interaction with the receptor for AGE, 
RAGE (Goldin et al., 2006; Ahmed, 2005; Zhang et al., 2006; Guimaraes et 
al., 2010). AGEs are also a potent source of reactive oxygen species (ROS), 
and as sperm are particularly susceptible to oxidative damage, elevated 
ROS levels can contribute to poor sperm function (Sharma et al., 1999; Aziz 
et al., 2004; Agarwal et al., 2014b).  
Research suggests that AGEs could be a source of damage to sperm. 
Firstly, higher levels of seminal plasma AGEs correlate with sperm lipid 
peroxidation levels, indicating a direct role for the action of AGE-generated 
ROS (Karimi et al., 2011). Secondly, RAGE is located on sperm cells as well 
as throughout the testis and epididymis, suggesting that the inflammatory 
response pathway could be a mechanism for ROS generation in sperm and 
in surrounding cells. Interestingly, higher levels of RAGE are found in 
diabetics than non-diabetics (Mallidis et al., 2007) and this directly correlates 
with nuclear DNA fragmentation though it does not reflect changes in 
standard semen parameters (Karimi et al., 2012). It seems that AGE-
mediated damage could occur as far as the DNA level without showing 
differences in sperm concentration, motility or morphology. This is important 
to consider as infertility is defined clinically by these features only. 
The occurrence of AGE and RAGE in healthy males shows that these 
compounds have some baseline effect on sperm function, and may cause 
oxidative stress, lipid peroxidation and sperm DNA damage. It is important to 
illustrate the mechanistic action of AGEs on these markers of sperm 
damage, and this can be achieved through the use of in vitro cell assays. 
Many in vitro glycation assays have been carried out on different cell types 
as well as on purified proteins to elucidate causes and consequences AGE-
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mediated damage (Portero-Otin et al., 2002; Nass et al., 2010; Ahmed et al., 
2005b). An in vitro assay for human sperm will provide some evidence for 
whether these compounds are an important factor to consider in regards to 
infertility, as has been achieved with oocytes (Liu et al., 2013). Importantly, 
as AGE levels are related to lifestyle and environment, AGE-mediated sperm 
damage could be reduced through lifestyle interventions. 
5.1.1 Aims 
1. To develop an in vitro cell-based assay to investigate the effects of 
glycation on sperm function. 
2. To measure CML formation in glycated sperm and determine the 
impacts on ROS generation, oxidative DNA damage and HA binding 
capacity. 
3. To investigate differences in CML levels between obese men 
compared with normal weight men. 
4. To determine the effects of in vitro glycation of the hyaluronidase 
protein.  
5.2 Results 
5.2.1 Formation of AGEs on sperm glycated in vitro over 6 days 
5.2.1.1 Glucose does not glycate sperm in vitro 
Glucose sugar was first utilised as the glycating agent for in vitro incubation 
with prepared sperm for 6 days at 37°C. The formation of the prominent 
AGE, carboxymethyllysine (CML), was measured in sperm glycated in the 
presence of SPM and glucose at 30 and 50 mM (fig. 5.1). As sperm are non-
dividing cells, they can be maintained in culture for a limited period of time. 
The number of days that sperm could be kept in culture in the presence of 
various compounds was determined based on sperm vitality measured using 
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the eosin-nigrosin stain (fig. 5.2). The results revealed that incubating sperm 
with glucose at 30 and 50 mM promoted much greater sperm survival after 6 
days of 43.4% (p<0.0001) and 51.4% (p<0.0001) compared with SPM 
samples at 7.1% survival. 
Incubation of sperm with glucose did not result in a significant difference in 
CML levels between sperm incubated with glucose at either concentration 
and sperm incubated with SPM alone (fig. 5.1, p>0.05). Sperm motility was 
also measured over the course of the first 72 hours of incubation. At 72 
hours, glucose supplementation had maintained sperm progressive motility 
at around 50% which was higher than sperm incubated with SPM, though not 
significantly so (p>0.05) (fig. 5.3). It is possible that the incubation period was 
Figure 5.1 CML formation on sperm glycated with glucose for 6 days  
Relative CML levels were measured as mean fluorescence intensity 
(MFI). CML levels in sperm incubated with glucose at 30 mM (n=4) and 50 
mM (n=3) were not significantly different from sperm incubated with SPM 




not sufficient for glycation by glucose to take place, however it was 
unadvisable to extend the incubation period as the vitality of sperm incubated 
with the control media (SPM) would have reached 0%. 
5.2.1.2 Fructose and mannitol do not glycate sperm in vitro 
Since glycation of sperm with glucose was not evident in the time frame 
necessary, fructose was then tested as a potential physiological glycating 
agent. Fructose is a reducing sugar with the same molecular weight as 
glucose (180.16) and is the abundant sugar in seminal plasma. As a control, 
the non-reducing sugar mannitol was used. This sugar lacks the glycating 
Figure 5.2 Vitality testing of glycated sperm incubated with glucose  
Results show the % live sperm following glycation with glucose (n=7) (30 
mM and 50 mM), MG (n=7) (50 µM) and GO (n=4) (50 µM) for 6 days, 
measured using the eosin-nigrosin stain. Sperm vitality decreased in all 
treatment groups during the incubation period but the presence of glucose 
significantly maintained vitality at a much higher level than SPM, MG and 
GO (**** = p<0.0001). 
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capacity of glucose and fructose yet also has a similar molecular weight 
(182.16). Neither fructose nor mannitol treatment resulted in a significant 
difference in CML levels compared to other treatments (p>0.05). 
5.2.1.3 Toxicity testing of MG 
As the reducing sugars were ineffective at glycating sperm over the 6 day 
time period, the reactive AGE intermediate, methylglyoxal (MG), was used. 
MG is a potent and rapid AGE precursor, reacting more readily with proteins 
than the aforementioned simple sugars.  A kill curve was carried out over 48 
hours and vitality measured with the eosin-nigrosin stain to determine the 
optimal concentration to use. Cell vitality was expected to consistently 
decrease over time, and as 48 hours was one third of the total incubation 
time of 6 days, a toxicity cut-off point was set at a decrease of one third of 
the original vitality. The concentration at which the number of live cells was 
reduced by less than one third was 50 µM (fig. 5.4), and this concentration 
was used for all further experiments with MG. 
Figure 5.3 Effects of glycation on sperm motility 
% Progressively motile sperm after 72 hours in culture with SPM, glucose, 
fructose, mannitol MG and GO (n=3). Two-way ANOVA with multiple 
comparisons showed that all treatments showed a significant decrease in 
sperm motility over time (p<0.05), however, none of the treatments were 
significantly different at 72 hours (p>0.05). Error bars represent the standard 
deviation of the mean. 
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MG treatment caused a substantial decrease in sperm vitality over 6 days to 
14.1% and this was not significantly different from survival rate in SPM 
(p>0.05). This vitality data correlated with sperm motility data which showed 
that by the end of the incubation period, 100% of cells exposed to SPM and 
MG were immotile, while 30 mM and 50 mM glucose samples showed 31% 
and 41% total motility, respectively. 
 
5.2.1.4 Glyoxal glycates sperm in vitro 
Another reactive AGE intermediate - glyoxal (GO) - was included in the 
glycation experiments as it is the major intermediate source of CML, while 
MG primarily forms carboxy-ethyl-lysine (CEL), a structurally similar AGE. In 
glycation research these compounds are usually investigated simultaneously 
as they have a similar potency and prevalence in the body and are both 
implicated in AGE-related disease. Due to their structural similarity and 
Figure 5.4 Methylgloxal kill curve 
Grey bars show the % live sperm after 48 hours incubation with 
various concentrations of MG (0-500 µM). Vitality was determined by 
the eosin-nigrosin stain. 
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similar physiological concentrations, GO was used alongside MG in all 
experiments at 50 µM.  
Figure 5.5 Glycation of sperm with MG and GO 
CML formation on human sperm after a 6 day incubation with SPM (n=8) and 
with glycating agents, MG (n=8) and GO (n=5). Relative CML was measured 
as mean fluorescence intensity (MFI) of flow cytometry detection. One-way 
ANOVA analysis showed that GO caused significantly more CML formation 
than MG or SPM. Error bars represent the standard deviation of the mean. 
****p<0.0001, **p<0.01.  
 177 
 
Glycation of sperm with reactive AGE intermediates over 6 days resulted in 
higher levels of CML formation in sperm treated with MG and GO compared 
with SPM-treated sperm (fig. 5.5). However, a one-way ANOVA showed that 
only GO was significantly different from MG (p<0.01) and SPM (p<0.0001), 
while MG did not cause significantly higher levels of CML than SPM control 
(p=0.771). In terms of the effects of these factors on sperm motility, there 
was a significant drop in sperm motility after 72 hours incubation, however 
motility was not significantly different to sperm incubated with SPM (p>0.05) 
(fig. 5.3).  
5.2.1.5 Intracellular ROS production is not affected by glycating agents 
Glycation of proteins and binding of AGEs to RAGE causes the release of 
reactive oxygen species (ROS). Intracellular ROS was therefore measured in 
sperm after the 6 day incubation period with sugars or intermediates to 
Figure 5.6 Intracellular ROS production in glycated sperm  
Relative ROS levels in sperm treated with SPM (n=6), with the reducing sugars 
glucose (n=3) and fructose (n=3) (10 mM), a non-reducing sugar control mannitol 
(n=3) (10 mM), MG (n=6) or GO (n=3) (50 µM) for 6 days. ROS was measured 
as mean fluorescence intensity (MFI) of flow cytometry detection. One-way 
ANOVA analysis revealed no difference in ROS levels between any of the 
treatment groups. Error bars represent the standard deviation of the mean. 
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identify if ROS generation was occurring. The results showed no significant 
difference in ROS levels between sperm from any of the treatment groups 
(p=0.992) (fig. 5.6). As the ROS levels were so low, a test was carried out 
with varying concentrations of MG (0-500 µM) to determine at what point 
high ROS production would occur (fig.5.7). There was a slight increase in 
ROS production from 50 µM onwards, but the clearest change was after the 
use of 500 µM MG, at which point ROS levels triple that of the preceding 
concentration.  
5.2.1.6 Oxidative DNA damage is elevated in sperm treated with MG and 
GO 
Due to the unstable nature of free radicals, ROS measurement can be 
unreliable and underestimate the level of damage caused to cells. Instead, 
the biological effects of damage by ROS were determined by measuring 8-
oxoguanine levels as a marker of oxidative DNA damage. The results 
showed that 8-oxoguanine levels were significantly higher in sperm treated 
with GO than with MG (p=0.043) and SPM (p=0.018) (fig. 5.8). However, MG 
did not cause significantly more oxidative DNA damage than SPM (p=0.754). 
This trend mirrored the results of the glycation experiment in which GO 




Figure 5.7 Intracellular ROS levels in sperm treated with MG  
Relative ROS levels were measured in sperm treated with MG at various 
concentrations (0-500 µM) for 48 hours. ROS levels were drastically elevated 
only at the highest concentration of MG. ROS levels were measured as mean 
fluorescence intensity (MFI) during flow cytometry detection.  
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5.2.1.7 Immunocytochemistry for AGEs 
Glycated sperm were stained by immunocytochemistry (ICC) for general 
AGEs and CML to identify the cellular locations of these compounds on the 
cells. Initial observations show AGE and CML staining on all anatomical 
regions of the sperm: the head, midpiece and tail. Corrected total cell 
fluorescence (CCF) was calculated to account for background levels of 
fluorescence in the images. This analysis was only carried out on the head 
regions of the sperm. 
AGEs seem to show an even distribution across all parts of the sperm cell 
(fig. 5.9 B, E, H). At higher magnification (100X), the AGE staining on the 
sperm head shows a fine speckled pattern. This staining, as well as tail 
staining, showed higher reactivity in sperm treated with GO than with SPM or 
Figure 5.8 Oxidative DNA damage in glycated sperm  
8-oxoguanine levels were measured in sperm treated with SPM (n=3) and 
reactive AGE intermediates, MG (n=3) and GO (n=3) (50 µM). 8-oxoguanine 
levels were determined as the mean fluorescence intensity (MFI) of flow 
cytometry detection. GO treatment caused significantly more 8-oxoguanine 
generation than SPM or MG (*p<0.05). Error bars represent the standard 
deviation of the mean. 
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MG. However, the CCF analysis showed that relative AGE intensity in the 
head region of GO-sperm was significantly higher than MG (p=0.0048) but 
not SPM (0.3232) (fig. 5.11). SPM-sperm also showed significantly higher 
AGE intensity than MG cells (p=0.044). The data suggest that AGE intensity 
in GO-sperm was not different from SPM-sperm, however it is clear from the 
images that tail intensity was very different between the treatment groups 
and should be accounted for alongside the CCF data. 
CML fluorescence was faint in SPM-treated sperm, while showing a more 
intense staining in the tail region of the MG- and GO- treated cells (fig. 5.10 
B, E, H). This was particularly prominent in the acrosomal head region in GO 
sperm, from the mid-section to the most anterior point (fig. 5.10 G). This is 
supported in the CCF data (fig. 5.12) which showed that GO cells had 
significantly higher CML staining than SPM (p=0.0419) and MG cells 
(p=0.0237), while CML in heads of MG-sperm was not different to SPM-
sperm (p=0.999). These CCF data match that of the flow cytometry results 
for CML levels in sperm. As the CCF data does not account for tail intensity, 
it is possible that CML levels on tail regions in MG-sperm could be higher 
than that of SPM-sperm, as the images suggest (fig. 5.10 B and E).  
Negative controls for AGEs (fig. 5.9 J-L) and CML (fig. 5.10 J-L) showed a 
slight amount of autofluorescence or non-specific binding, but these levels 
were minimal and unlikely to compromise the observations.  
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Figure 5.9 Immunocytochemistry for the detection of general AGEs on sperm. ICC was performed on sperm incubated with SPM 
(A-C), MG (D-F) and GO (G-I) for 6 days. Nuclear staining with DAPI is shown in the middle column, AGE positivity measured in the FITC 
channel is shown in the right hand column, and merged images are shown in the left-hand column. All treatment groups showed positive 
staining for AGEs in the head and tail regions. In MG and GO groups, there was more intense staining, particularly on the tail region in the 









Figure 5.10 Immunocytochemistry for the detection of CML on sperm. ICC was performed on sperm incubated with SPM (A-C), 
MG (D-F) and GO (G-I) for 6 days. CML was not as abundant on sperm treated with SPM as it was on MG- and GO-treated sperm, 




Figure 5.11 Corrected Total Cell Fluorescence for AGE ICC 
Fluorescence intensity of general AGEs in sperm treated with SPM, MG and 
GO for 6 days (n=3). Corrected total cell fluorescence (CCF) represents 
fluorescence of sperm heads only. GO showed higher CCF than MG and 
SPM showed higher CCF than MG. Error bars represent standard deviation 
of the mean. *p<0.05, **p<0.01. 
Figure 5.12 Corrected Total Cell Fluorescence for CML ICC  
Fluorescence intensity of CML in sperm treated with SPM, MG and GO for 6 
days (n=3). Corrected total cell fluorescence (CCF) represents fluorescence of 
sperm heads only. GO treatment showed significantly higher CML reactivity in 
sperm heads than SPM and MG treatment. Error bars represent standard 
deviation of the mean *p<0.05. 
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5.2.2 Short term glycation of sperm 
5.2.2.1 Glyoxal glycates sperm in 2 hours 
As the level of glycation was extremely high in sperm treated with GO after 6 
days, the same glycation experiment was carried out over a 4 hour time 
period, with CML measurements taken at 2 hour intervals. When comparing 
time points 0, 2 and 4 hours, a two-way ANOVA with Tukey’s test for multiple 
comparisons showed a significant increase in CML levels in GO-treated cells 
from 0 to 2 hours (p<0.0001), 0 to 4 hours (p<0.0001) and 2 to 4 hours 
(p<0.01) (fig. 5.13). However, there was no significant change with either 
SPM or MG across any of the time points (p>0.05). The levels of CML in GO-
treated cells was significantly higher than that of MG- and SPM-treated cells 
at 2 hours (p<0.0001) and 4 hours (p<0.0001). MG treatment was not 
significantly different to SPM treatment at any time (p>0.05). 
When CML values were compared as the percentage difference from the 
initial time point (0 hours), GO treatment showed a 225% increase after 2 
hours which increased to 259% at 4 hours and a 500% increase after 6 days. 
MG treatment showed a non-significant 37% increase after 2 hours and this 
did not change up to 4 hours, and there was a 179% increase in MG levels 




5.2.2.2 Sperm motility is not affected by short term glycation 
To determine whether the increase in glycation seen in sperm is associated 
with a change in sperm motility, the percentage of progressively motile 
sperm was simultaneously measured at each time point when removing cells 
for CML analysis. The results showed no significant difference in sperm 
motility across the 4 hours of incubation with SPM, MG or GO treatments 
(fig. 5.14). 
  
Figure 5.13 Short-term glycation of sperm 
CML levels in sperm treated with SPM, MG and GO for 4 hours (n=3). CML 
was measured as the mean fluorescence intensity (MFI) of flow cytometry 
fluorescein detection. Sperm incubated with GO showed an increase in 
CML at 2 hours (BA) and 4 hours (BB), and this was significantly higher 
than MG and GO at these time points (AA and AB). Error bars represent 




Figure 5.14 Effects of short-term glycation on sperm motility 
Sperm progressive motility during 4 hour glycation with SPM, MG and GO (n=3). 
Two-way ANOVA was performed to identify differences between treatment and 
time. There was no significant difference in progressive motility over 4 hours. 
Error bars represent standard deviation of the mean. 
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5.2.3 Sperm glycation in obese men 
5.2.3.1 Semen parameters are not different between obese and normal 
weight men 
To determine whether there is an elevation in sperm AGEs in obese men, 
CML levels were compared between two groups of obese and normal weight 
men. The mean BMI of the obese group was significantly higher than the 
control group at 34.34±3.88 kg/m2 compared to 23.28±1.31 kg/m2 (p=0.001). 
The semen parameters for both groups are shown in table 5.1. The mean 
sperm concentration, semen volume, % progressive motility and % total 
motility were all lower in the obese group, however this was not significant 
(p>0.05). Similarly, the % immotile cells was higher in the obese group but 
again this was not significant (p>0.05). The mean age for the obese group 
was 48.4 years (±4.88) while the mean age for the control group was 29.2 
years (±5.12) (p=0.0003). Abstinence time was between 2 and 5 days for all 
cases. 
Figure 5.16 CML levels in the sperm of obese and non-obese men  
CML was detected using an anti-CML fluorescent antibody and the Mean 
Fluorescence Intensity (MFI) was recorded by flow cytometry by fluorescein 
detection. There was no significant difference in sperm CML levels between 
obese men (n=5) and normal weight men (n=5). Error bars represent 
standard deviation of the mean.  
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5.2.3.2 CML levels are not elevated in the sperm of obese men 
CML levels were measured in the prepared sperm of obese and control men 
by flow cytometry using the same method as for sperm that underwent in 
vitro glycation. There was no significant different in CML levels between the 
obese and control groups (p=0.344) (fig. 5.16).  
5.2.4 Effects of glycation on sperm hyaluronidase 
Increased AGE production has been associated with male infertility (Mallidis, 
et al 2009). This study has demonstrated that glycation does not affect 
sperm motility. However, as AGEs are important instigators of oxidative 
stress and cell dysfunction in numerous diabetic complications, lifestyle 
exposures and aging, we tested if these compounds would have an effect on 
sperm at a molecular level by perturbing hyaluronidase function. We chose 
to investigate hyaluronan binding capacity of sperm as this is an essential 
process for successful fertilization. To investigate the effects of glycation on 
Table 5.1 Semen parameters of obese and non-obese men  
Means and SD are shown for each semen parameter in the obese 
(n=5) and control (n=5) groups. Independent t-tests for differences 
between the groups were carried out and p-values are shown. 
Semen parameters were not statistically significantly different 
between the groups (p>0.05). 
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hyaluronan binding, the hyaluronan binding assay (HBA) was therefore 
carried out on glycated sperm over 4 hours to determine whether there was a 
change in capacity for sperm to bind to HA. In addition to the cell-based 
assay, we also glycated recombinant hyaluronidase in vitro and used a 
hyaluonidase-substrate gel assay to determine enzymatic activity. Molecular 
cloning was first attempted to generate the recombinant protein, however this 
was unsuccessful. As an alternative, a commercial hyaluronidase enzyme, 
Cumulase™, was used for the in vitro glycation. 
5.2.4.1 Hyaluronan binding capacity is not affected by short term 
glycation 
The HBA assay showed that sperm showed no significant changes in binding 
to HA following incubation with MG or GO (fig. 5.17). Hyaluronan binding did 
not drop below 90% in any of the treatment groups, showing that the 
glycation seen in 4 hours by GO was most likely not affecting the function of 
the cell surface hyaluronidase protein.  
Figure 5.17 Hyaluronan binding assay for glycated sperm  
HA binding of sperm incubated with MG and GO over 4 hours (n=3). 
No difference was seen in hyaluronan binding capacity at 2 or 4 hours. 
Sperm maintained a high level of binding throughout. Error bars 
represent the standard deviation of the mean. 
 191 
 
5.2.4.2 Recombinant SPAM1 is insoluble when expressed in E.coli 
Numerous extraction methods were tested for the purification of cloned 
SPAM1 protein, however it remained insoluble and could be seen in the 
insoluble pellet following each extraction (fig. 5.18 lane 6). The protein was 
successfully expressed in E.coli when the cells were induced (fig. 5.18, 
arrow), however, the protein could not be seen in the supernatants of the 
extraction buffers (wells 3, 4 and 5) whereas a large band was seen in the 
pellet. The SPAM1 transcript product was 58 kDa and the GST tag is 
approximately 26 kDa, making the total weight around 84 kDa, which can be 
seen as the band above the 75 kDa molecular weight mark.
Figure 5.18 Recombinant SPAM1  
SPAM1 was expressed in E.coli and extracted with lysozyme, sodium 
deoxycholate, lysis buffer 1 and 2 and extracted in solubilisation buffers 1 
and 2. Wells represent 1) E.coli cells not induced, 2) E.coli induced with 
0.2 mM IPTG, 3) 1st supernatant, 4) 2nd supernatant, 5) 3rd supernatant, 6) 
cell pellet. All SPAM1 transcript was present in the insoluble protein pellet. 
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5.2.4.3 Hyaluronidase substrate gel assay development 
In order to determine the effect of glycation on hyaluronidase function, a 
substrate gel assay was developed in which a polyacrylamide gel was 
embedded with HA, which was then degraded by the hyaluronidase enzyme 
that was electrophoresed onto the gel. The gel is then stained for 
undegraded HA: the gel stains blue for HA while degraded zones remain 
unstained, resulting in a negative image. A second stain with coomassie blue 
reveals the remaining electrophoresed protein that is left in the gel, 
visualised as a dark band (fig. 5.19). The optimal incubation buffer 
composition and pH for observing hyaluronidase activity in the Cumulase 
enzyme was determined. All tests using sodium acetate buffer showed some 
degradation of HA in the gels (fig. 5.19), however incubation buffers at pH 4 
Figure 5.19 Hyaluronidase substrate gel assay development 
Measurement of Cumulase activity in a substrate gel assay using enzyme 
activation buffer at pH 3 (A), pH 4 (B), pH 6 (C) and pH 7 (D). Two 
concentrations of Cumulase were used: 0.25 mg/ml (well 1) and 0.125 mg/ml 
(well 2). BSA was also tested at 0.25 mg/ml (well 3). White bands represent 
areas of the gel where HA has been degraded due to hyaluronidase activity. A 
higher concentration of Cumulase caused greater degradation of HA in the gel, 
observable as larger and brighter bands, while BSA showed no degradation of 
HA. pH 4 (B) and pH 7 (D) showed the clearest bands in this experiment. 
 193 
 
and pH 7 were the most optimal (fig. 5.19 B and 1D). The Cumulase enzyme 
contains HSA (66.5 kDa) as a cofactor and a control was run for this 
containing BSA (66.5 kDa) at 0.25 mg/ml (fig. 5.19 A-D, well 3). The protein 
bands in the Cumulase wells (1 and 2) showed the same sized protein band 
as the BSA control well. Therefore the protein band visualised most likely 
corresponds to the cofactor, rather than the hyaluronidase. Although the gels 
incubated at pH 7 showed high levels of enzyme reactivity and clear regions 
of HA degradation, they did not stain well for protein (fig. 5.19 D). This is in 
comparison with pH 4 where the protein bands could be seen clearly (fig. 
5.19 B). Different concentrations of Cumulase were used in this assay 
development (0.25 mg/ml and 0.125 mg/ml) and can be identified by the size 
of the dark protein bands (fig 5.18 A and B). 
5.2.4.4 Glycation of Cumulase does not affect enzyme function 
The conditions used for the hyaluronidase substrate gel assay, based on the 
assay development, were incubation in sodium acetate buffer at pH 4 for 16 
hours. Cumulase which had been glycated with glucose, fructose, mannitol, 
MG or GO for 0, 3, 7 or 14 days were electrophoresed onto the gel and their 
HA degradation capacity was observed. The results showed that HA 
degradation by Cumulase, measured by the size of degraded HA sites, was 
not different following incubation with sugars and AGE intermediates (fig. 
5.19). The enzyme retained a similar level of activity at 14 days as at start of 
the experiment. Unlike during the assay development, the protein band 
which was visualised as a dark band, was not present. Instead, a clear band 
appeared in the same position but was absent from the control BSA well. 
This could indicate HA degradation, or alternatively the protein present in the 
gel could be preventing penetration of the dye, however this is unlikely as the 






Figure 5.20 Cumulase activity measured using a hyaluronidase 
substrate gel assay 
Cumulase was incubated with 1) PBS; 2) glucose; 3) fructose; 4) mannitol; 
5) MG and 6) GO over 0, 3, 7 and 14 days (A-D, respectfully) to determine 
the changes that could occur in this enzyme as a result of glycating 
conditions. There was no observable difference in band size between the 
treatment groups (1-6) indicating no change in hyalurondiase activity. BSA 
alone (7) did not cause any HA degradation. Two bands appear around the 





Glycation is the spontaneous non-enzymatic reaction of a carbonyl group of 
a reducing sugar with a protein amine group, which through multiple 
successive reactions forms covalent irreversible AGEs. AGE-modification 
causes damage to biomolecules and modifies their function as well as 
causing cellular stress through the generation of ROS and become elevated 
with age and in disease. As AGEs have been located on sperm cells and in 
the male reproductive tract, this study sought to use an in vitro experimental 
model to show the mechanism by which sperm is glycated by physiological 
compounds. The reactive AGE intermediates, MG and GO are potent 
glycating agents, around 20,000 times more reactive than glucose 
(Thornalley, 1996), and are physiologically elevated in disease states. These 
intermediates were therefore used as an accelerated model for glycation. 
The main findings of this study were that CML, a common and potent AGE, 
was rapidly formed on sperm when incubated with the AGE intermediate GO. 
Glycated sperm experienced higher levels of oxidative DNA damage, 
indicating a role for oxidative stress in AGE-mediated cellular damage.  
Over a 6 day period in culture, CML levels did not increase in sperm 
incubated with glucose compared with SPM alone. This was unsurprising as 
most studies investigating the chemical processes of glucose-mediated 
glycation have shown that this can take from 1 to 4 weeks, often as long as 
the turnover time of the proteins in vivo (Coussons et al., 1997; Kislinger et 
al., 2003). This low reactivity is logical as being the most abundant sugar 
within biological systems, glucose reactivity would cause immense damage 
to biomolecules. Glycation is directly dependent on glucose concentration 
and time (Kislinger et al., 2003) but due to the limited time that sperm can be 
maintained in culture, the concentration of glucose was used at 
concentrations (30 mM and 50 mM) higher than physiological levels (5 mM in 
blood; 1 mM in seminal plasma). However, neither 30 mM nor 50 mM 
glucose had an effect on CML levels. Although this end-stage AGE had not 
been formed, early-stage products of the Maillard reaction such as fructose-
lysine may have been generated. In fertility clinics, sperm are maintained in 
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sperm preparation media for a number of hours. This media is optimised for 
sperm function and contains glucose at approximate levels of less than 0.1% 
(Origio, 2015), which the results of this study suggest would be insufficient 
for glycation-mediated damage to occur to sperm.  
Another reason for the lack of CML formation could be in part due to sperm 
metabolising the glucose in solution, causing the concentration to decrease 
to levels insufficient for glycation. In support of this, the vitality test showed 
that the presence of glucose promoted sperm survival in comparison to SPM, 
MG and GO, and furthermore, sperm progressive motility was maintained at 
a high level following three days of incubation in comparison to other 
compounds. This suggests that sperm are actively utilising the glucose as a 
source for ATP generation through glycolysis as well as using oxidative 
phosphorylation for ATP generation in the mitochondria. Both these 
mechanisms for ATP generation are thought to be relevant to sperm function 
(reviewed in du Plessis et al., 2015). Although replenishment of glucose in 
the media would have increased the rate of glycation, this is likely to have 
been negligible in this time frame.  
Unlike the stable ring carbonyl structure of glucose, fructose exists more 
abundantly in the open-chain aldose form (Bunn and Higgins, 1981) and can 
form AGEs up to 10 times more readily than glucose, resulting in fluorescent 
and cross-linking products (Suárez et al., 1989; Takeuchi et al., 2010). 
However, in this study fructose (10 mM) did not show higher CML levels than 
SPM or glucose when incubated with sperm. Fructose is secreted from the 
seminal vesicles and is another energy source for sperm in the ejaculate to 
drive motility, however sperm only come into contact with seminal plasma 
upon ejaculation, in which case there would be no window of time for 
glycation to occur.  
The AGE intermediates GO, MG and 3-deoxyglucosone (3DG) are reactive 
carbonyl compounds (RCC). They are formed during the Maillard reaction 
but also from the oxidation of AGEs (Thornalley et al., 1999). RCCs rapidly 
form Schiff’s bases with amino acids, hence their greater reactivity than 
glucose, and eventually form imidazolone adducts with molecules. This can 
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cause cytotoxicity to different cell types (Suzuki et al., 2010). This study 
showed that exposing sperm to GO for as little as 2 hours caused a 
significant increase in CML levels compared with SPM and MG. This semi-
quantitative method of analysis showed that CML levels were 225% higher 
after 2 hours, 259% higher after 4 hours and a 500% higher after 6 days in 
culture. Therefore this in vitro model has resulted in extremely rapid glycation 
by this intermediate compound. In vivo concentrations of MG and GO are 
approximately 1-5 µM and 0.1-1 µM intracellularly and 100-120 nM in blood 
plasma (Thornalley et al., 1999). Although the in vitro concentrations used in 
this study were much higher than physiological levels, this was necessary in 
order to illustrate the potential effects of these compounds at a measurable 
level. Furthermore, the concentrations were lower than those used in in vitro 
cell assays elsewhere (Cantero et al., 2007). The major AGE product of MG 
is carboxyethyllysine (CEL), and isomer of CML. This may explain the small 
increase in CML levels in MG-treated sperm as some antibodies against 
these compounds show cross-reactivity (Koito et al., 2004). To further this 
investigation, CEL could be measured to determine the full effects of MG, as 
well measurement of the glyoxal-lysine-dimer (GOLD) and methylglyoxal-
lysine-dimer (MOLD) would reveal whether glycated molecules were 
undergoing cross-linking, one of the damaging features of glycation (Odani et 
al., 1998). 
Immunocytochemical staining of glycated sperm was carried out in order to 
demonstrate the distribution of general AGEs and CML on the sperm cells. 
The staining of AGEs and CML along the entire length of the cell, including 
head, midpiece and tail is in accordance with that staining pattern found by 
Mallidis et al. (2009). The paper also describes high immunoreactivity to 
CML on the head acrosomal cap region in diabetics, compared to non-
diabetics where immunoreactivity was low, and this is similar to the higher 
level of CML staining found here on sperm glycated with GO compared with 
SPM. The use of this in vitro assay may therefore be a good model for 
mimicking the diabetic environment and shows that this region may be 
particularly vulnerable to glycation in diabetic and ageing men.  
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AGEs and AGE intermediates have been found to increase with advancing 
age and in obese individuals (Uribbari et al., 2007; Uribbari et al., 2015) and 
sperm quality has also been shown to be reduced in these groups (Begueria 
et al., 2014; Hammoud et al., 2008). To investigate whether obesity might 
also lead to elevated sperm AGEs, CML was measured in obese men. No 
significant difference was found in CML or semen parameters between the 
groups, despite sperm concentration, motility and volume being lower in the 
obese group. One explanation for there being no difference in CML levels 
may be that prepared sperm was used for the flow cytometry analysis, which 
was separated by density gradient centrifugation before CML measurement. 
This was for the purpose of removing non-sperm cells and debris, however it 
would also have removed non-motile or immature sperm from the samples 
which could be the cells with the highest levels of AGEs. Mallidis et al., 
(2009) located CML throughout the cells of the seminiferous epithelium, and 
particularly in the nuclei of spermatogonia and spermatocytes, while less so 
in the nuclei of mature spermatids. Therefore, the reason for no difference 
being seen in CML between obese and normal weight men may be because 
of the removal of the CML-positive population of immature sperm. The 
finding of no difference in semen parameters between the obese and non-
obese group has been shown elsewhere (Eisenberg et al., 2014), but the low 
numbers of participants used in this small study mean that there is 
insufficient evidence to draw conclusions from. 
RCCs cause rapid changes to proteins: GO and MG have been shown to 
cause rapid generation of CML on proteins such as BSA and lysozyme in 
vitro (Glomb and Monnier et al., 1995; Millar et al., 2002). Therefore the CML 
production seen in the first four hours on sperm is probably occurring on 
structurally available proteins such as receptors on the sperm membrane, 
while later CML generation is occurring as a result of adduct formation on 
intracellular proteins and DNA. Although AGE formation was originally 
thought to only effect stable extracellular proteins, such as collagen, 
research now shows that glycation adducts can quickly occur on intracellular 




Cell-based in vitro glycation assays have previously shown that cell 
receptors such as the platelet derived growth factor receptor are vulnerable 
to glycation (Cantero et al., 2007). Critically, modification of these receptors 
by AGE intermediates can alter their function, as was shown through 
inhibited epidermal growth factor receptor signalling (Portero-Oterin et al., 
2002). Sperm participate in a number of receptor-ligand interactions to which 
glycation could be detrimental, such as for the hyaluronidase activity of 
Spam1, which is responsible for degradation of HA oligosaccharide chains 
found in the cumulus layer of granulosa cells surrounding the oocyte (Evison 
et al., 2009). Additionally, as Spam1 is located on the acrosomal membrane 
where a high level of CML immunoreactivity was observed and as Spam1 
contains a number of lysine and arginine residues, this enzyme could be 
affected by glycation. Therefore, the function of cellular and recombinant 
Spam1 protein was investigated in response to glycation. 
Cellular hyaluronidase activity was analysed using a HA binding assay 
(HBA), in which sperm bind to HA-coated plates, and is often used as a 
measure of sperm quality though not routinely in fertility clinics. Sperm 
binding to HA was not affected following short-term glycation and this may be 
because the CML levels seen at this stage are affecting proteins other than 
Spam1. As the HBA requires motile sperm in order to distinguish between 
sperm that are bound (hyaluronidase active) and unbound (hyaluronidase 
inactive), the experiment could not be carried out at 6 days when sperm 
motility is mostly zero. 
As an alternative, the effects of glycation on recombinant Spam1 were 
investigated for up to 14 days. Other in vitro protein glycation models have 
shown significant effects on protein structure and function in response to 
AGE intermediates, such as with histones (Ashraf et al., 2015) and insulin 
(Jia et al, 2006). A hyaluronidase substrate gel assay was developed to 
measure the changes in hyaluronidase activity and this was successful in the 
first stages. The assay was based on two previous studies (Mio et al., 2001; 
Zhu et al., 1994) and the optimal conditions used for subsequent analysis of 
activity of a commercial hyaluronidase enzyme, Cumulase, were incubation 
of gels in sodium acetate buffer (pH 4) for 16 hours. As the use of 
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recombinant protein allowed the assay duration to be extended, the simple 
reducing sugars glucose and fructose and the non-reducing sugar mannitol 
were investigated alongside MG and GO. No difference was observed in the 
hyaluronidase activity between Cumulase incubated with any of these 
compounds and SPM alone. In addition, the enzyme maintained the same 
level of activity after 14 days as at the beginning of the assay. This therefore 
likely concludes that the CML compounds located on sperm in this study and 
elsewhere (Mallidis et al., 2009) were not affecting the membrane-bound 
Spam1 protein. 
Sabeur et al. (1997) previously reported two versions of Spam1. The first 64 
kDa protein is GPI-anchored to the sperm plasma membrane and has a role 
in initial degradation of HA in the cumulus layer surrounding the oocyte and 
is functional at neutral pH (Lin et al., 1994). Following binding to the ZP, the 
acrosome reaction is initiated and a soluble cleaved version of Spam1 is 
released which has acidic function and is responsible for further HA 
degradation following ZP binding. In this assay, the full length Spam1 (64 
kDa) was observed to have activity at both pH 7 and pH 4. In the Cumulase 
assay, the protein bands which revealed the HSA cofactor and BSA were not 
observed. Instead, a white band appeared in the test wells below the 
degraded HA.  
In this study oxidative DNA damage, measured by the levels of oxidised 
guanine nucleotide (8-oxoguanine), was elevated in samples which showed 
higher CML levels. Oxidative damage is caused when ROS become 
extremely elevated and/or when the antioxidant capacity of cells is unable to 
protect against ROS. AGE-related ROS generation can happen in a number 
of ways. Firstly, AGE intermediates can cause ROS generation during the 
glycation process as well as independently of AGE formation (Amicarelli et 
al., 2003). Therefore the process of CML formation seen here is likely to be 
triggering ROS formation, such as has been demonstrated in endothelial 
cells, and which is inhibited in the presence of radical-scavenging 
antioxidants (Liu et al., 2013). Secondly, another major source of ROS is 
from AGEs binding to their receptor, RAGE, on the cell membrane. This 
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activates NFκB-induced expression of pro-inflammatory genes and also of 
RAGE, leading to a sustained inflammatory response. AGE-RAGE binding is 
important in AGE pathology in various tissues but RAGE has also been 
located on the sperm membrane and its expression positively correlates with 
DNA damage (Mallidis et al., 2007; Karimi et al., 2012). Importantly, both of 
these parameters are elevated in the sperm of diabetic men (Karimi et al., 
2012). Although mature sperm are transcriptionally quiescent, which may 
suggest a limited capacity for NFκB cell signalling, immature sperm still have 
active gene expression and would be vulnerable to ROS generation through 
this pathway. This is in accordance with the results from Karimi et al. (2012) 
who found that RAGE expression was more prominent in the immature cells 
of the seminiferous epithelium. Furthermore, although almost no human 
studies have investigated NFkB in sperm, a mouse study has shown that 
NFkB is activated in stage-specific manner in spermatogenesis. 
Despite there being changes in the level of oxidative DNA damage, ROS 
levels were not different between sperm incubated with different compounds. 
This may be due to the fact that sperm had been incubated for an extensive 
period of time, in which case ROS generation would be at a maximum across 
all samples as cell death began to occur. Furthermore, as the sperm were 
separated from the seminal plasma, which is the source of antioxidants and 
radical scavenging enzymes important for fertility (Lewis et al., 1997; 
Khosravi et al., 2014), protection again ROS would be low, allowing levels to 
accumulate. Finally, the lack of difference in ROS levels might be explained 
by the fact that ROS are unstable, so the sensitivity of the assay may 
insufficient for determining differences between these cells. 
Sperm are particularly susceptible to DNA damage as they lack the repair 
mechanisms usually present in cells. Furthermore, the glyoxalase pathway, 
which detoxifies AGE intermediates through the action of Glyoxalase 1 (Xue 
et al., 2011), has not been identified in sperm. This makes sperm particularly 
vulnerable to DNA damage which occurs primarily due to oxidative stress in 
these cells (Aitken et al., 2010). The implications of such damage for sperm 
in vivo are reduced cell function, ultimately leading to poorer fertilisation 
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capacity. In accordance with this, 8-oxoguanine levels have been linked to 
lower pregnancy rates independent of semen quality (Loft et al., 2003; 
Mulholland et al., 2011). This supports the results here which did not see a 
significant change in the motility of sperm treated with GO where oxidative 
damage was highest. Oxidative DNA damage can occur in normal sperm as 
well as in abnormal sperm, and as ART treatment does not involve the 
analysis of DNA damage, this may have consequences for embryonic 
development and offspring health (Zhang et al., 2008; Erenpreiss et al., 
2008; Oleszczuk et al., 2013).  
5.3.1 Conclusion 
AGEs have important roles in the pathologies of ageing and disease. This 
study found that AGEs are formed on human sperm when exposed to 
reactive AGE intermediates in vitro and leads to oxidative DNA damage in 
these cells. As high levels of AGE and RAGE are found in the seminiferous 
epithelium (Mallidis et al., 2009; Karimi et al., 2012), it is possible that sperm 
are exposed to AGE modification and AGE-RAGE signalling during 
spermatogenesis. This could present a risk to older men or diabetics where 
intermediates and AGEs are elevated. The consequences of this for sperm 
function may not manifest as a change to standard semen parameters as 
this study found no inhibition of sperm motility in response to glycation, 
however evidence from other studies suggests that glycation-mediated 
oxidative damage could impair fertility (Oleszczuk et al., 2013). Finally, 
although in vitro glycation elicited no change to cellular or recombinant 
sperm hyaluronidase function, the high levels of AGEs found on the sperm 









Elucidating the effects of lifestyle and environmental factors on fertility has 
become a major research question in recent years in light of the changing 
lifestyle habits that have profoundly transformed developed and developing 
countries (Popkin et al., 2006). Some of the consequences resulting from 
these changes include the obesity and diabetes epidemics, exposure to 
environmental toxicants and an ageing population. These changes have 
paralleled the publication of numerous reports describing a decrease in 
semen quality in various populations of men, and the role of lifestyle and 
environment in this therefore requires investigation (Carlsen et al., 1992; 
Auger et al., 1995; Rolland et al., 2013; Romero-Otero et al., 2015; Centola 
et al., 2016). Furthermore, lifestyle-induced changes to sperm quality may 
occur beyond the parameters observed by standard semen analysis, 
resulting in deregulate DNA methylation and increased oxidative DNA 
damage.  
This study, which investigated semen quality and DNA methylation in men 
attending a fertility clinic, found that the BMI was negatively associated with 
sperm concentration, while alcohol consumption and having an unhealthy 
diet were positively associated with sperm concentration and sperm motility, 
respectively. Furthermore, wearing boxer shorts was negatively correlated 
with % immotile sperm. Exposure to glues, adhesives and resins was 
correlated with an increase in global methylation while ex-smokers showed a 
higher level of SNPRN methylation than non-smokers. Global DNA 
methylation was negatively correlated with fertilisation rates in IVF patients 
while BMI was negatively correlated with fertilisation rates in ICSI patients. 
Overall, concentration and % progressive motility were associated with 
higher fertilisation rates in ICSI patients and % progressive motility was 
associated with higher cleavage rates in IVF patients. An investigation into 
the effects of glycation on sperm as a model for diabetes and obesity 
showed that CML is formed on sperm incubated with AGE intermediates in 
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as little as two hours and this was linked to an increase in oxidative DNA 
damage. However, sperm parameters and levels of sperm-CML were not 
different between obese and normal weight men in this study.  
A number of studies have investigated the complex relationship between 
lifestyle, DNA methylation, sperm parameters and ART outcomes with 
varying results. This study showed that increased global DNA methylation 
was present in men exposed to glues, adhesives or resins, and this also 
positively correlated with % immotile sperm and negatively correlated with 
fertilisation rates in IVF patients. Many epoxy resins, as well as widespread 
everyday-use polymers, contain the endocrine disruptor Bisphenol A (BPA). 
High levels of urinary BPA have been associated with decreased semen 
parameters in exposed factory workers compared to non-exposed factory 
workers in China (Li et al., 2011), and therefore the components of these 
glues, adhesives and resins could be a reason for the abnormal methylation 
seen in the men in this study. In terms of the effects of EDCs on sperm 
methylation, BPA exposure has previously been linked to a decrease in 
global methylation in sperm, measured using LINE-1 methylation as a proxy 
(Miao et al., 2011), however this is the opposite trend to that seen in this 
study. Indeed, our results contradict many existing studies which report a 
decrease in global methylation in response to environmental stress, i.e. 
exposures, which is often associated with an increase in DNA damage 
(Montjean et al., 2015; Tunc and Tremellen, 2009). Of particular relevance, 
Meeker et al. (2010) found higher levels of DNA damage in the sperm of men 
exposed to BPA. The mechanism behind this is that the relaxing of chromatin 
in response to demethylation makes DNA vulnerable to oxidative attack, 
causing DNA damage. Furthermore, as one of the major roles of methylation 
is in the suppression of transposable elements to prevent their movement 
about the DNA strand, a decrease in global methylation could deregulate this 
and contribute further to genomic instability. Studies have shown that this 
genomic instability is associated with demethylation and can have negative 
implications for fertilisation rate, in contrast to that presented in this study, 
which found a decrease in fertilisation rates with increasing global 
methylation in IVF patients. Despite this logical mechanism for the effects of 
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global hypomethylation, other groups have shown that exposure to certain 
hazards, such as ionizing radiation, can increase global methylation, 
concurrent to the findings of this study (Kumar et al., 2013).  
The world is currently in the midst of an obesity epidemic, with around 13% 
of the world’s population being obese (World Health Organization, 2015). 
Obesity gives rise to numerous comorbidities of which male infertility is 
thought to be one. In this study, few lifestyle factors were associated with 
sperm parameters and ART outcomes, however BMI was strongly negatively 
correlated with sperm concentration and fertilisation rates in ICSI patients. 
The link between obesity and low sperm quality has been reported 
elsewhere (Sermondade et al., 2013), although MacDonald et al. (2013) 
found no such association. Mouse studies have been conclusive of findings 
in support of these associations (Bakos et al., 2011). One of the 
consequences of obesity for sperm is thought to be the disruption of DNA 
methylation and therefore gene expression, leading to cellular dysfunction. 
This was illustrated in a recent human study which showed that men who 
underwent rapid weight loss following bariatric surgery showed completely 
remodelled sperm methylome (Donkin et al., 2016). However, the study did 
not find significant differences in methylation of any of the imprinted genes 
with BMI, which is in accordance with the findings here, rather the effected 
genes were already known to be implicated in the severe onset of obesity. 
Alternatively to methylation, obesity could be having an effect on sperm by 
causing DNA damage. Our in vitro glycation assay presented a potential 
model for investigating obesity-related risks to sperm, namely exposure to 
reactive AGE intermediates and AGE compounds themselves, which are 
elevated under hyperglycaemic conditions, a metabolic characteristic of 
obesity. The major causes of DNA damage in sperm are oxidative stress and 
poor chromatin compaction (De luliis et al., 2009) and the glycation model 
showed that CML formation was accompanied by an increase in oxidative 
DNA damage. This is in accordance with other studies that have found 
higher levels of DNA damage in the sperm of obese men (Dupont et al., 
2013) and with our sister study which used a similar population of men at the 
same fertility clinic and found a non-significant increase in DNA damage in 
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the obese group (Altakroni, 2015). In the present study, BMI was also found 
to be negatively correlated with fertilisation rates in ICSI patients, during 
which treatment sperm bypass the normal sperm selection processes, 
suggesting that oxidative DNA damage could be a mechanism behind this 
failed fertilisation. In support of this idea, DNA damage has been shown to 
be negatively associated with ART outcomes in a small number of human 
studies, and is thought to be more relevant following ICSI treatment (Simon 
et al., 2011; Simon et al., 2013; Jin et al., 2015; Loft et al., 2003; Zini et al., 
2011).  
As AGEs have such widespread damaging effects on various tissue types 
(Goldin et al., 2006), it is likely that they might also influence reproductive 
function. AGEs are primarily a function of age and hyperglycaemia, and 
therefore pose a significant risk to the health of the world’s ageing population 
in which the prevalence of high-sugar diets is negatively affecting global 
health trends (Siervo et al., 2014). Additionally, as delaying childbearing has 
become a common life choice for couples, the risks of AGE-accumulation on 
fertility may be greater in these cases. In the light of the claims of decreasing 
semen quality, AGEs are a possible contributing factor to these trends. 
Although numerous mouse models have been used for glycation, only one to 
date has investigated the effects on male reproduction (O’Neill et al., 2010). 
However, this study simply supported existing human studies which show the 
localisation of CML on sperm and in the reproductive tract (Mallidis et al., 
2009; Karimi et al., 2011), but did not investigate the effects on fertilisation 
capacity or pregnancy outcomes. In women undergoing ART, studies have 
shown that AGE accumulation is associated with reduced oocyte quality, 
lower fertilisation rates and poor embryonic development (Jinno et al., 2011) 
and is thought to be one of the causes of ovarian ageing (Stensen et al., 
2013). The presence of AGEs on sperm, particularly DNA adducts, may 
therefore also have an effect on the embryo. Although this study did not 
identify on which biomolecules AGE-adducts were forming, as there was a 
high level of oxidative DNA damage, it is likely that there would also have 
been DNA adduct formation and intermediate-adducts which have been 
described in vitro (Frischmann et al., 2005). What is more, as DNA adducts 
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have been found to be elevated in sperm of infertile men, this therefore 
warrants further investigation (Horak et al., 2003; Gaspari et al., 2003).  
One of the major findings of this study was that prepared sperm and neat 
semen show distinct methylation patterns, with prepared sperm showing 
significantly higher methylation levels across all genes as well as for global 
methylation. Preparation of sperm for ART involves the removal of non-
sperm cells, debris and immotile and immature sperm, and results in a 
purified population of high quality sperm. Considering the implications 
discussed with regards to the instability of the genome in a hypomethylated 
state, these findings fit with the idea that these prepared sperm which exhibit 
good general sperm characteristics (i.e. mature and motile) also contain 
quality DNA. This is in accordance with our sister study that found DNA 
fragmentation was lower, and therefore genomic integrity higher, in prepared 
sperm than neat semen (Altakroni, 2015). However, there is a disparity here 
against our other finding that global methylation was positively correlated 
with % immotile sperm as these cells are removed during the preparation 
process. There were not sufficient prepared sperm samples with DNA 
methylation analysis to determine whether methylation of these cells used for 
ART were associated with the outcomes. Laurentino et al. (2014) found that 
sperm exhibit methylation mosaicism where discrete populations of sperm 
from infertile men show abnormal methylation, in comparison to fertile men 
who show a generally homogeneous methylation pattern in cells of a single 
sample. Therefore, density gradient centrifugation of samples is likely to 
result in the isolation of sperm with a distinct methylation profile from the neat 
sample, which limits the validity of using neat semen analysis when 
considering ART outcomes, although these analyses are still insightful. 
One of the main aims of this study was to determine the effects of lifestyle 
and environmental factors on imprinted gene methylation, as these factors 
are the target of much of the research on the sperm methylome. The reason 
for such attention is due to the crucial role of these genes in embryonic 
parent-of-origin gene expression. As these genes avoid the first round of 
epigenetic reprogramming that occurs following fertilisation (Reik et al., 
2001), it is hypothesised that aberrant methylation marks harboured from the 
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parental gametes could affect embryonic development and consequently 
offspring health. The epigenome is responsive to environmental cues which 
confers the ability of cells to respond to their environment, and which also 
makes cells vulnerable to damage. In sperm, DNA methylation has been 
shown to be affected by age, obesity, smoking and other environmental 
toxicants (Jenkins et al., 2014; Ding et al., 2015; Xu et al., 2013; Miao et al., 
2014).  In this study, imprinted genes that showed variation with lifestyle and 
environment were SNRPN and H19. These genes showed elevated 
methylation levels in men who were ex-smokers and men who were exposed 
to glues, adhesives and resins, respectively, despite not being significant 
following multivariate analysis, and this has not been shown elsewhere. 
Another reason for the particular interest in imprinted genes is that 
aberrations are associated with poor sperm quality. Several studies have 
described aberrant imprinted gene methylation in the sperm of infertile men 
(Hammoud et al., 2010; Houshdaran et al., 2007; Marques et al., 2008; 
Poplinski et al., 2009), however imprinted gene changes do not always 
manifest in changes to semen parameters. In accordance with this, our study 
found that only MEG3 was negatively correlated with sperm progressive 
motility, while H19, SNRPN and PLAGL1 were not associated with semen 
parameters. The fact that changes in DNA methylation may not always be 
reflected in a change in semen parameters is important as sperm DNA 
quality is not assessed before ART. There is a growing amount of evidence 
arguing for routine DNA damage testing, which can be carried out using 
various assays such as Terminal Deoxynucleotidyl Transferase-mediated 
Nick End Labeling (TUNEL) (Sun et al., 1997), Single Cell Gel 
Electrophoresis (COMET) assay (Ribas-Maynou et al., 2012) or the Sperm 
Chromatin Structure Assay (SCSA) (Bungum et al., 2011), however markers 
that definitively indicate adverse sperm DNA methylation have not yet been 
identified, and therefore do not warrant routine clinical use. 
One candidate gene for the determination of sperm quality is DAZL. The 
present study found that DAZL methylation was consistently highly 
negatively correlated with sperm concentration and was a characteristic of all 
oligozoospermic men, which is supported in other studies (Navarro-Costa et 
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al., 2010; Li et al., 2013). DAZL expression is controlled by methylation at its 
promoter and is essential for spermatogenesis and spermiogenesis; if the 
causes behind deregulated DAZL methylation and gene silencing were 
identified, this could be an important therapeutic target. The lifestyle and 
environmental exposures investigated here did not show any associations 
with differential DAZL methylation, although exposure to metal dust and 
fumes was almost significantly associated with an increase in methylation. 
No human studies have investigated the effects of environmental exposures 
on DAZL expression, however, one mouse study found that low dose 
exposure to an endocrine-disrupting pesticide, methoxychlor, downregulated 
expression of DAZL among other spermatogenic genes resulting in 
disruption of sperm differentiation (Du et al., 2014). Given the importance of 
DAZL expression during germ cell development, in which it inhibits 
pluripotency in PGCs and prevents differentiation to somatic cell lineages 
while inducing apoptosis if this does occur (Chen et al., 2014), environmental 
modifications during the PGC development period would negatively affect 
adult male offsprings’ fertility. In this study DAZL methylation was not related 
to IVF or ICSI outcomes. Therefore, although this gene has critical roles for 
spermatogenesis, it may have less significance for the developing embryo. In 
accordance with this, maternal-derived DAZL has been shown to be 
important during embryogenesis at the 2-cell stage while the contribution of 
paternal DAZL has not yet been determined (Cauffman et al., 2005). Overall, 
this work suggests that defining which lifestyle and environmental factors 
affect DAZL could provide an important target for interventions to improve 
male fertility, but to our knowledge, the use of sperm with aberrant DAZL 
methylation in IVF and ICSI treatment is not a risk for embryonic 
development. 
Overall, DNA methylation tended to show an increase when men were 
exposed to factors considered to be damaging and in men with abnormal 
sperm, and this was in both imprinted and non-imprinted genes. For 
example, DAZL methylation was elevated in men with low sperm 
concentration and MEG3 methylation was higher in men with lower % 
progressive motility. In combination with the global methylation results which 
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were elevated in response to environmental exposures and in men with high 
% immotile sperm, this implies that generally an increase in methylation is 
associated with negative outcomes. It is logical to suspect that the source of 
this hypermethylation is aberrant de novo methylation occurring during 
sperm development at various life stages, potentially caused by improper 
DNMT activation. DNMTs are activated during PGC development to 
establish new gender-specific imprints following the global demethylation that 
occurs in PGCs (Kaneda et al., 2004), but their overexpression causes gene 
silencing and has been implicated in a number of cancers and in aberrant 
imprinting (Robertson et al., 1999; Biniszkiewicz et al., 2002). In fact, a 
recent study did investigate the correlation between DNMT expression and 
global methylation, and not only did they find a similar trend to that of this 
study in that global methylation was elevated in the sperm of men with 
impaired spermatogenesis, but this also correlated with an increase in 
DNMT1 and DNMT3a expression (Jaiswal et al., 2013).  
Another candidate gene for deregulated methylation is MTHFR. The 
transcript of this gene, mthfr, is essential for the generation of methyl donors 
for methylation by DNMTs and therefore its disruption could affect the 
methylation of other genes. Indeed, aberrant MTHFR methylation has been 
implicated in infertility (Botezatu et al., 2014) and hypermethylation of its 
promoter has been linked to hypomethylation of H19 previously (Rotondo et 
al., 2013), which therefore warrants further investigation. An alternative 
explanation for the higher levels of methylation described here is that there 
has been improper erasure of methylation during the second wave of 
developmental reprogramming in PGCs (Mayer et al., 2000), as opposed to 
de novo methylation, in which case these aberrant methylation marks would 
have occurred in utero during PGC development. This would indicate that in 
effect it is maternal lifestyle factors and environmental exposures that are the 
cause of aberrant sperm methylation in adult men, rather than these being 
acquired paternal epimutations. Animal models have been crucial for 
exploring these scenarios, and in utero exposure experiments have 
illustrated the importance of the vulnerable time of PGC formation for adult 
sperm quality (Sobinoff et al., 2014). This has been supported in a small 
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number of human studies in which subfertility has been linked to parental 
exposures (Axelsson et al., 2013; Cirillo et al., 2011).  
These data lead on to the question of whether these epigenetic abnormalities 
have the potential to be inherited transgenerationally, and forming the crux of 
these investigations. Longitudinal health studies have suggested that the 
paternal germline can harbour both beneficial and harmful marks that are 
influence the health of future generations (Bygren et al., 2001; Northstone et 
al., 2014). This is supported by mouse studies which highlight an important 
role for male exposures on offspring health, for example in the nutritional 
availability of fathers on the metabolism of offspring (Anderson et al., 2006; 
Binder et al., 2012; Fullston et al., 2013; Jiminez-Chillaron et al., 2009), and 
in relation to other factors such as stress (Mychasiuk et al., 2013) and toxins 
exposure (Mao et al., 2015). Some studies have found that aberrant 
methylation is involved in this (Soubry et al., 2015; Kobayashi et al., 2009). In 
this study, the first indication of whether epimutations could be heritable was 
in looking at the effects of ART outcomes. Although our study showed that 
global DNA methylation was elevated in the sperm of men with lower 
fertilisation rates, we did not see an association with pregnancy outcomes 
which would suggest that sufficiently accurate epigenetic reprogramming had 
occurred during development, and which would have erased aberrant 
paternal methylation patterns. This robust reprogramming has been 
illustrated in animal studies in which epigenetic aberrations caused by 
parental exposures are prevented in the embryo and offspring (Iqbal et al., 
2015; Hesson et al., 2015).  
6.1 Conclusion 
In conclusion, while the data presented in this study does not show a 
causative relationship between lifestyle and environment and changes to 
sperm parameters, DNA methylation or ART outcomes, some of the variation 
within the study population may be explained by this. It seems that small 
changes to lifestyle and environment may not drastically improve semen 
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parameters or the success rates of those using ART, however, 
improvements to DNA methylation and reduction in oxidative DNA damage 
may be achievable. This is critical in the advent of increasing use of ART 
treatment, where DNA integrity is not currently considered for analysis. As 
some studies have reported an increase in imprinting disorders in children 
born through ART (Lazaraviciute et al., 2014), and as DNA modifications 
may be heritable through the paternal germ line (Laubenthal et al., 2012), it 
is important that possible improvements via lifestyle and environment are 
made known.  
6.2 Future work 
1. To further investigate MTHFR and DNMT methylation and transcript levels 
in human sperm. These are functionally important genes for the methylation 
process, and this may shed light on the mechanisms behind changes in DNA 
methylation and particularly the overall increase in methylation seen here. 
2. To investigate the correlations between DNA methylation and DNA 
damage to determine whether these processes are linked, leading to a 
collective effect on genomic integrity. To determine whether the combination 
of both methylation defects and DNA damage could confer a more severe 
infertile phenotype and poorer ART outcomes. 
3. Use an aged, obese or diabetic mouse model to determine the effects of 
glycation and AGE accumulation on sperm function and on fertilisation 
capacity of mouse oocytes and embryonic development. In humans, to 
determine whether sperm AGEs are correlated with serum AGEs and to 
define the protein, lipid and DNA adducts forming on sperm other than CML.  
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6.3 Study limitations 
This study used bisulphite pyrosequencing to analyse CpG site methylation 
which is considered to be a robust and precise method for measuring DNA 
methylation. However, the fragment length for sequencing was limited to 50 
bp, since we found that longer sequences with dense CpG sites or 
sequences with a high number of cytosines and thymines resulted in poorer 
reads. This limit on the number of CpG sites that could be analysed meant 
that potentially relevant sites could have been missed. The CpG site-specific 
analysis carried out in this study showed that most of the CpG sites within 
each region had the same kind of variation, i.e. positively correlated with the 
mean methylation across the region, except for MEG3 which had one 
differential site and NR3C1 in which the 5th CpG site was less strongly 
correlated with the mean. However, some studies do show that certain CpG 
sites are more relevant than others. 
Participants were recruited for this study from a fertility clinic. A major 
limitation of this is that semen quality is likely to be lower than that of the 
general population, even considering that many couples will present to the 
clinic with female-factor infertility, therefore significant lifestyle and 
environmental effects will only be specific for this subpopulation. This is the 
main issue with all studies involving subfertile men. Furthermore, within men 
undergoing ART, there may be a difference between men who chose to 
participate in the research study and those who did not. Our sister study 
which analysed the same cohort of men that were included in our 
methylation analysis (chapter 3), but not for the questionnaire (chapter 4), 
found that sperm concentration and % progressive motility were higher in the 
research group compared to the group which underwent ART treatment but 
did not participate. Fertilisation rate was also higher in the research group, 
while pregnancy rate was higher in the non-participant group. Finally, in 
terms of men who decided to complete the questionnaire, semen parameters 
and clinical outcomes were not significantly different from men who did not 
complete the questionnaire (Altakroni, 2015). 
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The questionnaire format used in this study is one used widely for collecting 
public health data. However, self-reported data can often be under or over-
stated. Upon consultation at the hospital, men were advised to improve their 
diet and to stop smoking. Therefore, many participants may not declare 
certain information on the questionnaire for fear of repercussions. 
Furthermore, those who participated in the questionnaire may have been 
aware of their semen quality. Additionally, the questionnaire did not include 
any information on the female partner’s lifestyle habits, so the ART results 
were compromised to an extent, since maternal factors could not be 
controlled for. These may have included BMI, previous smoking, lifestyle 
exposures and oocyte quality. 
There are some limitations with regard to the in vitro glycation study. These 
include that exposure of sperm to AGE intermediates may not be 
physiologically relevant as these compounds have not been identified in the 
male reproductive tract. Furthermore, the concentrations used were higher 
than normal physiological levels. However, all in vitro studies must consider 
these limitations in that they cannot truly represent in vivo scenario. Finally, 
all in vitro studies on mature sperm have the same drawback which is that 
these cells are physiologically distinct from pre-ejaculate sperm and have a 
limited lifespan post-ejaculate. However, as a model to determine whether 
these cells may be vulnerable to damage by certain compounds, this is a 




























































































Figure 1. Frequency distribution histograms and Q-Q plots for 
untransformed and transformed semen parameters.  
Sperm concentration and total sperm count were positively skewed (A and E) 
and did not show the expected linear trend (B and F). Log10 transformation 
made sperm concentration normal (C and D) while sperm count still showed 
some skewness (G and H). % Progressive motility and % immotile cells 
showed a normal bell-shaped Gaussian curve (I and K) and fitted the expected 
normal distribution (J and L), therefore did not require transformation. 
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Appendix 12: Methylation Data Transformations 
Figure 1  
Histograms showing the normal distributions of raw data for global DNA 
methylation (A) (n=64) and the 6th CTCF binding site of H19 (B) (n=91). Two 
outliers were excluded from the global methylation dataset (686 µM and 719 µM) 
as these caused a skew in the data. Once removed the Shapiro-Wilk statistic was 
0.968 (p=0.098). No outliers were excluded from H19/CTCF6 and the Shapiro-Wilk 
statistic was 0.985 (p=0.406). 
Figure 2  
Transformation of DAZL methylation data to a normal distribution using a 
reciprocal transformation. One extreme lower outlier (0.42%) was excluded from 
the analysis. Shapiro-Wilk value after transformation was 0.979 (p=0.283) 








Histograms illustrating the distribution of the MEG3 gene before (A) and after 
(B) reflection and log10 transformation.  
Figure 3  
Histograms showing original (A) and log10 transformed (B) hNR3C1 data. The 
original data was slightly positively skewed (Shapiro-Wilk 0.95, p=0.006) while 
the transformed data showed a distribution closer to a Gaussian curve 
(Shapiro-Wilk 0.98, p=0.286). 
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Appendix 13: Data Tables 
 
  
Table 1 Sperm DNA methylation and semen parameters  
Pearson’s correlation, r, and significance (p) values are shown. 
Table 2 Sperm DNA methylation and semen parameters in men with 
normal sperm 




Table 3 DNA methylation in fertile and infertile men 
Independent t-test significance (p-values) are shown along with the number of 
participants in each group. ***p<0.001. 
Table 4 DNA methylation in oligozoospermic men and men with normal 
sperm  
Independent t-test significance (p-values) are shown along with the number of 
participants in each group. Levene’s test was used to confirm homogeneity of 
variance between normal and oligo groups. If Levene’s test was not significant (
a
) 
then results were taken from t-tests assuming equal variance, while if Levene’s 
test was significant (
b





Significant associations were identified using Pearson’s correlation between 
fertilisation and cleavage rates and DNA methylation (
a
), and Mann-Whitney U test 
for DNA methylation in sperm of pregnant and not pregnant couples (
b
) Tests were 
run for IVF and ICSI patients separately. Significant correlations are shown in bold. 
*p<0.05. 
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